,index,key,score,total_mentions
0,2210,alone combination,106.55789473684283,191.0
1,3303,ligament acl,46.666666666666494,224.0
2,1940,disease characterized,39.25925925925925,212.0
3,2795,tomography used,38.26666666666693,164.0
4,2496,tested whether,37.592592592592446,203.0
5,2164,patients male,35.14626865671653,406.0
6,3755,breast imaging,33.81104294478545,332.0
7,3580,patients suspected,33.29126213592201,762.0
8,100,widely available,31.909090909090455,135.0
9,2194,acoustic radiation,31.048780487804812,201.0
10,1674,mitral regurgitation,30.793911007025812,487.0
11,285,body surface,30.500000000000192,305.0
12,1784,investigate potential,29.190909090908985,169.0
13,1820,much higher,27.63529411764672,243.0
14,332,vessel disease,26.87445887445887,320.0
15,1851,recurrence rate,26.39999999999986,231.0
16,918,patients women,25.24285714285718,279.0
17,3192,aortic regurgitation,23.629239766081874,227.0
18,1655,ventricular hypertrophy,23.588679245282922,266.0
19,1107,patients ra,23.41935483870965,220.0
20,170,amino acid,21.410367170626234,431.0
21,1518,prospective observational,20.89122807017533,458.0
22,2810,radiation force,20.211320754716905,206.0
23,399,records patients,18.899999999999853,378.0
24,188,investigated effects,18.600000000000023,217.0
25,975,angiography performed,18.16410256410237,154.0
26,2165,unknown whether,17.344444444444413,223.0
27,1506,frontal cortex,15.441328413284053,427.0
28,2395,revealed presence,14.666666666666673,220.0
29,2330,plays crucial,14.599999999999907,146.0
30,870,right atrium,14.464285714285758,225.0
31,3288,cell viability,14.450162866449645,541.0
32,1367,patients experienced,13.887627365356641,536.0
33,2880,endovascular treatment,13.458306188925068,523.0
34,2463,staphylococcus aureus,13.33750000000007,388.0
35,35,even though,13.28985507246382,393.0
36,1577,anterior posterior,13.160574948665309,654.0
37,301,patients multiple,13.159259259259224,323.0
38,856,transthoracic echocardiography,13.144010767160196,514.0
39,830,data regarding,13.128089887640396,254.0
40,866,real data,12.365517241379274,163.0
41,641,inversely associated,12.333333333333279,185.0
42,1228,left ventricular,12.077654859015965,4516.0
43,226,groups however,12.055555555555529,217.0
44,3430,patients including,11.967741935483971,318.0
45,1899,long term,11.96610169491522,353.0
46,2882,epithelial cell,11.739130434782576,150.0
47,339,spearman rank,11.676422764227592,167.0
48,568,chronic liver,11.651162790697601,167.0
49,3503,default mode,11.63654485049832,633.0
50,2822,used detect,11.096774193548354,344.0
51,1743,found groups,10.977272727272673,161.0
52,2351,suspected coronary,10.870588235294122,132.0
53,2532,cataract surgery,10.709762532981529,205.0
54,2073,energy dispersive,10.645161290322573,275.0
55,1250,still unknown,10.579591836734684,162.0
56,1334,validated using,10.547368421052653,167.0
57,1002,cell death,10.50310077519373,797.0
58,2385,associated greater,10.415709969788567,442.0
59,1619,coronary arteries,10.177730192719533,679.0
60,1457,examination performed,10.096969696969737,196.0
61,3717,treatment patients,9.983668005354707,761.0
62,2202,previously published,9.741891891891918,267.0
63,3692,outpatient clinic,9.697674418604706,139.0
64,193,proximal femur,9.635971223021599,181.0
65,1813,cerebral arteries,9.611111111111072,173.0
66,2000,patients demonstrated,9.591836734693915,282.0
67,2949,previously shown,9.490909090909003,174.0
68,142,older patients,9.481481481481449,256.0
69,1767,conducted using,9.327272727272684,261.0
70,2705,thickness patients,9.225000000000058,123.0
71,2989,eight patients,9.094594594594568,673.0
72,2303,range months,8.73196159122089,872.0
73,2773,results present,8.723287671232876,199.0
74,2381,de novo,8.711111111111052,392.0
75,34,evaluated using,8.660869565217125,1328.0
76,1636,effective doses,8.642857142857192,121.0
77,2224,lung cancer,8.57522548236098,2304.0
78,1560,older adults,8.535143582730978,899.0
79,1330,resonance energy,8.46445497630336,190.0
80,3678,pd patients,8.375809935205284,554.0
81,964,new bone,8.375103734439818,348.0
82,124,coronary interventions,8.33333333333331,125.0
83,3726,survival pfs,8.321428571428521,233.0
84,801,observed patients,8.15484414490319,949.0
85,2402,assess association,8.136690647482041,195.0
86,186,receiver operating,8.125011937732854,2055.0
87,1578,aortic arch,7.997430013767777,636.0
88,1133,sons ltd,7.991558038485404,532.0
89,1429,admitted hospital,7.91020408163262,342.0
90,2818,five patients,7.697247706422016,839.0
91,2410,supine position,7.674390243902445,217.0
92,1047,left right,7.6551467855815405,1000.0
93,766,sought determine,7.56657963446478,414.0
94,464,showed mean,7.551181102362178,137.0
95,2567,technical success,7.49712159780691,801.0
96,3261,benign malignant,7.437796208530824,775.0
97,1212,imaging studies,7.285279187817288,1196.0
98,1090,secondary outcomes,7.27740805604204,263.0
99,991,specific brain,7.248062015503875,187.0
100,305,acuity bcva,7.245901639344307,260.0
101,2086,cortical surface,7.148654244306421,208.0
102,2478,malignant lesions,7.144554455445531,328.0
103,1776,patients died,7.110944527736119,527.0
104,2599,mice treated,7.079302832244006,211.0
105,2290,used identify,7.064183381088829,587.0
106,2973,bone density,6.88525214081825,458.0
107,707,brain abnormalities,6.858992805755401,227.0
108,2787,normal subjects,6.732954545454557,237.0
109,37,added value,6.72515337423316,203.0
110,1164,using data,6.641379310344871,321.0
111,1563,tomography angiography,6.600828157349886,839.0
112,1463,world health,6.599999999999976,198.0
113,2963,four different,6.589081225033282,278.0
114,2800,subjects underwent,6.575206611570248,442.0
115,3636,parietal cortex,6.559239130434822,447.0
116,2812,cardiopulmonary bypass,6.531722054380684,230.0
117,3347,disorder mdd,6.509589041095867,264.0
118,1552,procedure time,6.485813148788944,396.0
119,307,studies shown,6.4588235294118705,549.0
120,2983,less likely,6.397959183673486,330.0
121,403,hypertensive patients,6.390887290167858,325.0
122,545,achieved patients,6.328124999999976,405.0
123,708,left ventricle,6.253577371048207,696.0
124,925,obtained using,6.2405857740586,785.0
125,330,clinically relevant,6.204938271604899,718.0
126,3244,fractional flow,6.170032573289893,231.0
127,3330,method based,6.166037735849053,456.0
128,2452,volume total,6.149999999999999,123.0
129,1239,functional outcomes,6.118446601941743,411.0
130,2680,examination showed,6.105263157894758,290.0
131,2789,resonance cmr,6.020576131687237,418.0
132,1115,parameters patients,6.016279069767423,199.0
133,3510,performed patients,5.991878722252287,1785.0
134,2578,skeletal muscle,5.931998932479322,736.0
135,3270,enhanced depth,5.886111111111096,163.0
136,1997,lung function,5.848282630029473,359.0
137,2852,university hospital,5.825439783491216,525.0
138,150,functional status,5.808333333333317,164.0
139,3513,individual differences,5.7894135962636035,461.0
140,3575,reserve ffr,5.789189189189148,153.0
141,1426,showed better,5.7757009345794605,309.0
142,3262,peripheral nerve,5.766497461928929,284.0
143,3011,left temporal,5.761904761904752,165.0
144,223,higher mean,5.755339805825213,228.0
145,2542,artery pressure,5.684210526315806,180.0
146,346,aimed assess,5.6496688741721695,449.0
147,1843,routine use,5.628664495114005,192.0
148,3704,mean patients,5.608791208791189,232.0
149,1878,cingulate gyrus,5.581881533101051,178.0
150,2108,neural mechanisms,5.566406250000001,375.0
151,3734,closely related,5.563265306122463,319.0
152,3024,associated high,5.511111111111122,448.0
153,2718,months months,5.4769497400346925,687.0
154,798,total hip,5.473052733430159,716.0
155,3284,intraocular pressure,5.472027972027963,313.0
156,3372,cells cultured,5.4632911392404555,166.0
157,1026,results demonstrate,5.460431654676274,1012.0
158,2283,medical imaging,5.4322580645161445,421.0
159,3474,lung tissue,5.424427480916031,187.0
160,3427,readily available,5.3999999999999835,162.0
161,1768,higher frequency,5.379423868312758,152.0
162,1275,single center,5.356834532374057,219.0
163,754,patients acute,5.261980830670937,1098.0
164,590,provide information,5.231896551724156,289.0
165,30,complications occurred,5.229807692307689,294.0
166,2012,patients undergone,5.219047619047611,548.0
167,1711,largely unknown,5.2155339805825385,316.0
168,2997,patients malignant,5.1955307262569805,150.0
169,2937,normal control,5.175892857142848,187.0
170,270,training set,5.163888888888884,169.0
171,45,fusiform gyrus,5.148387096774196,171.0
172,2872,comprised patients,5.125114155251158,244.0
173,2829,detection limit,5.087463556851285,349.0
174,1364,trend toward,5.0820846905537485,269.0
175,1408,females mean,5.069387755102048,207.0
176,911,septal defect,5.034026927784566,388.0
177,1385,exact test,5.028721541155875,293.0
178,3073,patients reported,4.97851239669419,251.0
179,1615,class ii,4.930805687203765,289.0
180,1909,blood cell,4.902325581395355,272.0
181,1640,years men,4.841463414634131,397.0
182,2075,spectrum disorders,4.79277108433735,117.0
183,1632,nerve head,4.772727272727293,150.0
184,2816,play role,4.705555555555521,484.0
185,103,endothelial cell,4.658227848101288,230.0
186,3237,mechanisms underlying,4.65320485965648,624.0
187,155,tumor cells,4.6082543978349,695.0
188,3597,energy transfer,4.5585365853658635,267.0
189,1040,revealed differences,4.5360824742268,200.0
190,1328,collected patients,4.530751708428252,195.0
191,667,aim develop,4.487804878048785,184.0
192,1788,echocardiography tte,4.473170731707309,131.0
193,2793,plays role,4.464197530864194,226.0
194,2673,retrospective review,4.426952526799371,1022.0
195,254,regression models,4.404023470243095,710.0
196,586,complications including,4.367647058823535,135.0
197,3502,inferior frontal,4.325806451612894,745.0
198,1256,balloon angioplasty,4.316666666666648,196.0
199,324,cardiovascular factors,4.311953352769674,435.0
200,111,determine incidence,4.301369863013695,157.0
201,526,brain development,4.267140825035548,283.0
202,2589,patients found,4.246153846153844,324.0
203,2312,cerebral amyloid,4.24615384615384,138.0
204,1647,predictive value,4.235767105368521,2906.0
205,2656,breast cancers,4.227533460803059,201.0
206,2837,cardiac arrest,4.201091901728842,285.0
207,2551,newly formed,4.1806451612903235,144.0
208,2466,high resolution,4.167533818938598,801.0
209,2156,findings suggest,4.166832804712258,1703.0
210,1151,characteristic curves,4.1641025641025635,464.0
211,774,prospective studies,4.153339980059805,393.0
212,1032,factors associated,4.100662092211393,941.0
213,3336,associated presence,4.056030631780459,321.0
214,1153,fraction lvef,4.00928961748633,319.0
215,3267,female patients,3.998488120950316,561.0
216,1335,american college,3.9929328621907874,226.0
217,3594,initial treatment,3.981481481481472,215.0
218,2097,particularly important,3.9348837209302268,141.0
219,1656,success achieved,3.9310344827586223,171.0
220,222,ad patients,3.9007092198581526,250.0
221,1450,ventricular septal,3.881993204983005,197.0
222,147,cells vitro,3.8659090909090814,189.0
223,839,previous studies,3.8649068322981543,1310.0
224,757,therapeutic efficacy,3.860784313725491,179.0
225,834,diastolic dysfunction,3.8487667371388277,581.0
226,2427,conventional imaging,3.8423076923076938,333.0
227,138,ms ms,3.8238683127571984,202.0
228,1869,among women,3.8215909090909186,399.0
229,2849,quantitative computed,3.8199395770392686,218.0
230,1824,left frontal,3.8197802197802044,158.0
231,3493,lv systolic,3.8090520922288578,378.0
232,3110,blood vessel,3.807829181494662,214.0
233,939,area curve,3.7867924528301957,1338.0
234,1907,weeks months,3.7827715355805274,202.0
235,3710,predictive values,3.7644464049404505,502.0
236,3447,different patterns,3.7402597402597433,160.0
237,2149,level dependent,3.740080971659923,149.0
238,433,quantified using,3.7376146788990887,291.0
239,2661,images reviewed,3.7303964757709265,146.0
240,1930,calculated using,3.7141993957703168,683.0
241,3615,using dynamic,3.707142857142862,173.0
242,2274,odds ratios,3.6430555555555477,244.0
243,3398,treatment options,3.632608695652173,557.0
244,3722,small vessel,3.6292134831460623,323.0
245,578,hip joint,3.6242085661080012,263.0
246,2076,data collected,3.62255639097744,759.0
247,241,reviewed medical,3.6065217391304296,158.0
248,2206,first reported,3.598019801980176,237.0
249,3453,months later,3.567755991285408,356.0
250,2745,remains controversial,3.5651785714285746,242.0
251,3486,descending artery,3.544715447154481,218.0
252,3724,disease control,3.5411764705882454,172.0
253,2026,diagnostic imaging,3.5381679389313017,515.0
254,370,blood flow,3.529380376783197,3029.0
255,1783,muscle cells,3.5241935483871103,230.0
256,2136,test used,3.520871398453982,533.0
257,1557,analysis patients,3.518037518037528,530.0
258,2114,central peripheral,3.511111111111105,158.0
259,1838,whole body,3.473684210526327,429.0
260,3139,reconstruction using,3.4477611940298556,154.0
261,3092,present investigated,3.4354430379746903,236.0
262,1411,performed compare,3.4186046511627852,147.0
263,2432,patients chronic,3.412345679012346,691.0
264,1025,tricuspid annular,3.398373983739834,220.0
265,2647,pulmonary fibrosis,3.3730158730158886,250.0
266,2267,characteristic analysis,3.372580007902009,440.0
267,1866,much less,3.3717277486910997,140.0
268,2653,annular plane,3.3474120082815744,188.0
269,2644,electroencephalography eeg,3.3154819863680545,227.0
270,1493,lower limbs,3.3113207547169776,234.0
271,1284,coherence tomography,3.2942845561410583,2709.0
272,2079,provide evidence,3.2874952776728263,458.0
273,2884,john sons,3.273399371828942,579.0
274,255,ultrasound imaging,3.256538384041901,657.0
275,1277,focused ultrasound,3.254082998661312,206.0
276,1120,depressive symptoms,3.2526731252242467,346.0
277,198,factors affecting,3.2507374631268533,190.0
278,2133,photon emission,3.2352941176470664,275.0
279,829,studies used,3.2268656716417867,207.0
280,990,breast lesions,3.2267002518891728,366.0
281,3554,health organization,3.2148648648648654,183.0
282,1214,range patients,3.212565445026177,236.0
283,2307,depth imaging,3.208510638297879,174.0
284,2674,early stages,3.2027842227378227,476.0
285,2491,histopathological examination,3.194285714285725,215.0
286,1701,patients results,3.1911764705882346,217.0
287,2728,institutes health,3.1803183791606338,268.0
288,1623,data provide,3.170040485829951,261.0
289,2040,findings associated,3.162790697674433,136.0
290,2048,medline embase,3.1581395348837233,194.0
291,3667,time required,3.1565118912797203,208.0
292,989,compare performance,3.1555555555555355,142.0
293,3285,doppler ultrasound,3.14326923076923,467.0
294,2651,wild type,3.1350427350427386,262.0
295,210,retinal vein,3.127845884413303,190.0
296,1399,domain optical,3.1191860465116203,370.0
297,2223,breast tissue,3.1179968701095437,293.0
298,1606,reactive oxygen,3.1169117647058844,471.0
299,509,plane systolic,3.1121951219512223,174.0
300,2894,events mace,3.0899182561307867,162.0
301,3497,areas involved,3.081871345029227,155.0
302,352,ventricular diastolic,3.0742268041237097,142.0
303,2711,conventional methods,3.0552763819095463,160.0
304,3332,coronary angiography,3.0339351520453866,1585.0
305,3366,lesions using,3.0300791556728255,174.0
306,2036,patients referred,3.0250543714658447,519.0
307,3535,target vessel,3.0165577342047842,161.0
308,1953,arterial phase,3.015463917525762,225.0
309,664,anterior descending,3.001709401709402,439.0
310,2217,superior inferior,2.9899497487437166,175.0
311,217,key role,2.978231292516994,398.0
312,440,fisher exact,2.972341733251389,372.0
313,603,review discuss,2.96319018404909,161.0
314,656,scoring system,2.962732919254647,477.0
315,3289,consistent previous,2.9512195121951286,121.0
316,1539,spinal cord,2.939923885465748,2163.0
317,448,mode network,2.939092872570197,504.0
318,900,vascular disease,2.9370370370370336,244.0
319,52,cardiac computed,2.926283987915403,167.0
320,1106,differences found,2.9256138223704404,766.0
321,862,histopathological findings,2.9225806451612897,151.0
322,2311,present patients,2.9200362647325475,488.0
323,209,aim compare,2.9169557338855756,547.0
324,78,rate patients,2.901724137931032,306.0
325,126,values obtained,2.885714285714284,303.0
326,1527,different conditions,2.882878411910672,157.0
327,3305,doppler echocardiography,2.875000000000006,230.0
328,144,side effects,2.8639927073837628,683.0
329,2667,temporal lobe,2.8576734762789124,806.0
330,2976,amino acids,2.822060513213328,338.0
331,1329,syndrome acs,2.8100313479623953,166.0
332,1857,response evaluation,2.8059071729957803,175.0
333,468,valve implantation,2.7861975642760646,355.0
334,1999,treated using,2.7818181818181817,153.0
335,1301,median period,2.7575581395348796,153.0
336,1447,patients requiring,2.7499999999999964,187.0
337,3355,common type,2.749999999999984,110.0
338,2843,cognitive control,2.7352071005917176,430.0
339,2431,aim describe,2.72786885245901,192.0
340,2418,human brain,2.726757369614525,925.0
341,385,using various,2.7142857142857255,152.0
342,2162,showed complete,2.6934984520123746,174.0
343,1584,proposed algorithm,2.6886524822695055,223.0
344,485,atrial septal,2.6838966202783316,270.0
345,914,patients likely,2.673076923076918,139.0
346,3668,reference values,2.6707423580785985,278.0
347,1926,immune cells,2.6689655172413778,129.0
348,2774,scale score,2.6590233545647504,404.0
349,1036,times higher,2.6550143266475668,339.0
350,451,surface area,2.653387302939927,1175.0
351,2440,designed synthesized,2.6526315789473656,156.0
352,1045,classified groups,2.63260869565218,173.0
353,467,review performed,2.6309523809523796,221.0
354,723,performed assess,2.6246679316888146,364.0
355,2576,pain score,2.623719676549866,157.0
356,2612,patients previously,2.619047619047607,165.0
357,3490,participants performed,2.6140845070422563,232.0
358,2289,well understood,2.6123629112661932,397.0
359,2525,objective compare,2.6075892857142864,177.0
360,3196,higher levels,2.6043956043956094,395.0
361,312,lv volume,2.6025641025641018,203.0
362,3163,using new,2.600000000000008,208.0
363,60,treatment modality,2.6000000000000028,169.0
364,2531,future research,2.595593461265105,332.0
365,3441,treatment response,2.5726964239101906,640.0
366,1550,showed normal,2.5641076769690936,167.0
367,1226,treatment choice,2.5632911392405218,225.0
368,2604,cases controls,2.5548387096774174,180.0
369,2831,connectivity fc,2.5473684210526195,242.0
370,1966,patients findings,2.5470869149952224,226.0
371,2877,control subjects,2.544837476099422,1401.0
372,2495,physical activity,2.5339769542198614,573.0
373,1680,achilles tendon,2.5325802615933424,361.0
374,3143,therapy pdt,2.5302325581395473,136.0
375,1215,carcinoma hcc,2.5270358306188614,431.0
376,2851,neurological deficits,2.526785714285715,283.0
377,3538,patients classified,2.520184544405991,437.0
378,775,patients range,2.519786096256681,152.0
379,1823,associated lower,2.5112476951444496,659.0
380,2188,different regions,2.509090909090902,184.0
381,2802,cerebral blood,2.5051229508196617,978.0
382,905,system used,2.499928520371685,261.0
383,2655,stay days,2.4684210526315793,134.0
384,2596,oxygen species,2.4648408586232406,450.0
385,2975,tested hypothesis,2.4545454545454444,205.0
386,3358,using optical,2.44764397905759,374.0
387,1216,gestational weeks,2.442238648363254,196.0
388,1005,novel therapeutic,2.438383838383839,142.0
389,2684,prospective multicenter,2.4375000000000098,195.0
390,1532,high specificity,2.4235807860262017,259.0
391,3242,data show,2.4173267326732764,257.0
392,3350,human subjects,2.4149377593360986,194.0
393,3122,without known,2.414814814814812,163.0
394,2893,major challenge,2.400000000000002,156.0
395,3082,atrial appendage,2.369458128078819,185.0
396,149,optical coherence,2.3686351338744247,2701.0
397,985,interquartile range,2.3678571428571438,816.0
398,3716,species ros,2.3676975945017187,265.0
399,232,overall patients,2.364273204903678,250.0
400,2477,chest pain,2.3450690335305664,553.0
401,1266,radiological findings,2.3446366782006915,308.0
402,2833,present review,2.343434343434349,145.0
403,1828,routine practice,2.3402985074626903,196.0
404,3432,american society,2.3397417503586793,302.0
405,2248,bone resorption,2.3354735152487938,291.0
406,50,major depressive,2.3291814946619205,374.0
407,1775,lv ejection,2.328953131844064,409.0
408,3639,coil embolization,2.3267556587347626,211.0
409,2811,article review,2.3222222222222277,171.0
410,3301,occurred cases,2.317557251908397,138.0
411,816,aortic valve,2.3166666666665585,1668.0
412,1294,patients admitted,2.314720812182747,380.0
413,495,without use,2.310192444761218,222.0
414,3725,mitral annulus,2.3101391650099363,166.0
415,2536,knowledge first,2.3066584841976105,561.0
416,1948,bone formation,2.304192546583852,781.0
417,1708,tomography performed,2.3031963470319727,194.0
418,2750,subgroup patients,2.3001897533206903,209.0
419,2251,showed differences,2.293345008756574,485.0
420,3460,pulmonary venous,2.2888888888888856,206.0
421,2889,high sensitivity,2.2811881188118828,768.0
422,2669,frontal gyrus,2.2760070052539443,1083.0
423,1676,test test,2.2701298701298747,138.0
424,589,stent placement,2.2700564971751587,287.0
425,2535,venous thrombosis,2.2499999999999987,190.0
426,3329,control groups,2.2481359649122896,707.0
427,933,technique allows,2.2431095406360475,138.0
428,1016,iliac artery,2.240179910044979,241.0
429,1121,lumbar spine,2.2391221616136088,929.0
430,3544,healthy volunteers,2.2387674090022207,1422.0
431,3293,men mean,2.238392857142855,436.0
432,549,used assess,2.2361366473726023,1247.0
433,2646,years old,2.2096493221237594,1006.0
434,3729,per day,2.2061797752809063,231.0
435,2794,differ groups,2.1981109799291567,321.0
436,3608,ultrasound findings,2.19545454545454,276.0
437,2615,electrical stimulation,2.1928934010152332,240.0
438,786,initial presentation,2.185714285714284,153.0
439,3113,hounsfield units,2.177533577533575,241.0
440,1512,twenty patients,2.1772556390977393,297.0
441,3423,mean total,2.1770270270270236,179.0
442,507,resting state,2.1599005799502873,790.0
443,2186,bold signal,2.148254975483129,392.0
444,472,patients bone,2.1290322580645378,110.0
445,722,analyses conducted,2.127272727272726,156.0
446,1839,groups patients,2.1251672671126975,558.0
447,2005,studies suggest,2.1209302325581345,399.0
448,3402,normal range,2.1176470588235268,236.0
449,3596,mechanism underlying,2.1108433734939744,219.0
450,2517,confocal microscopy,2.109217737917299,1114.0
451,1332,feasibility safety,2.1066176470588185,191.0
452,2123,cbct scans,2.1041666666666625,202.0
453,3648,patients clinically,2.093305144467934,316.0
454,1159,well tolerated,2.0885093167701827,269.0
455,2489,different groups,2.087418936446183,619.0
456,1019,difference found,2.080818414322275,452.0
457,1258,peripheral quantitative,2.0707818930041126,148.0
458,1292,surgical interventions,2.06428571428571,153.0
459,1992,animal studies,2.0639175257731956,143.0
460,562,pain scores,2.05924276169265,201.0
461,2143,recently developed,2.0529019980970524,372.0
462,3556,computational fluid,2.0447368421052587,222.0
463,3226,layer thickness,2.041864890580398,290.0
464,2722,provides useful,2.0363636363635975,112.0
465,3749,years mean,2.0234221760701594,923.0
466,2183,literature search,2.017177914110434,274.0
467,204,volume index,2.008163265306127,246.0
468,3718,spect imaging,1.9983402489626516,168.0
469,75,regression analysis,1.9977563383441814,2520.0
470,1622,structural changes,1.9925782759953625,526.0
471,2954,similar results,1.989076196898181,343.0
472,727,previously reported,1.9853921238639913,1017.0
473,1149,therapeutic interventions,1.9789473684210592,188.0
474,162,surgery years,1.978512396694212,133.0
475,1424,preserved ejection,1.9770491803278778,134.0
476,2841,femoral head,1.9721362229102137,455.0
477,1254,descriptive statistics,1.9640287769784102,195.0
478,3346,remained unchanged,1.963494539781588,217.0
479,592,recent advances,1.960050568900127,456.0
480,1177,reconstructed using,1.9518341307814944,211.0
481,968,arterial spin,1.9432692307692248,301.0
482,2007,article describes,1.9378068739770862,160.0
483,3208,ex vivo,1.936138079827391,1282.0
484,690,mr angiography,1.930362116991644,165.0
485,97,transcatheter aortic,1.929147982062777,478.0
486,857,lobe epilepsy,1.9268576979116034,239.0
487,814,patients average,1.925925925925937,260.0
488,3162,independent factors,1.9243951612903232,415.0
489,319,surgical resection,1.9217252904663422,827.0
490,51,adolescent idiopathic,1.9166023166023156,146.0
491,3588,preterm birth,1.91395793499044,616.0
492,3433,acute chronic,1.9123674911660753,246.0
493,1081,single photon,1.9116994022203322,287.0
494,3637,good agreement,1.907269862705375,446.0
495,1352,total patients,1.8961997487437159,2875.0
496,612,national institutes,1.8960526315789443,262.0
497,3585,cell count,1.8959932517924898,247.0
498,3730,values calculated,1.895535714285711,193.0
499,2052,patients lesions,1.8955070603337578,321.0
500,3455,patients symptoms,1.8949494949494818,134.0
501,729,coefficient icc,1.891228070175441,253.0
502,1763,developed method,1.8883435582822103,171.0
503,3252,body temperature,1.88780487804878,129.0
504,519,patients prospectively,1.8749999999999958,150.0
505,53,spinal canal,1.864236902050114,396.0
506,1359,events patients,1.8589437819420782,176.0
507,478,literature review,1.8585669781931486,471.0
508,2120,used treat,1.8580777096114502,231.0
509,2355,directly related,1.8557823129251747,124.0
510,2908,provide novel,1.8500000000000103,222.0
511,2984,rat brain,1.844444444444443,166.0
512,1041,prior surgery,1.8390243902439005,174.0
513,157,lipoprotein cholesterol,1.83076923076923,182.0
514,802,cerebral small,1.8252747252747246,151.0
515,1724,acute aortic,1.8121212121212085,138.0
516,331,patients control,1.8105263157894829,344.0
517,1077,ionizing radiation,1.7930200936697345,460.0
518,1691,immune response,1.7903925014645556,259.0
519,2741,respectively median,1.7903225806451613,185.0
520,1271,arterial blood,1.7877504293073851,256.0
521,3308,estimated using,1.7830151415404838,366.0
522,3642,surface roughness,1.782334384858041,226.0
523,1809,disc degeneration,1.7739751786385827,265.0
524,1168,diagnostic yield,1.7735537190082662,464.0
525,3128,combination therapy,1.771122994652406,184.0
526,82,months patients,1.7711119230300876,817.0
527,265,obtained results,1.7670043415340073,185.0
528,3383,lesion volume,1.7649909145972136,310.0
529,3470,performed single,1.756495468277953,153.0
530,1598,together results,1.7502679528403011,355.0
531,1531,vascular factors,1.7458193979933092,180.0
532,1144,cells using,1.7409326424870464,168.0
533,427,bone health,1.7379310344827557,224.0
534,696,changes patients,1.737494134209291,187.0
535,3444,quantitative image,1.7333333333333327,117.0
536,2574,months following,1.7296060991105435,166.0
537,3586,image acquisition,1.7291666666666714,415.0
538,1754,review focuses,1.7276785714285687,129.0
539,3660,anal sphincter,1.7206703910614538,140.0
540,1123,outer retinal,1.7165048543689319,221.0
541,2247,neck cancer,1.7125374925015027,234.0
542,3255,safety profile,1.7101449275362328,118.0
543,653,left inferior,1.7021144920061855,446.0
544,3687,total cases,1.695652173913042,195.0
545,1938,electron microscopic,1.6916578669482523,178.0
546,2691,visual analogue,1.6854838709677487,209.0
547,2229,patients based,1.6842105263157876,160.0
548,136,fluorescent protein,1.6788553259141406,352.0
549,3574,cm range,1.678014184397164,169.0
550,2865,median months,1.6760869565217362,771.0
551,57,wt mice,1.6703502713369516,209.0
552,2260,thyroid carcinoma,1.6676056338028156,208.0
553,274,cancer treatment,1.6655844155844108,285.0
554,951,conducted prospective,1.6635071090047404,135.0
555,2094,recorded patients,1.658730158730154,165.0
556,3360,cord compression,1.6563380281690125,196.0
557,3058,imaging showed,1.655845942228337,463.0
558,500,data demonstrate,1.6512295081967288,237.0
559,3541,important role,1.6413465534643488,1342.0
560,2119,patients often,1.625806451612901,126.0
561,2526,analogue scale,1.6250000000000078,195.0
562,1723,male presented,1.6249999999999967,169.0
563,2140,particularly patients,1.6204724409448816,147.0
564,2917,neural basis,1.619834710743804,196.0
565,602,using system,1.6107728337236553,181.0
566,3552,among subjects,1.6073059360730613,160.0
567,2458,referred hospital,1.6039603960396007,135.0
568,3640,analysis conducted,1.6009280742459386,300.0
569,3511,analysis results,1.59297423887588,179.0
570,2447,value patients,1.586842105263159,134.0
571,1766,surgical technique,1.5844155844155903,305.0
572,3680,myocardial ischemia,1.5835164835164823,262.0
573,3087,randomized controlled,1.5774987928536963,605.0
574,680,depressive disorder,1.565413533834586,347.0
575,2231,well described,1.5630550621669563,176.0
576,3051,posterior wall,1.561996779388083,194.0
577,1474,differences among,1.5518308406395045,255.0
578,1400,long axis,1.5484777517564425,174.0
579,1148,posterior fossa,1.546082949308755,305.0
580,1383,ascending aorta,1.545945945945947,533.0
581,3701,oxidative stress,1.54341090296234,799.0
582,1986,cognitive functions,1.5383033419023144,272.0
583,2781,value predictive,1.5373790677220747,570.0
584,3591,tibial plateau,1.5328947368421055,233.0
585,2470,brain regions,1.5315221893702418,1993.0
586,2055,systematic literature,1.5301204819277112,127.0
587,2940,invasive coronary,1.5299638989169686,163.0
588,2509,malignant benign,1.5281690140845094,434.0
589,1150,image processing,1.5228136882129295,445.0
590,648,autosomal recessive,1.5186440677966082,224.0
591,3565,cell types,1.5123244929797213,393.0
592,2173,anterior chamber,1.5122137404580152,283.0
593,1993,successfully performed,1.5060402684563707,187.0
594,3088,femoral component,1.5057034220532337,220.0
595,3377,characteristic curve,1.5049812841923436,1074.0
596,365,low dose,1.5041227229146679,212.0
597,3338,endovascular aneurysm,1.4963369963369941,215.0
598,482,infarction stemi,1.4950980392156845,305.0
599,3052,respectively difference,1.4950524737631172,277.0
600,164,patients left,1.492339544513456,212.0
601,1513,criteria patients,1.4894495412844055,191.0
602,947,patients showed,1.4881319469343757,1297.0
603,2992,surgical treatment,1.4860103626942947,956.0
604,1874,present investigate,1.485889570552152,173.0
605,1927,abdominal aortic,1.4819434372733862,524.0
606,3246,controlled trial,1.481768813033358,382.0
607,2269,regions involved,1.478787878787879,244.0
608,3048,using image,1.4777202072538884,186.0
609,447,every months,1.4730173627404979,215.0
610,1370,functional magnetic,1.4698887866878745,2044.0
611,3583,preterm infants,1.4670681631535716,396.0
612,1038,systolic excursion,1.4645812310797177,177.0
613,2383,blood samples,1.4581717451523508,376.0
614,2308,cell culture,1.456223175965666,377.0
615,2424,investigate association,1.439759036144581,239.0
616,2285,investigated whether,1.4371647509578467,682.0
617,1161,carotid artery,1.4367504023511373,1683.0
618,1923,using quantitative,1.433790918690602,219.0
619,1848,reported patients,1.4310734463276873,298.0
620,46,underwent functional,1.427631578947366,155.0
621,3149,promising results,1.4263369752731467,234.0
622,2932,interstitial pneumonia,1.4210526315789478,135.0
623,3176,interstitial lung,1.4181159420289877,206.0
624,3576,contrast agents,1.4176601017347046,937.0
625,154,patients hcm,1.4148305084745758,159.0
626,481,neoadjuvant chemotherapy,1.4118152524167573,212.0
627,1203,early phase,1.4111420612813383,149.0
628,2181,biopsy performed,1.4075187969924816,156.0
629,676,repair evar,1.4000000000000001,158.0
630,2804,aim analyze,1.3999999999999961,161.0
631,2080,evaluated whether,1.399999999999989,163.0
632,3649,using techniques,1.3952456418383499,142.0
633,3386,cm respectively,1.3916666666666675,167.0
634,587,insulin resistance,1.390200179265014,423.0
635,3265,value respectively,1.3872711421098511,156.0
636,1735,macular thickness,1.384828781967921,326.0
637,2175,imaging fmri,1.3816577664267546,1026.0
638,1124,network connectivity,1.3731908693540547,211.0
639,2087,using either,1.3690778575372702,253.0
640,239,cortical bone,1.3650383528461865,642.0
641,3698,thoracic aorta,1.3559322033898333,200.0
642,976,complete response,1.3559254855330967,311.0
643,3461,postmenopausal women,1.3525263384218429,443.0
644,3613,techniques used,1.332248881659213,420.0
645,411,mr image,1.3311136624569448,187.0
646,2118,connective tissue,1.3304230423042285,379.0
647,1089,state functional,1.3219984305519186,266.0
648,3241,myocardial fibrosis,1.3175832687838842,315.0
649,1699,shed light,1.31489361702128,206.0
650,2805,muscle thickness,1.3103888566453852,213.0
651,2232,patients female,1.3087126137841336,296.0
652,3253,mdd patients,1.3076802507837009,309.0
653,1747,month months,1.3043478260869532,150.0
654,2310,aim assess,1.2914988814317654,753.0
655,2017,multidisciplinary approach,1.2891891891891913,159.0
656,80,proportional hazards,1.2889358703312148,295.0
657,1391,majority patients,1.288379204892964,383.0
658,629,purpose investigate,1.2863863150392043,564.0
659,278,rf ablation,1.286243386243384,187.0
660,1657,abdominal wall,1.284023668639057,217.0
661,3686,following parameters,1.2824427480916007,120.0
662,3005,obtained different,1.281250000000001,123.0
663,3610,vein occlusion,1.2812500000000004,205.0
664,1638,prognostic significance,1.2732283464566925,147.0
665,2263,cardiac dysfunction,1.2705813613789065,262.0
666,1608,regions associated,1.2702169625246522,230.0
667,2029,vivo studies,1.2701949860724246,285.0
668,855,angiography ccta,1.2698753760206285,197.0
669,1605,treatment planning,1.268837950261084,739.0
670,400,matter gm,1.2644701691896725,284.0
671,581,spectral domain,1.261739624786809,411.0
672,3401,atherosclerotic disease,1.2483660130718945,191.0
673,2553,clinically useful,1.2468468468468452,173.0
674,371,specificity predictive,1.2436621801508625,858.0
675,874,cystic lesions,1.2373008434864088,161.0
676,860,close proximity,1.2305084745762789,121.0
677,848,imaged using,1.2296296296296267,249.0
678,214,blood oxygen,1.2289156626506004,255.0
679,3211,included consecutive,1.2241900647948125,218.0
680,1849,patients stage,1.2235294117647086,208.0
681,1290,soft tissue,1.2227907522591324,1766.0
682,47,axial rotation,1.2130360205831905,208.0
683,2642,breast density,1.2057477678571424,527.0
684,3622,healthy adults,1.2041666666666642,289.0
685,220,vitro vivo,1.2036906854129985,761.0
686,637,compare results,1.194409148665819,188.0
687,1118,improved accuracy,1.1913669064748198,138.0
688,2541,role pathogenesis,1.1878594249201286,169.0
689,1044,improve outcomes,1.1875647668393758,191.0
690,2537,mass spectrometry,1.1851697851697927,503.0
691,3084,structural information,1.1846226862838158,192.0
692,521,volume cm,1.174209245742091,127.0
693,2345,months initial,1.1687203791469183,137.0
694,1873,tomography scans,1.1645979492714527,910.0
695,2339,wave elastography,1.1632653061224494,266.0
696,355,attention paid,1.1632653061224456,165.0
697,2817,patients whose,1.1550761421319784,246.0
698,1366,reach significance,1.1491408934707945,152.0
699,416,studies evaluating,1.148987854251016,129.0
700,1881,cells showed,1.1479944674965428,166.0
701,2286,however effects,1.1454545454545455,119.0
702,2950,poor prognosis,1.1410122164048857,467.0
703,1800,using fmri,1.1404547858276042,263.0
704,803,within years,1.139729036982789,197.0
705,1291,lumbar spinal,1.1358839050131928,205.0
706,3142,patients randomized,1.1356300141576214,256.0
707,3737,found higher,1.1334656084656078,209.0
708,1895,assess accuracy,1.130434782608697,156.0
709,1113,quality assessed,1.1294117647058823,144.0
710,2713,therapeutic strategies,1.1257731958762838,182.0
711,2692,retinal pigment,1.1203566121842503,290.0
712,1611,patients selected,1.1171875000000013,143.0
713,2151,ventricular mass,1.1166448230668415,284.0
714,3309,bone mineral,1.1165190735694668,1561.0
715,272,scans performed,1.1127823408624213,409.0
716,1172,subjects without,1.1108593012275743,346.0
717,3758,higher prevalence,1.1084521384928687,311.0
718,1300,cavernous sinus,1.106878908470723,165.0
719,2827,outcomes included,1.106198526224534,232.0
720,3328,brain responses,1.104112808460636,162.0
721,1321,associated higher,1.1000000000000025,913.0
722,1130,rv dysfunction,1.0994382022471914,206.0
723,564,cells cells,1.0961240310077502,202.0
724,3533,aortic aneurysm,1.0929487179487174,465.0
725,1519,antibacterial activity,1.0906779661016934,234.0
726,540,ultrasound ivus,1.0887218045112776,181.0
727,2281,aortic root,1.0850253807106596,342.0
728,1853,aneurysm sac,1.0837751855779416,146.0
729,1242,prefrontal cortex,1.0833829933532166,1818.0
730,574,pressure bp,1.0807980049875308,197.0
731,1790,aortic aneurysms,1.080459770114946,235.0
732,2014,stenosis patients,1.0784482758620688,139.0
733,1631,however patients,1.077518634287086,291.0
734,347,determine association,1.0751717369970546,166.0
735,2820,strain gls,1.0736842105263225,153.0
736,2411,present cases,1.0731286650569187,305.0
737,3709,results provide,1.0684709066305853,658.0
738,1975,sensitivity predictive,1.0666666666666684,164.0
739,27,gm volume,1.0652966265994572,241.0
740,1604,eyes healthy,1.0612452350698864,144.0
741,1901,cervical lymph,1.0612244897959184,156.0
742,2493,acute stroke,1.0575389948006941,339.0
743,424,fluid dynamics,1.055865921787711,252.0
744,3519,left upper,1.055555555555551,171.0
745,2077,imaging technology,1.0536834427425261,233.0
746,3040,skull base,1.0439146800501877,512.0
747,741,new method,1.0421901735517005,418.0
748,604,structural functional,1.0374449339207095,628.0
749,2928,mean change,1.034724931720641,204.0
750,486,unstable angina,1.0342105263157897,131.0
751,1782,water content,1.0337972166998013,200.0
752,1091,response therapy,1.03235294117647,156.0
753,3286,subclavian artery,1.0307189542483668,249.0
754,2550,vascular complications,1.030024610336341,146.0
755,815,cell adhesion,1.025385934819887,427.0
756,3400,children aged,1.0239785666443384,294.0
757,2780,scans acquired,1.02371888726208,152.0
758,2425,femoral artery,1.0209150326797387,213.0
759,1987,safe effective,1.0163934426229593,744.0
760,2681,mineral content,1.0152761457109287,160.0
761,3250,likert scale,1.0152410575427686,192.0
762,3203,pigment epithelium,1.0143112701252228,270.0
763,2828,investigate influence,1.0113074204946995,159.0
764,3573,least years,1.0071428571428558,188.0
765,1380,bone disease,1.0054054054054045,138.0
766,2910,jugular vein,1.0033180778032034,237.0
767,325,endovascular repair,1.0026986506746651,176.0
768,2276,useful predicting,0.9980879541108969,174.0
769,1952,complete resolution,0.9938362465501375,277.0
770,247,plasminogen activator,0.9938069216757759,248.0
771,76,plays important,0.9915736254476528,523.0
772,2034,angiography cta,0.9914163090128774,385.0
773,3248,auditory cortex,0.9907780979827076,191.0
774,2734,analysis mean,0.9894957983193293,157.0
775,1156,median nerve,0.9881271172769794,249.0
776,3076,longitudinal strain,0.9880673125956132,692.0
777,2362,spatial statistics,0.9876956680014557,266.0
778,720,patients unilateral,0.9867418899858946,318.0
779,2709,end points,0.9848714069591521,279.0
780,1594,available data,0.9819444444444454,202.0
781,1298,phase contrast,0.9799126637554559,238.0
782,406,pulmonary vascular,0.9793103448275856,142.0
783,1397,imaging technologies,0.9770392749244762,147.0
784,2887,open reduction,0.9695652173913009,223.0
785,1709,useful information,0.9642416769420459,170.0
786,2107,endothelial dysfunction,0.9627560521415277,235.0
787,1479,local anesthetic,0.9565217391304354,130.0
788,2366,living cells,0.9558341369334631,504.0
789,1200,birth weight,0.9536723163841813,422.0
790,1672,structural abnormalities,0.9483732876712322,209.0
791,2148,patients included,0.9477039157018342,1457.0
792,987,could used,0.9458229783980133,798.0
793,358,change time,0.9430894308943062,116.0
794,1341,disease activity,0.94291205271346,636.0
795,3569,frequently observed,0.9425400739827369,182.0
796,1689,studies included,0.939622641509431,249.0
797,259,groups similar,0.9388601036269436,151.0
798,1918,score patients,0.9375000000000012,250.0
799,1188,fifteen patients,0.9363881401617262,193.0
800,29,important implications,0.9354243542435418,195.0
801,3030,levels patients,0.9348837209302319,268.0
802,3282,image features,0.9333333333333355,182.0
803,1195,demographic characteristics,0.9303201506591321,190.0
804,3516,coronary artery,0.9271794549496823,3908.0
805,3553,fibrosis patients,0.9268047006155578,169.0
806,333,vascular access,0.924691358024689,214.0
807,2163,findings support,0.9216320787900093,397.0
808,3091,right inferior,0.9180834621329221,330.0
809,2824,morphological functional,0.9173076923076918,159.0
810,3650,sd sd,0.9122807017543847,180.0
811,3300,versus respectively,0.9118527042577663,283.0
812,576,patients history,0.9087591240875917,332.0
813,1295,angiography revealed,0.9066773934030555,161.0
814,3081,lower fa,0.9058905058905053,152.0
815,1715,orbitofrontal cortex,0.9054347826086965,357.0
816,1481,provide important,0.8946768060836511,181.0
817,2063,sensitivity specificity,0.8921615957982905,5096.0
818,2474,multidisciplinary team,0.8918032786885228,136.0
819,2939,coronary computed,0.8897535667963651,245.0
820,48,foot ankle,0.8879950495049509,287.0
821,1688,ventricular assist,0.8874815905743739,131.0
822,1797,somatosensory cortex,0.8858231707317068,298.0
823,3708,provides first,0.8857142857142869,124.0
824,3499,data patients,0.8833693304535564,818.0
825,3388,color doppler,0.8814814814814781,476.0
826,64,measured ultrasound,0.8812500000000038,141.0
827,132,best knowledge,0.8779951100244536,399.0
828,1642,intensive care,0.877784467188439,486.0
829,1488,early diastolic,0.8775280898876427,213.0
830,2211,thyroid nodules,0.8773662551440318,574.0
831,763,none patients,0.8738095238095462,367.0
832,2198,typically developing,0.8735161686451071,194.0
833,3287,high potential,0.8723618090452213,124.0
834,636,demonstrated high,0.8723311546840937,154.0
835,2386,detected patients,0.8721634954193099,476.0
836,3276,events occurred,0.870676691729324,193.0
837,3105,higher values,0.8705583756345209,245.0
838,1174,reaction time,0.869879518072288,171.0
839,3522,brain stem,0.8693877551020409,142.0
840,710,trauma patients,0.8684210526315786,231.0
841,3036,tomography showed,0.8679300291545182,229.0
842,418,anterior segment,0.866361788617886,275.0
843,2037,neurodegenerative diseases,0.8615508451837951,247.0
844,809,incidence rate,0.8602698650674665,151.0
845,1459,open surgery,0.8579587519830802,208.0
846,2103,episodic memory,0.8517125933556526,312.0
847,2528,demonstrated higher,0.848314606741574,151.0
848,1423,myocardial function,0.8468648513614787,226.0
849,2856,public health,0.846522161112907,267.0
850,2518,implantation tavi,0.8419243986254308,175.0
851,3482,learning curve,0.8416335381279363,164.0
852,3653,cerebral palsy,0.8396843291995477,196.0
853,118,element analysis,0.8376980817347801,186.0
854,2197,high affinity,0.8364633310486667,226.0
855,2213,resonance angiography,0.836043095004896,388.0
856,1368,neuroimaging findings,0.8352272727272748,147.0
857,393,formula see,0.8348676673053046,1144.0
858,906,patients men,0.8264655801508152,548.0
859,3235,review article,0.8262672811059913,163.0
860,628,different levels,0.8251155624036987,255.0
861,121,highlights importance,0.824537487828625,146.0
862,3641,neural responses,0.8237190558434067,292.0
863,3151,valve repair,0.8222614840989401,179.0
864,3592,see text,0.8169007135266437,1151.0
865,541,smooth muscle,0.8150422102839614,354.0
866,3313,spinal stenosis,0.8148418491484183,197.0
867,2446,residual disease,0.8136581122227055,199.0
868,3561,vs respectively,0.8131524236787396,509.0
869,277,cell cultures,0.812499999999996,130.0
870,473,flow cbf,0.8056389825314119,248.0
871,1951,dose index,0.8045454545454546,177.0
872,167,echocardiographic parameters,0.8044828517418305,331.0
873,2230,patients required,0.8041297935103224,423.0
874,2295,high rate,0.8016393442622924,326.0
875,321,intracerebral hemorrhage,0.8000000000000009,360.0
876,3123,carotid plaques,0.7991071428571432,179.0
877,256,however little,0.7970330411328381,394.0
878,1092,ductus arteriosus,0.7949351451513279,165.0
879,205,among different,0.7947194719471944,301.0
880,2215,information regarding,0.7939929328621906,321.0
881,2759,model parameters,0.7914110429447884,129.0
882,2539,fibrillation af,0.7907556859867889,317.0
883,3703,cardiovascular disease,0.7895826987511401,997.0
884,1713,transforming growth,0.7884892086330931,137.0
885,1326,patients presenting,0.7851851851851845,742.0
886,693,muscle volume,0.7849166062364036,164.0
887,2394,hippocampal volume,0.7840851779209848,424.0
888,139,echocardiography performed,0.7760683760683749,227.0
889,1068,patients advanced,0.7720136518771341,377.0
890,145,medical treatment,0.770277341705914,320.0
891,2369,survival rate,0.7688598467778283,517.0
892,2414,ischemic stroke,0.7671360255047797,1375.0
893,959,angiography patients,0.7668393782383408,140.0
894,123,mineral density,0.7654970760233872,1309.0
895,559,blood volume,0.7647458779534251,409.0
896,3496,medical center,0.7612236461347669,341.0
897,1502,years later,0.7612149532710292,181.0
898,1868,values higher,0.7593750000000008,243.0
899,2679,wall thickness,0.7590842726157802,783.0
900,1870,internal jugular,0.759062162579053,259.0
901,362,mass index,0.7586525926237342,2200.0
902,548,multicenter randomized,0.7582089552238799,127.0
903,961,high dose,0.7578947368421042,192.0
904,412,including patients,0.7575099529496931,299.0
905,3352,patients affected,0.7543463835434621,196.0
906,1750,across different,0.7538461538461553,217.0
907,1095,neural substrates,0.7529411764705884,128.0
908,1437,central retinal,0.7506493506493512,289.0
909,611,resection performed,0.7469740634005769,144.0
910,1265,vena cava,0.7463232094682813,640.0
911,2601,cell layer,0.744059405940594,167.0
912,2090,stroke scale,0.7434402332361496,255.0
913,2807,time series,0.7408450704225389,263.0
914,2233,optic neuritis,0.7379310344827552,214.0
915,2712,prospective randomized,0.7342710997442473,261.0
916,3564,retrospectively identified,0.7272727272727274,200.0
917,3055,investigate whether,0.7221853459280091,832.0
918,2284,patients hips,0.7208430913348945,162.0
919,456,collagen fibrils,0.7205882352941191,140.0
920,388,head circumference,0.7197943444730107,168.0
921,626,similar groups,0.7196261682242998,638.0
922,3411,information available,0.7195020746887982,153.0
923,514,findings consistent,0.7192368839427654,174.0
924,383,total lung,0.7187499999999991,115.0
925,1433,ability detect,0.7176470588235312,183.0
926,296,animal models,0.7171601855155194,437.0
927,1876,endoplasmic reticulum,0.7157684630738523,326.0
928,1006,external beam,0.7155778894472363,178.0
929,3042,data system,0.7147410358565738,299.0
930,445,remains unknown,0.71334214002642,300.0
931,3217,doppler imaging,0.713079896907216,357.0
932,3656,level iii,0.7124999999999999,209.0
933,912,contralateral side,0.7111111111111066,192.0
934,1280,thirteen patients,0.7100543478260858,201.0
935,3689,glucose metabolism,0.7097072419106307,376.0
936,2840,lower values,0.7086172344689379,136.0
937,2236,time months,0.7084548104956265,270.0
938,528,cancer therapy,0.7079889807162528,257.0
939,3079,data showed,0.7058470764617699,214.0
940,1511,common iliac,0.7052168447517285,170.0
941,1139,advantages disadvantages,0.7043478260869579,162.0
942,1079,model developed,0.7042471042471028,152.0
943,3310,therapeutic strategy,0.703265940902022,133.0
944,1600,limited data,0.699872935196951,306.0
945,1343,lesions detected,0.6989690721649499,226.0
946,2042,underwent preoperative,0.6955074875207993,190.0
947,772,quantitative measurements,0.6936555891238674,164.0
948,2169,cognitive processes,0.6929194956353045,188.0
949,1587,systolic function,0.692282430213463,496.0
950,280,class iii,0.690614281259743,226.0
951,2499,descending aorta,0.6885149099498088,212.0
952,3634,postoperative day,0.686453576864535,205.0
953,747,changes brain,0.6860597439544814,371.0
954,3390,used image,0.6857142857142846,216.0
955,1559,beneficial effect,0.6842105263157895,130.0
956,955,spin labeling,0.6840113528855236,241.0
957,681,artery stenosis,0.6816027088036146,549.0
958,2438,developed using,0.681329923273656,148.0
959,1114,matter wm,0.6779282329045357,323.0
960,3408,state examination,0.6767263427109971,147.0
961,762,used patients,0.6695205479452045,345.0
962,2775,patients studied,0.6672322375397659,242.0
963,308,years surgery,0.6657976412166362,173.0
964,3312,independent factor,0.6624040920716094,370.0
965,1249,range mean,0.6618276085547634,222.0
966,2415,logistic regression,0.6603719186968375,2545.0
967,1010,patients first,0.6556156968876855,255.0
968,87,knee osteoarthritis,0.6554196541543654,210.0
969,2399,nerve fiber,0.6552462526766584,510.0
970,1516,resolution symptoms,0.6546652030735453,142.0
971,1375,time reduced,0.6494845360824734,126.0
972,2450,neurologic deficits,0.6486254295532641,151.0
973,1573,femoral condyle,0.6481481481481475,150.0
974,3116,multiple linear,0.6476190476190475,272.0
975,2105,magnetic field,0.6449771689497702,565.0
976,2665,bladder cancer,0.6449716348633309,169.0
977,2603,shear wave,0.6428116395832203,578.0
978,2766,patients complete,0.6422018348623852,300.0
979,3177,microscope sem,0.6398773006134951,149.0
980,1974,alternative treatment,0.6388888888888901,138.0
981,853,mean diameter,0.6380208333333333,175.0
982,3223,carbon nanotubes,0.6379746835443054,168.0
983,2406,central nervous,0.637503726522905,972.0
984,1014,medical records,0.63662597114318,956.0
985,1261,cardiac structure,0.6358156028368778,163.0
986,895,brain networks,0.6331403762662813,625.0
987,1297,closely associated,0.6311078503301544,187.0
988,3331,arterial hypertension,0.6294478527607361,285.0
989,273,coronary atherosclerosis,0.6282245827010647,230.0
990,135,laboratory tests,0.627589908749329,158.0
991,3025,flow reserve,0.6274864376130186,347.0
992,1937,epidermal growth,0.6273291925465861,303.0
993,529,positively associated,0.6266438523588366,442.0
994,2690,controls underwent,0.6250999200639483,230.0
995,2365,fatty acids,0.6249999999999991,200.0
996,1554,little information,0.6236162361623621,130.0
997,1681,analysis indicated,0.6233250620347395,314.0
998,2520,growth restriction,0.622831050228311,198.0
999,2847,operating room,0.6224089635854377,303.0
1000,3611,imaging agents,0.6206546045944294,215.0
1001,1565,left atrium,0.6192109777015372,361.0
1002,2412,prediction error,0.6183206106870226,162.0
1003,26,six months,0.615813401858073,421.0
1004,1094,previous research,0.6136986301369867,168.0
1005,2004,associated adverse,0.6118421052631566,155.0
1006,1193,surgical intervention,0.6101694915254235,660.0
1007,2719,seen patients,0.6093171665603053,434.0
1008,1191,et al,0.6077767973955649,591.0
1009,634,thyroid cancer,0.6073770491803281,285.0
1010,3631,multivariable logistic,0.6065217391304119,279.0
1011,293,state art,0.6056116722783383,142.0
1012,1833,carotid plaque,0.6054376657824927,249.0
1013,926,using confocal,0.6029598308668069,186.0
1014,1920,membrane potential,0.601438848920863,176.0
1015,831,could predict,0.6007788161993768,203.0
1016,3032,records reviewed,0.6007025761124114,171.0
1017,18,normal controls,0.5987832212616087,374.0
1018,1425,early postoperative,0.5975961538461535,226.0
1019,3524,internal carotid,0.597585707387735,728.0
1020,669,fluorescent probe,0.5967741935483869,259.0
1021,3071,network dmn,0.595652173913068,274.0
1022,2654,beneficial effects,0.5951903807615243,165.0
1023,2560,older years,0.5947289905519639,260.0
1024,2573,male mean,0.5935483870967743,184.0
1025,3446,media thickness,0.5914935707220578,130.0
1026,444,randomized trials,0.5898876404494393,175.0
1027,638,relatively low,0.5891696750902541,272.0
1028,923,reporting data,0.5840208423795029,269.0
1029,199,patients cervical,0.5833249115715007,156.0
1030,2790,deep vein,0.5809585914574498,151.0
1031,1163,review patients,0.5808168316831687,361.0
1032,779,red blood,0.580264608599779,277.0
1033,1246,images patients,0.5788213627992655,449.0
1034,364,routinely used,0.5784172661870467,134.0
1035,3732,copyright john,0.5743031463093669,381.0
1036,2994,foveal thickness,0.569001751313485,171.0
1037,3757,rotator cuff,0.5670024313997903,583.0
1038,1190,months postoperatively,0.5669691470054441,426.0
1039,1358,local recurrence,0.5667077681874224,383.0
1040,1325,women underwent,0.5661196911196911,255.0
1041,2368,peripheral blood,0.5648033126293989,341.0
1042,3413,task performance,0.5641791044776109,216.0
1043,2300,patients atrial,0.5635193133047208,202.0
1044,3296,acl reconstruction,0.561849710982657,324.0
1045,635,adjusted odds,0.5615550755939522,260.0
1046,2652,patients females,0.5607476635514035,200.0
1047,2592,proximal distal,0.5603512014787426,258.0
1048,2521,retinal thickness,0.5603176572775764,426.0
1049,2947,left main,0.5589147286821718,309.0
1050,262,days range,0.557674561673333,245.0
1051,1659,data indicate,0.5555555555555558,425.0
1052,3292,central role,0.555352032054951,231.0
1053,2382,participants included,0.5548961424332338,165.0
1054,2255,renal artery,0.5533141210374629,320.0
1055,717,anatomical landmarks,0.5490196078431371,140.0
1056,1780,achieved cases,0.5488497970230038,156.0
1057,1753,survival analysis,0.5487179487179491,214.0
1058,3404,vs min,0.5472440944881893,139.0
1059,1855,days patients,0.5471247199402537,222.0
1060,3108,connectivity patterns,0.5464208242950098,229.0
1061,2,lesions patients,0.545540647198107,432.0
1062,396,method applied,0.5452442902572999,230.0
1063,2318,pleural effusion,0.545072697899838,241.0
1064,705,texture analysis,0.5449770190413659,166.0
1065,3368,provide insights,0.5410821643286592,150.0
1066,2839,situ hybridization,0.5406250000000002,173.0
1067,2650,congestive heart,0.5371394938198933,169.0
1068,12,success rates,0.5357975262743975,371.0
1069,3209,especially patients,0.5321525885558581,217.0
1070,1973,metabolic parameters,0.529952456418385,152.0
1071,2710,liver cancer,0.5271966527196645,140.0
1072,659,hearing loss,0.5267778753292357,375.0
1073,228,polymerase chain,0.524822695035462,370.0
1074,610,range median,0.5232876712328783,191.0
1075,3380,without additional,0.5226804123711342,156.0
1076,3431,disease duration,0.5218184028199817,477.0
1077,2227,cognitively normal,0.5211641706696806,174.0
1078,3566,uterine artery,0.5208698702209749,275.0
1079,181,upper lower,0.5191633691351046,336.0
1080,668,emission computed,0.5183569979716006,538.0
1081,2558,complications observed,0.5175311503911902,190.0
1082,41,cuff tears,0.5170506912442374,153.0
1083,3754,needle aspiration,0.5150467159392002,313.0
1084,1458,image guidance,0.5149630384909497,273.0
1085,3501,bone regeneration,0.5135380701435586,314.0
1086,417,level iv,0.511023310944293,223.0
1087,1576,compare diagnostic,0.5097621000820364,239.0
1088,579,salivary gland,0.5093990755007706,171.0
1089,2448,patients categorized,0.5087719298245635,145.0
1090,2613,cbct images,0.5081404032860348,243.0
1091,1796,invasive breast,0.5074337427278603,157.0
1092,2023,axial length,0.5072853620264507,310.0
1093,2134,microstructural changes,0.5069958847736635,176.0
1094,1063,aneurysm repair,0.5067285382830625,312.0
1095,1102,based findings,0.5050554870530208,256.0
1096,732,chronic pain,0.5049295774647897,239.0
1097,1716,low levels,0.5040871934604902,185.0
1098,314,body fat,0.5037223290440268,601.0
1099,1884,findings highlight,0.5018691588785048,179.0
1100,2384,based imaging,0.500227790432802,183.0
1101,58,children adolescents,0.4993174061433428,418.0
1102,2776,microscopic examination,0.4991610738255035,175.0
1103,2479,diabetes mellitus,0.4987165079552879,1081.0
1104,520,back projection,0.4971962616822446,133.0
1105,318,intervertebral disc,0.4968840880764434,260.0
1106,2088,volume changes,0.49664252797893343,164.0
1107,2633,males mean,0.49638554216866965,206.0
1108,3547,revealed higher,0.49621993127147734,152.0
1109,2587,preoperatively postoperatively,0.4947867298578202,174.0
1110,2341,aim work,0.4929101156926736,268.0
1111,1467,great promise,0.4919803600654661,167.0
1112,2475,systolic velocity,0.4893789901334865,248.0
1113,2046,hodgkin lymphoma,0.4886363636363651,215.0
1114,3216,population patients,0.48526211671612524,223.0
1115,382,followed years,0.4851063829787227,152.0
1116,2212,alcohol consumption,0.48362989323843447,151.0
1117,1030,ischemic attack,0.4823529411764715,164.0
1118,539,end point,0.4821716801173879,424.0
1119,2291,studies required,0.48093841642228685,205.0
1120,1235,simulation results,0.4805653710247336,136.0
1121,1410,local control,0.4788027477919524,287.0
1122,2305,however role,0.47797619047619055,146.0
1123,739,ultrasound images,0.4776754955667248,381.0
1124,924,regurgitation mr,0.47761194029850723,160.0
1125,1988,models used,0.47759662335512626,458.0
1126,2001,metastatic disease,0.4771723122238598,360.0
1127,2176,purpose assess,0.4763948497854081,370.0
1128,322,imaging demonstrated,0.4755609955120356,188.0
1129,3442,quantitative qualitative,0.4745762711864406,160.0
1130,3135,recent developments,0.47416331994645317,161.0
1131,196,large number,0.4738516350680732,380.0
1132,1555,median range,0.47292064357785696,299.0
1133,83,patients suffering,0.4725806451612881,293.0
1134,1994,images taken,0.46893203883495277,161.0
1135,311,cutoff values,0.4644337212602904,303.0
1136,2616,signal changes,0.46425339366515944,171.0
1137,1314,lung disease,0.46412721893490966,502.0
1138,2641,pulmonary valve,0.4641200545702593,189.0
1139,59,factor receptor,0.46369426751592474,364.0
1140,746,lung volume,0.46342850642702743,210.0
1141,1950,weighted imaging,0.46338939197930057,199.0
1142,431,months respectively,0.4618421052631587,351.0
1143,3046,medial lateral,0.4613026819923368,301.0
1144,1486,multivariate regression,0.4603152844413974,292.0
1145,1057,neurological disorders,0.45983263598326424,157.0
1146,3505,hepatocellular carcinoma,0.45968324534593014,752.0
1147,2085,cm cm,0.4579881656804725,486.0
1148,3707,tube current,0.4557692307692302,158.0
1149,977,artery disease,0.4549981691688017,1635.0
1150,764,tracking echocardiography,0.45352706819779764,236.0
1151,3673,high low,0.4535019455252893,333.0
1152,3568,la volume,0.4511756569847847,233.0
1153,743,chronic total,0.4510242085661077,173.0
1154,3666,body fluid,0.45076142131979674,148.0
1155,3323,simulated body,0.4503282275711156,147.0
1156,2244,authors present,0.4488372093023252,193.0
1157,606,results consistent,0.44839531329597593,163.0
1158,1069,treated patients,0.4475524475524472,320.0
1159,700,imaging characteristics,0.4470873786407777,307.0
1160,1065,procedural success,0.44701986754967094,225.0
1161,1273,patients least,0.446734322144158,232.0
1162,1169,excellent agreement,0.44564315352697115,179.0
1163,1274,quality assurance,0.44528650646950124,219.0
1164,426,peak systolic,0.44488448844884476,337.0
1165,725,angiography showed,0.4441558441558438,171.0
1166,1653,classified according,0.4441256300891806,249.0
1167,3228,potential complications,0.4411764705882357,150.0
1168,1736,national health,0.43921568627451113,112.0
1169,1296,patients persistent,0.4391922900413027,165.0
1170,3515,patients symptomatic,0.4387351778656124,370.0
1171,177,groups different,0.43859649122806893,125.0
1172,937,imaging imaging,0.43749999999999944,245.0
1173,225,psychiatric disorders,0.4360400444938817,280.0
1174,1351,subset patients,0.4350311850311848,279.0
1175,2420,arthroplasty tka,0.43385579937304125,173.0
1176,2815,parahippocampal gyrus,0.43338323353293384,193.0
1177,2588,artery ica,0.43333333333333196,182.0
1178,1585,tissue sections,0.4327411167512681,155.0
1179,3166,temporal artery,0.43067484662577354,117.0
1180,2172,connectivity within,0.43028485757121465,205.0
1181,1451,many patients,0.42797202797202866,204.0
1182,2844,cell migration,0.4279291553133509,349.0
1183,533,increasingly used,0.4276859504132238,345.0
1184,158,image data,0.4273092369477923,304.0
1185,2168,carried using,0.42480983031012304,198.0
1186,2942,blood supply,0.423391812865498,181.0
1187,316,single institution,0.42322097378276874,226.0
1188,777,support use,0.4231200897867562,145.0
1189,1872,vertebral fractures,0.4229220065909924,175.0
1190,2084,stress testing,0.4222797927461152,163.0
1191,2982,hepatitis c,0.42045184304399497,221.0
1192,3213,carpal tunnel,0.4193169298567751,173.0
1193,3063,cox proportional,0.4189453125000017,429.0
1194,389,liver function,0.41892124763053534,221.0
1195,1624,low incidence,0.41830065359477026,128.0
1196,1313,right left,0.41814190425262415,895.0
1197,3298,dynamic changes,0.41761006289308167,166.0
1198,2871,review literature,0.4172661870503594,580.0
1199,2068,software used,0.4168126094570934,170.0
1200,1205,western blotting,0.4165457184325117,287.0
1201,9,subchondral bone,0.41628431448790704,265.0
1202,3740,imaging brain,0.41318681318680756,188.0
1203,3571,diagnostic challenge,0.412987012987012,159.0
1204,218,foreign body,0.4128440366972484,300.0
1205,2019,filtered back,0.41250000000000003,121.0
1206,706,retinal layers,0.4119349005424945,201.0
1207,2566,medial prefrontal,0.41176470588235214,490.0
1208,1097,health stroke,0.4108695652173905,243.0
1209,2569,lumen area,0.4099173553719015,124.0
1210,3187,results revealed,0.4096614368290652,451.0
1211,3035,studies identified,0.4090909090909087,189.0
1212,1643,pearson coefficient,0.40620155038759614,262.0
1213,1181,used characterize,0.40323395654370997,210.0
1214,1361,values respectively,0.402333840690006,305.0
1215,2138,middle temporal,0.40082508250825144,347.0
1216,1033,infants born,0.39999999999999974,136.0
1217,575,fibroblast growth,0.3993808049535584,129.0
1218,102,remains unclear,0.39867518334516383,766.0
1219,2953,cartilage damage,0.3984374999999996,153.0
1220,1466,associated factors,0.39761904761904054,167.0
1221,817,pressure gradient,0.3974694221847331,248.0
1222,3662,used predict,0.39736408566721515,268.0
1223,684,idiopathic scoliosis,0.3962686567164175,177.0
1224,3103,high degree,0.3939393939393944,260.0
1225,2445,contrast media,0.393625291526301,245.0
1226,1084,hospital stay,0.39356706336442715,532.0
1227,407,image noise,0.3934634974533104,515.0
1228,595,proportion patients,0.3930348258706458,395.0
1229,3238,matter tracts,0.39265536723163874,278.0
1230,1420,medical students,0.3904306220095688,272.0
1231,2792,dilated cardiomyopathy,0.38867187499999944,199.0
1232,3317,aortic stenosis,0.38724986158348484,544.0
1233,3563,connectivity analysis,0.3867187500000001,165.0
1234,2873,aortic repair,0.3865546218487388,184.0
1235,2436,procedures performed,0.3863169897377429,484.0
1236,2453,tomography scan,0.3858928075534579,772.0
1237,714,stent graft,0.38368456832086967,306.0
1238,2540,mean mean,0.38313253012048165,159.0
1239,2686,ventricular lv,0.3816085643700111,993.0
1240,2057,surgical excision,0.38102189781021883,261.0
1241,2487,within h,0.38058252427184514,392.0
1242,3156,third trimester,0.3804878048780491,156.0
1243,1305,complications related,0.3796376186367566,200.0
1244,2316,speckle tracking,0.37949728930507737,462.0
1245,469,molecular imaging,0.37853022322548224,686.0
1246,127,major adverse,0.37683397683398184,488.0
1247,2021,reconstruction algorithm,0.37675896504766165,166.0
1248,3015,nerve sheath,0.3749999999999984,165.0
1249,323,height weight,0.3735799207397616,202.0
1250,1206,navigation system,0.37294763626623756,236.0
1251,3340,fdg uptake,0.3729257641921393,441.0
1252,1176,cardiovascular events,0.3727974370176184,512.0
1253,1023,tricuspid valve,0.3723625232316603,262.0
1254,1794,cortical subcortical,0.3691652470187398,197.0
1255,2104,results suggested,0.36801040312093614,283.0
1256,89,cell wall,0.3678958785249457,424.0
1257,3026,radial artery,0.3667481662591692,250.0
1258,286,used compare,0.36491228070175585,520.0
1259,703,dorsal anterior,0.36458333333333387,175.0
1260,73,vivo experiments,0.364438122332859,183.0
1261,2459,fractures treated,0.36365838885523827,158.0
1262,3074,ellipsoid zone,0.36290162305399076,166.0
1263,1289,aim review,0.3625960717335597,193.0
1264,1138,pericardial effusion,0.36190476190476134,182.0
1265,2703,high spatial,0.3605530703538043,341.0
1266,952,liver metastases,0.358325219084711,368.0
1267,3723,women mean,0.3582125314484239,598.0
1268,2563,solid tumors,0.3577405857740587,285.0
1269,685,finite element,0.35754596527068466,683.0
1270,2112,available article,0.3559129612109757,297.0
1271,2480,lower extremities,0.3529638183217857,262.0
1272,2062,vein thrombosis,0.3523427041499327,329.0
1273,1421,cochrane library,0.3512069520437724,176.0
1274,2594,index pi,0.3500000000000018,154.0
1275,1378,acquired using,0.34972826086956454,234.0
1276,1219,microscopy showed,0.3496254013556899,196.0
1277,243,computer tomography,0.34897959183673427,171.0
1278,1731,functional recovery,0.34879518072289317,193.0
1279,2855,imaging used,0.3483652762119508,515.0
1280,3484,thickness cimt,0.3482758620689623,303.0
1281,3181,photodynamic therapy,0.3477240732050668,285.0
1282,335,wall shear,0.34725181082232626,163.0
1283,3204,zeta potential,0.3467987804878048,325.0
1284,3115,showed higher,0.34407582938388703,968.0
1285,2113,patients myocardial,0.34324324324324096,127.0
1286,2649,tests used,0.34128366066005267,196.0
1287,1568,visual acuity,0.3410420475319919,1599.0
1288,2056,neuroendocrine tumors,0.34099378881987547,183.0
1289,531,transesophageal echocardiography,0.33899566968016387,333.0
1290,660,images analyzed,0.33844537815126174,179.0
1291,1984,median duration,0.3379947229551457,183.0
1292,2814,twin pregnancies,0.3373167981961659,136.0
1293,1682,identify factors,0.3372093023255802,290.0
1294,2325,dose reduction,0.33674963396778884,460.0
1295,771,used functional,0.33577948809736924,268.0
1296,788,nuclear medicine,0.3345543345543349,548.0
1297,619,area receiver,0.3344757870414945,599.0
1298,1991,performed better,0.3340590979782271,179.0
1299,1692,fluorescent imaging,0.332545649838883,172.0
1300,1686,subjects aged,0.33241061130334454,131.0
1301,1538,nucleic acids,0.33233674272226504,192.0
1302,3548,current evidence,0.33136094674556116,140.0
1303,3469,imaging method,0.33034825870646617,332.0
1304,3365,liver stiffness,0.3296438722621632,434.0
1305,1035,cardiovascular magnetic,0.3287703471268873,254.0
1306,99,muscle mass,0.32863698944469927,651.0
1307,1498,inferior temporal,0.3286219081272085,155.0
1308,2145,level evidence,0.3281437125748514,274.0
1309,1932,vivo using,0.326959847036331,171.0
1310,1913,frontal parietal,0.3261231281197996,196.0
1311,2272,brain mapp,0.32525032558338157,556.0
1312,2067,hum brain,0.32525032558338157,556.0
1313,3697,liver cirrhosis,0.3251461988304097,278.0
1314,678,data using,0.3244712990936545,179.0
1315,391,mortality rates,0.3199703593923666,254.0
1316,2106,female male,0.3199296305604427,335.0
1317,3733,subretinal fluid,0.319874804381845,146.0
1318,2648,regression model,0.31787126932758053,520.0
1319,3382,adult male,0.31739961759082463,166.0
1320,1398,paper present,0.31535060012634125,192.0
1321,810,residual tumor,0.3146221786064755,229.0
1322,2875,giant cell,0.3142857142857141,186.0
1323,3342,disease associated,0.3133235724743767,214.0
1324,3421,outcomes patients,0.3131331652532674,759.0
1325,691,severe aortic,0.3128834355828221,255.0
1326,2047,spontaneous preterm,0.31280211480362574,251.0
1327,1158,reviewed retrospectively,0.31255060728745016,193.0
1328,452,dense breasts,0.3125326370757187,171.0
1329,327,proportional hazard,0.3115384615384631,162.0
1330,613,studies including,0.31039603960396056,198.0
1331,461,care unit,0.3093767135806981,403.0
1332,3750,frontal temporal,0.30897009966777417,217.0
1333,950,mapp periodicals,0.30779496511980625,516.0
1334,1773,ventricular systolic,0.30581651009394417,306.0
1335,1236,volume left,0.30556222488995605,166.0
1336,3478,neovascular macular,0.3050067658998657,161.0
1337,21,gastric cancer,0.3047237452551664,425.0
1338,2695,heart catheterization,0.30263157894736925,138.0
1339,1979,four groups,0.30217391304347513,417.0
1340,3706,cancer mortality,0.3020833333333337,145.0
1341,2024,laser ablation,0.30139442231075714,178.0
1342,3271,trabecular number,0.29879518072289246,124.0
1343,1547,image analysis,0.29691714836223443,804.0
1344,1900,cell population,0.2962843295638119,131.0
1345,1196,thoracic spine,0.29477611940298526,158.0
1346,993,common complication,0.2907340553549939,151.0
1347,2329,ultrasound examination,0.2888604353393101,376.0
1348,697,aortic diameter,0.28884826325411395,158.0
1349,392,slice thickness,0.2886297376093301,165.0
1350,818,selected patients,0.28818654305380026,446.0
1351,1908,functional imaging,0.2876997915218926,460.0
1352,3745,groups using,0.28744804655029177,247.0
1353,3500,tomography scanning,0.2873730043541365,198.0
1354,2825,type diabetes,0.283560342096928,1119.0
1355,2869,cases mean,0.2830848995463387,168.0
1356,2900,underwent surgery,0.28168346176644987,432.0
1357,1243,months range,0.2810603990161262,857.0
1358,1836,data consecutive,0.2807017543859647,160.0
1359,2929,approach based,0.28032786885246097,228.0
1360,1304,quantitative assessment,0.27980769230769365,291.0
1361,1929,randomized groups,0.27961165048543685,144.0
1362,3438,rectal cancer,0.2779989790709535,389.0
1363,2451,duration years,0.2776859504132233,168.0
1364,72,acute kidney,0.2776259866423802,295.0
1365,551,harris hip,0.27649769585253436,200.0
1366,367,degeneration amd,0.27625899280575544,224.0
1367,1546,nineteen patients,0.2762157382847038,142.0
1368,3251,atrial fibrillation,0.27586868880783266,958.0
1369,630,treatment results,0.275436554132713,182.0
1370,3182,coefficient variation,0.27425545996029177,259.0
1371,3545,linear regression,0.2740570327965325,1348.0
1372,3362,ultrasound guidance,0.273178887031288,301.0
1373,3518,pulmonary embolism,0.27306969557773403,536.0
1374,605,function assessed,0.27258105051520437,319.0
1375,1445,independent predictors,0.27258064516128794,845.0
1376,90,core biopsy,0.2725450901803608,204.0
1377,3147,image reconstruction,0.2707990497616539,528.0
1378,1831,procedure patients,0.2707317073170743,148.0
1379,3731,respectively multivariate,0.27054714784633244,166.0
1380,928,acute coronary,0.27040898155573495,562.0
1381,3224,analysis revealed,0.26882947505705473,1649.0
1382,450,obese patients,0.2685524126455909,269.0
1383,2967,control patients,0.267871556413406,449.0
1384,922,acute appendicitis,0.2652599849284096,176.0
1385,2178,total number,0.2651946542707731,326.0
1386,1579,h e,0.26445743989603643,185.0
1387,828,patients median,0.2621283105459394,596.0
1388,1791,neuromyelitis optica,0.2619542619542624,180.0
1389,2911,optic disc,0.2616822429906552,392.0
1390,1386,examination patients,0.2612513721185502,170.0
1391,2934,green fluorescent,0.26022566995768726,205.0
1392,2964,input function,0.2593406593406621,118.0
1393,920,brain region,0.2593264248704659,182.0
1394,721,surgery performed,0.25898617511520805,281.0
1395,1333,plays key,0.2569940476190479,157.0
1396,2826,measurements obtained,0.25599173553719057,354.0
1397,1859,upper extremity,0.25537625818820875,216.0
1398,688,patients pd,0.25504322766570603,295.0
1399,3695,overall results,0.2549256305238199,219.0
1400,2379,chronic kidney,0.25394692643600997,420.0
1401,865,articular cartilage,0.2534048699958726,307.0
1402,1510,twelve patients,0.2530171501164516,239.0
1403,2214,within normal,0.2518254674977746,202.0
1404,1490,upper limb,0.2513278990270844,177.0
1405,3414,high uptake,0.2509433962264154,133.0
1406,995,traumatic brain,0.2504927975739188,472.0
1407,745,patients assigned,0.24873096446700438,210.0
1408,3290,healthy individuals,0.2485094427969414,419.0
1409,2543,years included,0.24620355411955072,254.0
1410,134,first evidence,0.2436412315930395,182.0
1411,1536,microscopy imaging,0.24263322884012578,129.0
1412,3683,relatively small,0.24069218668064968,153.0
1413,2171,within days,0.24051883878939034,649.0
1414,609,patients patients,0.24020887728459966,2340.0
1415,2498,objective present,0.2401326699834163,181.0
1416,2547,stromal cells,0.24009094353921934,288.0
1417,1865,without compromising,0.23878504672897138,146.0
1418,143,chain reaction,0.23868065967016777,398.0
1419,2874,children years,0.23867893526125522,269.0
1420,376,patients known,0.23863636363636404,140.0
1421,1052,visual cortex,0.23848252236249495,508.0
1422,502,abdominal pain,0.2355173088206517,669.0
1423,49,prospectively collected,0.2354166666666678,226.0
1424,2629,brain tissue,0.23498465585269668,536.0
1425,176,assess effect,0.23476733977172898,191.0
1426,2961,found difference,0.2342696629213484,139.0
1427,3558,elevation myocardial,0.2338028169014126,332.0
1428,1897,temporal cortex,0.23358449946178736,217.0
1429,1649,left heart,0.23343108504398863,199.0
1430,3385,mean period,0.23342696629213544,277.0
1431,3677,ventricular outflow,0.23240418118466913,368.0
1432,2863,associated worse,0.23167132030315044,264.0
1433,1223,dice similarity,0.23123732251521298,190.0
1434,1607,cell membranes,0.23056300268096583,172.0
1435,1317,outflow tract,0.23036845810842552,409.0
1436,980,protein expression,0.230177514792899,389.0
1437,287,within hours,0.22926829268292695,419.0
1438,2336,hepatic artery,0.22847888376728542,262.0
1439,921,however limited,0.2284518828451886,156.0
1440,1218,january march,0.22758620689655126,143.0
1441,2969,area product,0.22692307692307534,118.0
1442,3097,cac score,0.22680412371134015,270.0
1443,38,symptomatic patients,0.22568578553615953,362.0
1444,2848,underwent surgical,0.2236953779103104,424.0
1445,3243,found associated,0.22345679012345826,181.0
1446,1896,subtraction angiography,0.22252497729336992,343.0
1447,981,cruciate ligament,0.22102425876010787,410.0
1448,2554,left hemisphere,0.2203125000000008,282.0
1449,1211,cesarean section,0.21984621017942152,158.0
1450,3713,patients moderate,0.21967213114754092,201.0
1451,1416,foreign bodies,0.2167761495704907,195.0
1452,3646,however whether,0.2164383561643835,158.0
1453,1816,aimed compare,0.21531809759110365,249.0
1454,2716,functional structural,0.21343283582089503,242.0
1455,1777,length stay,0.21323662737987345,294.0
1456,310,mr scanner,0.2105263157894731,140.0
1457,3218,texture features,0.20991580916744654,238.0
1458,1968,recent studies,0.20805369127516557,620.0
1459,2111,acquisition time,0.2074132492113561,263.0
1460,2607,hela cells,0.20719225449515888,214.0
1461,591,activity within,0.2071428571428561,116.0
1462,3001,arthroplasty tha,0.20537884665115125,209.0
1463,1921,controls differences,0.20382775119617277,142.0
1464,1885,power doppler,0.20378939697576987,329.0
1465,751,symptom severity,0.20345140781108034,224.0
1466,3672,healthy children,0.203183791606367,234.0
1467,1654,number studies,0.20226308345120322,143.0
1468,795,range days,0.20176356299506826,250.0
1469,2617,temporal gyrus,0.2010732668930028,540.0
1470,2898,patients abnormal,0.19844961240310063,256.0
1471,360,strongly correlated,0.19723586106564958,319.0
1472,3111,imaging tests,0.19633943427620645,177.0
1473,716,imaging positron,0.19627329192546586,158.0
1474,1415,hip score,0.1961123110151186,227.0
1475,960,remaining patients,0.19600886917960408,442.0
1476,2347,median number,0.19589041095890433,143.0
1477,3065,forty patients,0.19577922077922022,201.0
1478,2662,connectivity left,0.19562043795620462,134.0
1479,886,eye movement,0.19517743403093726,195.0
1480,3744,carotid arteries,0.19473543559593778,347.0
1481,640,limiting membrane,0.19468911917098394,167.0
1482,2407,tomography patients,0.19329608938547493,173.0
1483,1231,total participants,0.19210526315789753,146.0
1484,1461,monte carlo,0.1907807409195136,527.0
1485,1263,injury sci,0.19054054054054012,141.0
1486,1727,next generation,0.18947368421052851,126.0
1487,2069,tracer uptake,0.18945199835187382,209.0
1488,2725,nitric oxide,0.18815331010452963,270.0
1489,3466,survival patients,0.18722924187725742,461.0
1490,1575,facet joint,0.18721560130010848,216.0
1491,1220,lv dysfunction,0.18653295128939848,186.0
1492,1401,volume patients,0.18633045786330346,156.0
1493,3623,cases showed,0.18448023426061508,210.0
1494,1248,signaling pathways,0.18443113772455152,198.0
1495,1875,inferior longitudinal,0.18312655086848684,123.0
1496,343,patients less,0.18260869565217458,159.0
1497,1096,cancellous bone,0.1824644549763033,154.0
1498,432,could applied,0.1818181818181816,152.0
1499,125,nervous system,0.18124999999999625,1276.0
1500,2315,parameters including,0.18073387286870432,371.0
1501,3165,reliable method,0.1806516967752831,214.0
1502,3193,rates respectively,0.17942430703624726,374.0
1503,284,neuropsychological tests,0.1780821917808217,135.0
1504,3652,revision surgery,0.17618283881315147,338.0
1505,1473,knee pain,0.17607995374576707,209.0
1506,793,using multiple,0.17496962332928356,144.0
1507,1484,brain activation,0.17395678283631874,458.0
1508,2101,histological findings,0.1730210016155087,153.0
1509,384,morphological changes,0.17208727871551988,418.0
1510,3422,graphene oxide,0.17187896358035892,279.0
1511,404,remains poorly,0.17159763313609447,174.0
1512,2664,autism spectrum,0.17085893759388215,272.0
1513,573,associated disease,0.1704545454545465,150.0
1514,2152,fundus autofluorescence,0.16949152542372956,150.0
1515,2631,superior mesenteric,0.16892911010558043,224.0
1516,3462,scale vas,0.16892523364485978,241.0
1517,395,fellow eyes,0.16879761510433922,196.0
1518,712,findings patients,0.16820903647250968,515.0
1519,2322,acute myocardial,0.16651982378854213,378.0
1520,2862,commercially available,0.16414842498665155,559.0
1521,3205,developmental delay,0.16333845366103414,165.0
1522,1129,health care,0.16329728679660682,467.0
1523,3627,cancer cell,0.16293879387938756,557.0
1524,1312,ten patients,0.1620967741935485,469.0
1525,523,recurrence rates,0.16109154929577463,183.0
1526,2241,exhibited higher,0.16104190260475534,237.0
1527,348,still unclear,0.15903614457831491,198.0
1528,2396,imaging contrast,0.15896649879570832,242.0
1529,245,coronary flow,0.15895994378074507,261.0
1530,1665,u test,0.15821152192605437,184.0
1531,948,patients tumor,0.15723270440251483,125.0
1532,1537,past decades,0.15702479338843098,285.0
1533,2146,artery calcium,0.15693430656934265,215.0
1534,2128,oxide nanoparticles,0.15583722481654433,292.0
1535,2683,animal model,0.15390655673340992,392.0
1536,122,lean mass,0.15334732513813337,351.0
1537,2082,period months,0.1531197301854968,454.0
1538,996,central venous,0.15267097899556709,389.0
1539,3409,present novel,0.15226586102719195,252.0
1540,1846,greater activation,0.15204678362573182,130.0
1541,299,shoulder arthroplasty,0.1499999999999996,144.0
1542,3225,weight loss,0.14994446985039572,604.0
1543,2240,investigate relationship,0.14848280512474243,367.0
1544,3245,aim investigate,0.1482239919099985,1066.0
1545,11,analyzed data,0.14774281805745584,180.0
1546,3605,higher number,0.14716636197440583,161.0
1547,61,conservative management,0.14551004833375705,220.0
1548,1072,different time,0.1450053705692799,225.0
1549,896,anisotropy fa,0.14465626805314727,626.0
1550,2582,assess feasibility,0.14437869822485128,183.0
1551,3178,first second,0.14330177668266134,325.0
1552,970,tomography magnetic,0.14328482907470513,686.0
1553,3506,shear stress,0.14316469321851474,385.0
1554,1976,total occlusion,0.1424528301886792,151.0
1555,512,target lesion,0.14202401372212717,322.0
1556,185,cerebral ischemia,0.14189189189189264,210.0
1557,3542,examined whether,0.14118183892311187,238.0
1558,2988,information processing,0.14081632653061232,207.0
1559,2668,transient ischemic,0.13888334995015,199.0
1560,1755,k trans,0.13846153846153914,243.0
1561,524,body mass,0.13758789969484173,2074.0
1562,1276,intraclass coefficient,0.1371928987630764,491.0
1563,3655,improved image,0.13673929376408728,130.0
1564,1066,median survival,0.136181575433911,255.0
1565,3756,prediction model,0.13583943931188228,164.0
1566,405,chronic inflammatory,0.13570019723865884,172.0
1567,2763,patients cases,0.13477672530446558,166.0
1568,1590,model using,0.13475609756097404,221.0
1569,3670,prognostic information,0.13459119496855396,214.0
1570,3311,sensitive specific,0.1330316742081481,294.0
1571,2008,aseptic loosening,0.1323943661971832,141.0
1572,3306,diffusion weighted,0.13186913749714002,262.0
1573,2182,propose new,0.13150367220718978,189.0
1574,2996,underwent successful,0.13139969237530258,230.0
1575,2836,spectroscopy xps,0.13080168776371415,155.0
1576,1591,wall thickening,0.12994011976048234,217.0
1577,883,investigated relationship,0.1291666666666669,186.0
1578,1651,cells results,0.12769189042582088,214.0
1579,2786,patients early,0.12632972853674634,318.0
1580,1207,images images,0.1263204225352115,205.0
1581,1183,vertebral bodies,0.12466124661246546,138.0
1582,718,left coronary,0.12406459235919702,175.0
1583,2544,children hospital,0.12386706948640523,205.0
1584,838,results patients,0.1230100434717441,373.0
1585,956,years women,0.1222625090645398,281.0
1586,430,months surgery,0.12100840336134153,576.0
1587,2915,combined use,0.11830985915492934,168.0
1588,1764,coronary syndrome,0.11752423564504148,394.0
1589,439,ra patients,0.11647717018588692,461.0
1590,2738,patients idiopathic,0.11615566037735785,197.0
1591,3059,rnfl thickness,0.11615231776007583,540.0
1592,489,atherosclerotic plaques,0.11562814632509279,304.0
1593,2348,node dissection,0.11530470914127428,185.0
1594,1669,field strength,0.11393341553637482,154.0
1595,558,cohen kappa,0.11277609354699011,186.0
1596,2392,epilepsy surgery,0.11261352169525712,186.0
1597,2092,january december,0.1120621129494399,866.0
1598,694,using fluorescence,0.11102886750555076,250.0
1599,484,general population,0.1103055642040655,496.0
1600,3197,symptom onset,0.10877447425670746,250.0
1601,3603,development novel,0.10841487279843326,277.0
1602,1221,wilcoxon test,0.10714285714285755,234.0
1603,269,specific activity,0.1069182389937111,170.0
1604,2006,young modulus,0.10578806767586904,198.0
1605,1574,cell growth,0.10511713933415538,341.0
1606,1646,replacement therapy,0.1048758865248227,169.0
1607,1956,urinary tract,0.1046668465066099,388.0
1608,1742,imaging techniques,0.103656622724421,1321.0
1609,565,radiologic findings,0.10337161911819207,155.0
1610,3606,patients older,0.10275689223058279,205.0
1611,1558,low cytotoxicity,0.10223266745005903,145.0
1612,1695,arterial stiffness,0.09997576540916045,364.0
1613,736,cortical areas,0.09986168741355542,361.0
1614,2886,thickness measurements,0.09933055907363815,183.0
1615,402,mutation carriers,0.09868421052631561,150.0
1616,264,imaging reporting,0.09712586719524355,245.0
1617,1303,taken account,0.09686411149825723,278.0
1618,250,m respectively,0.09641873278236986,175.0
1619,2494,patients severe,0.09334241654796582,942.0
1620,2324,kidney injury,0.09324452901998105,350.0
1621,2287,response assessment,0.09321439949028369,209.0
1622,3659,ganglion cell,0.09095844140177334,260.0
1623,654,current guidelines,0.09077380952380955,183.0
1624,631,peak velocity,0.09057665260196923,161.0
1625,780,patients achieved,0.09050772626931594,205.0
1626,2584,inclusion criteria,0.0902573529411756,982.0
1627,1821,oct images,0.08918918918918926,231.0
1628,221,brain changes,0.08848433530906005,209.0
1629,3107,ultrasound scan,0.08719570028454,197.0
1630,1009,model based,0.08504584255453676,269.0
1631,463,remains challenge,0.08486352357320025,171.0
1632,3144,determine optimal,0.08292682926829233,204.0
1633,3164,using visual,0.08241758241758217,150.0
1634,3448,likely due,0.0822928075940126,161.0
1635,1827,accuracy sensitivity,0.08211243611584312,241.0
1636,1302,renal cell,0.08085106382978793,247.0
1637,3098,changes occur,0.08009950248756263,161.0
1638,601,preoperative evaluation,0.07991071428571425,179.0
1639,1064,selected cases,0.0781334780249594,144.0
1640,2326,included studies,0.07794208256315513,253.0
1641,1104,single molecule,0.07764227642276426,191.0
1642,3394,olfactory bulb,0.07639956092206364,174.0
1643,787,improved patients,0.07608695652173918,140.0
1644,2332,examination revealed,0.07300642331192321,466.0
1645,543,retrospective patients,0.07231270358306176,296.0
1646,5,microscopy revealed,0.07040498442367575,226.0
1647,3335,cortical thinning,0.06905537459283435,212.0
1648,107,common patients,0.06762589928057647,235.0
1649,2697,following treatment,0.06637265711135841,301.0
1650,375,computerized tomography,0.06576763485477072,317.0
1651,2746,could detected,0.06566826787228018,166.0
1652,597,anterior temporal,0.0652557319223988,185.0
1653,1666,results show,0.06324691309008645,1593.0
1654,891,critical role,0.06250445950767047,292.0
1655,1786,performed determine,0.06232813932172341,340.0
1656,2195,contrast medium,0.05893719806763459,366.0
1657,2761,spectrum disorder,0.056960873521383196,313.0
1658,410,postoperative period,0.05575221238938024,231.0
1659,2663,plays critical,0.05564202334630217,143.0
1660,1170,achieved using,0.055443322109987224,247.0
1661,2132,intracranial aneurysms,0.055322862129145105,317.0
1662,2611,proposed method,0.05528575522012894,1574.0
1663,2861,fatty acid,0.05523833964200918,287.0
1664,2483,single nucleotide,0.05446623093682009,125.0
1665,537,pulmonary function,0.05357423409269482,341.0
1666,2038,children adults,0.05346534653465079,189.0
1667,767,disease ckd,0.052598622417032136,180.0
1668,2920,transcription factor,0.05250757320767328,260.0
1669,2089,retrospective chart,0.0518940663761309,258.0
1670,1185,dual energy,0.051327433628318604,232.0
1671,1004,values patients,0.05122615803814693,188.0
1672,851,interventional procedures,0.05020026702269726,188.0
1673,1815,participants aged,0.049812734082397524,133.0
1674,1365,overall mortality,0.04948784896565573,176.0
1675,3419,volume associated,0.049342105263157465,150.0
1676,2938,treatment decisions,0.049263721552877726,184.0
1677,2530,monoclonal antibody,0.0488400488400504,200.0
1678,1569,analysis performed,0.04880340625457821,1662.0
1679,1154,last years,0.048625429553265195,283.0
1680,1521,lung cancers,0.047924330005255096,152.0
1681,2275,cardiomyopathy hcm,0.04667444574095768,200.0
1682,397,respectively however,0.046009808292465496,172.0
1683,850,tetralogy fallot,0.045943304007819964,235.0
1684,2854,healthy male,0.045161290322580205,161.0
1685,2262,observed cases,0.0432852386237512,195.0
1686,3232,chest radiography,0.041248849083451965,224.0
1687,493,dorsolateral prefrontal,0.039932744850773916,475.0
1688,1661,genetic testing,0.03984962406015115,212.0
1689,437,years average,0.03964656165962414,172.0
1690,621,surgical approach,0.039574262215773134,409.0
1691,2301,average years,0.0391070690367922,473.0
1692,216,gy gy,0.03907838265190899,173.0
1693,3512,small molecules,0.037906647807637875,134.0
1694,1157,deep brain,0.037346437346437,304.0
1695,116,correlated negatively,0.03718140929535223,124.0
1696,1541,physical examination,0.0341743692230823,684.0
1697,160,imaging revealed,0.03341827448125251,459.0
1698,1201,retinal nerve,0.032749925838030394,552.0
1699,115,january january,0.03234172387490511,212.0
1700,1485,per cent,0.03211360917706969,349.0
1701,799,tumor resection,0.032038834951457144,231.0
1702,292,results confirm,0.031195840554592905,180.0
1703,279,anterior cingulate,0.030365939479242366,863.0
1704,3037,patients could,0.030324400564175055,215.0
1705,957,optical properties,0.030178689609531496,228.0
1706,3191,cancer underwent,0.02937062937062966,189.0
1707,2980,interobserver variability,0.029312340819633853,211.0
1708,501,carotid stenosis,0.028921568627451162,236.0
1709,3017,nerve root,0.027659574468085278,208.0
1710,1503,knee injury,0.02764883955600392,137.0
1711,1267,crucial role,0.027186761229314182,345.0
1712,2565,saphenous vein,0.02467700258397946,191.0
1713,1629,images reconstructed,0.024440465532676734,273.0
1714,826,found cases,0.02225293711126494,161.0
1715,2083,sagittal plane,0.022207176709546767,328.0
1716,871,mechanisms involved,0.021864520456069313,163.0
1717,2757,range cm,0.02126328955597228,170.0
1718,2400,score improved,0.021062992125985176,214.0
1719,1561,retrospectively analyzed,0.020733788395904576,729.0
1720,2193,time minutes,0.019416243654822224,306.0
1721,105,could improve,0.0191872899480602,314.0
1722,1152,investigated effect,0.018500224517287493,206.0
1723,224,different stages,0.018157980989839652,277.0
1724,353,preliminary results,0.01806069578090287,244.0
1725,1722,pathological changes,0.01795774647887315,204.0
1726,2465,right ventricle,0.016736294106305206,434.0
1727,738,patients similar,0.016721097322011894,128.0
1728,1737,cases respectively,0.016693837626344927,256.0
1729,1514,pulmonary disease,0.016584230433517325,285.0
1730,1522,left posterior,0.015754001684919795,187.0
1731,2317,versus versus,0.01563439567047491,312.0
1732,2899,resistive index,0.01289566236811274,165.0
1733,491,disc herniation,0.01162584833284161,197.0
1734,3014,screw placement,0.011114108443485265,206.0
1735,317,access site,0.010637149028078021,197.0
1736,86,interventional radiology,0.010247093023255736,282.0
1737,2370,december patients,0.009459189782478733,237.0
1738,2857,transit time,0.008409565077836523,262.0
1739,704,internal fixation,0.007434834123222583,251.0
1740,2319,systolic pressure,0.006933511974543399,207.0
1741,3066,quantitative susceptibility,0.0045229029652708586,196.0
1742,1535,vocal fold,0.002029190683250671,301.0
1743,1720,neuroendocrine tumor,2.397450342011515e-15,124.0
1744,1804,range range,1.6135832791295311e-15,275.0
1745,1232,blue light,1.4876437709634117e-15,167.0
1746,459,detailed analysis,1.4860532215552903e-15,127.0
1747,783,data support,8.761294796383246e-16,258.0
1748,1769,receptor egfr,7.783605688944764e-16,120.0
1749,3481,locally advanced,7.745447186002749e-16,461.0
1750,3236,early late,7.602010436355963e-16,351.0
1751,1942,angiography mra,5.769358637161564e-16,149.0
1752,1890,ultrasound performed,5.48065216750818e-16,159.0
1753,2025,currently available,5.126127376011478e-16,310.0
1754,1772,weight gain,3.6555592213255053e-16,168.0
1755,3489,levels higher,3.206746728538656e-16,225.0
1756,1507,treatment strategy,1.9500046219288359e-16,218.0
1757,183,malignant transformation,5.4970889944320924e-17,219.0
1758,963,electron microscopy,0,4498.0
1759,1564,using linear,0,286.0
1760,2454,mean years,0,4305.0
1761,3682,operating characteristic,0,1806.0
1762,2675,investigate effects,0,209.0
1763,276,conducted patients,0,261.0
1764,3635,fiber layer,0,417.0
1765,2511,delivery system,0,390.0
1766,2635,last decades,0,169.0
1767,1356,first time,0,1538.0
1768,614,identify patients,0,450.0
1769,796,functional brain,0,383.0
1770,1803,major complications,0,401.0
1771,2257,controls hc,0,223.0
1772,1392,minimally invasive,0,1050.0
1773,2895,weeks later,0,148.0
1774,2016,male female,0,930.0
1775,2360,occurred patients,0,737.0
1776,1141,studied patients,0,325.0
1777,2353,randomized trial,0,375.0
1778,112,patients large,0.0,207.0
1779,3279,less invasive,0,203.0
1780,1982,distal femur,0.0,165.0
1781,3339,purpose determine,0,566.0
1782,3604,morbidity mortality,0,866.0
1783,1340,negatively correlated,0,665.0
1784,474,valve disease,-1.509209002524304e-16,144.0
1785,62,showed low,-2.2837315302633147e-16,169.0
1786,979,paired test,-2.499126565582621e-16,166.0
1787,3425,bypass graft,-3.527850557088534e-16,153.0
1788,3090,field view,-3.6050308965426936e-16,284.0
1789,1970,pattern analysis,-3.75034318971437e-16,187.0
1790,3494,underwent magnetic,-3.9172333685551753e-16,251.0
1791,298,eighteen patients,-5.173023529165248e-16,175.0
1792,2583,visual assessment,-1.306076598392839e-15,207.0
1793,1683,analyzed patients,-2.5550491885473246e-15,334.0
1794,2660,among groups,-2.8470597267772435e-15,688.0
1795,2457,rate higher,-5.214451782195262e-15,172.0
1796,1616,volume loss,-0.004716178436854299,194.0
1797,2740,knee joint,-0.00536639526276823,290.0
1798,3743,systolic diastolic,-0.005878120329883356,531.0
1799,2767,pulmonary nodules,-0.005954465849387318,289.0
1800,1018,tricuspid regurgitation,-0.006774488861763807,259.0
1801,671,patients metastatic,-0.006819392647842466,192.0
1802,1603,brachial artery,-0.0077505074737037475,210.0
1803,1460,however difference,-0.010887617641630936,295.0
1804,336,online supplemental,-0.01126251846987385,343.0
1805,940,supplemental material,-0.01126251846987385,343.0
1806,268,women years,-0.011739953713444292,279.0
1807,3661,pancreatic duct,-0.01271901362751451,196.0
1808,3370,magnetic stimulation,-0.012813226556444447,248.0
1809,92,white blood,-0.013355408388521063,242.0
1810,3487,investigate feasibility,-0.014009878760664892,156.0
1811,1122,females males,-0.01562561190522598,399.0
1812,867,structural connectivity,-0.016170590848511468,182.0
1813,113,complication rates,-0.01708067187130343,361.0
1814,15,histological examination,-0.017245657568238204,278.0
1815,2610,reported literature,-0.017510843196353737,397.0
1816,556,hyaluronic acid,-0.017664493183165254,149.0
1817,2191,years female,-0.019003260363297563,204.0
1818,3034,complications included,-0.01931385006353232,152.0
1819,2753,cross sectional,-0.019732205778717773,140.0
1820,1886,live cells,-0.02004773269689756,336.0
1821,759,patients heart,-0.020168067226890792,216.0
1822,1847,sinus rhythm,-0.021097046413501967,175.0
1823,1811,resonance images,-0.02171522814733335,395.0
1824,1728,rate lower,-0.02177361211247324,151.0
1825,2545,rsna online,-0.02217514124293768,314.0
1826,1931,poorly understood,-0.022462590371573367,668.0
1827,2363,energy absorptiometry,-0.02423768569194724,155.0
1828,2791,analyzed retrospectively,-0.025237053245805864,173.0
1829,622,characteristics patients,-0.025434506146672135,300.0
1830,2751,coronary lesions,-0.026623376623376573,164.0
1831,2028,af patients,-0.02694775435380335,147.0
1832,1412,potential role,-0.027376760563379635,311.0
1833,644,therapeutic option,-0.027768313458262247,163.0
1834,662,cases patients,-0.028644719965797892,335.0
1835,3367,cardiac involvement,-0.029078014184397125,164.0
1836,3509,visual analog,-0.029282075431311318,380.0
1837,904,wistar rats,-0.030128597672994417,246.0
1838,2503,papillary thyroid,-0.030673896204492703,198.0
1839,1108,play important,-0.030933750652061515,593.0
1840,1748,optical imaging,-0.03172043010752706,413.0
1841,1452,cells could,-0.03255240443896393,132.0
1842,2659,imaging modality,-0.03312689418895676,838.0
1843,971,important prognostic,-0.03391622610817437,139.0
1844,3184,ventricular function,-0.034952229299362265,439.0
1845,2724,using vivo,-0.03537906137184013,147.0
1846,1194,machine learning,-0.03562753036437256,396.0
1847,2702,bone defects,-0.03684749232343898,180.0
1848,2359,average months,-0.03722721437740675,145.0
1849,422,insular cortex,-0.038249483115092756,185.0
1850,2903,circumferential strain,-0.03842215331362181,296.0
1851,3096,method using,-0.03855693348365288,342.0
1852,2253,cardiac death,-0.03875315922493702,460.0
1853,3465,cognitive function,-0.03877264823021315,384.0
1854,2858,method could,-0.03922018348623867,171.0
1855,663,needed determine,-0.03973063973063841,177.0
1856,927,pediatric patients,-0.039868546225027925,922.0
1857,1902,time years,-0.04058355437665764,153.0
1858,1917,inner outer,-0.040860215053762985,133.0
1859,567,successfully used,-0.04094650205761251,199.0
1860,530,showed improvement,-0.04196771714066055,273.0
1861,596,lesion revascularization,-0.04260190435433821,181.0
1862,672,vs vs,-0.042693409742118195,447.0
1863,3106,outcomes assessed,-0.04275668073136469,152.0
1864,1627,survival time,-0.043240697126707285,153.0
1865,28,limited number,-0.04335343095032993,151.0
1866,2533,overweight obese,-0.04542483660130742,139.0
1867,1864,differential diagnoses,-0.04658493870402659,133.0
1868,175,cardiac hypertrophy,-0.04838981621986216,205.0
1869,129,frame rate,-0.04847934634589219,178.0
1870,249,however use,-0.04873501997336826,183.0
1871,1237,trabecular bone,-0.04957311605785362,578.0
1872,3277,healthy young,-0.05079365079365075,192.0
1873,3488,therapeutic options,-0.05136436597110714,160.0
1874,3126,right posterior,-0.05219638242893943,202.0
1875,566,studied using,-0.052241513345426996,336.0
1876,140,provide overview,-0.05255255255255282,175.0
1877,755,based data,-0.05273631840796029,159.0
1878,2003,neural activation,-0.052773613193402506,176.0
1879,1020,brain tumor,-0.052970237377996686,314.0
1880,3233,hypertension diabetes,-0.053401797175866364,208.0
1881,3294,portal venous,-0.05384615384615359,189.0
1882,2346,periodicals clin,-0.05497896213183705,196.0
1883,897,clin ultrasound,-0.05497896213183705,196.0
1884,1443,diastolic blood,-0.0564943253467833,224.0
1885,1582,lateral wall,-0.05700712589073582,168.0
1886,784,postoperative complications,-0.05738341968911868,443.0
1887,423,high accuracy,-0.058058188950638204,296.0
1888,2909,patients recruited,-0.058801498127340666,157.0
1889,2561,functional connectivity,-0.05883833559942893,2909.0
1890,3387,hazard hr,-0.059525480836726465,424.0
1891,1379,groups difference,-0.05957446808510721,182.0
1892,3019,analyzed total,-0.06015037593985056,120.0
1893,453,transgenic mice,-0.06122766122766129,197.0
1894,1285,regression used,-0.06126250431183,296.0
1895,547,echocardiographic examination,-0.06150442477876128,139.0
1896,885,pathological findings,-0.06193181818181761,218.0
1897,965,patients whereas,-0.06329526916802622,194.0
1898,2239,recurrence patients,-0.06485013623978193,119.0
1899,3013,prospective included,-0.06514560192134491,155.0
1900,887,multidetector computed,-0.06613312512199872,242.0
1901,949,mean attenuation,-0.06651884700665188,150.0
1902,3375,square error,-0.06660973526900041,130.0
1903,2309,groups according,-0.06704675028506292,588.0
1904,808,thus far,-0.06770025839793328,131.0
1905,2408,predictive factors,-0.0677992888186483,286.0
1906,1496,medial temporal,-0.06791131855309208,291.0
1907,843,using different,-0.06892590465249887,600.0
1908,535,tomography revealed,-0.06934189406099457,216.0
1909,1492,eyes patients,-0.06990521327013466,590.0
1910,1357,folic acid,-0.07065217391304336,130.0
1911,2011,stereotactic body,-0.07079236552920785,204.0
1912,1227,physicochemical properties,-0.07139079851930175,225.0
1913,3727,cerebral cortex,-0.07256529661874889,256.0
1914,2914,cystic fibrosis,-0.07277075503928881,213.0
1915,1418,lupus erythematosus,-0.0732475598935225,254.0
1916,1430,hypertrophic cardiomyopathy,-0.07366931533688856,376.0
1917,1633,nucleus accumbens,-0.0741326841144255,203.0
1918,1381,visual areas,-0.07448421795097843,192.0
1919,2403,rate per,-0.0749891634156915,173.0
1920,3629,corona radiata,-0.07728237791932042,182.0
1921,2072,preoperative computed,-0.07794004611837038,169.0
1922,2033,however due,-0.07836257309941493,134.0
1923,3699,crohn disease,-0.07853187786742574,438.0
1924,3121,tumor progression,-0.0801119023397759,225.0
1925,1508,surgically treated,-0.08036454018227007,194.0
1926,2754,incidental findings,-0.08046875000000005,206.0
1927,1914,gastrointestinal tract,-0.08093716719914773,190.0
1928,3054,volume measurements,-0.08113766541576127,158.0
1929,2859,feasible safe,-0.08128342245989262,228.0
1930,2720,quality assessment,-0.08173258003766173,217.0
1931,3077,changes observed,-0.08178308178308188,233.0
1932,3517,duplex ultrasound,-0.08180242634315407,236.0
1933,2482,type b,-0.08221024258760089,305.0
1934,110,transcranial doppler,-0.08300395256916922,245.0
1935,3138,ultrasound examinations,-0.0833333333333339,245.0
1936,1524,demographic data,-0.08371902518943244,292.0
1937,3124,tissue samples,-0.08406304728546282,240.0
1938,3578,systemic lupus,-0.08480888598497206,236.0
1939,3004,excluded patients,-0.08501529051987845,139.0
1940,1694,macular hole,-0.08568617806197724,201.0
1941,2051,disease onset,-0.08580060422960908,142.0
1942,2600,preoperative postoperative,-0.08699271592091463,418.0
1943,2696,boys girls,-0.08722316865417516,256.0
1944,3222,subjects years,-0.08736141906873528,197.0
1945,812,series patients,-0.08744007670182403,456.0
1946,876,gene delivery,-0.08744769874476985,209.0
1947,2216,calcium phosphate,-0.08822972546544633,233.0
1948,2901,body composition,-0.08863476391125336,938.0
1949,2593,index suspicion,-0.08894878706199487,165.0
1950,281,reconstructed images,-0.08942038353803046,249.0
1951,2388,thyroid gland,-0.09153209925167417,166.0
1952,625,analog scale,-0.09202593045922305,350.0
1953,790,imaging scans,-0.09272237196765608,344.0
1954,1903,correlated positively,-0.09294037011651775,226.0
1955,1549,developed novel,-0.09294871794871815,232.0
1956,1453,time course,-0.09541928333949015,287.0
1957,1844,nerve injury,-0.09638189869316333,194.0
1958,698,based analysis,-0.09721918108167278,148.0
1959,3132,anatomic landmarks,-0.09833249115715022,139.0
1960,1730,retinal ganglion,-0.09918902058640007,159.0
1961,2100,chronic obstructive,-0.09923514414591081,230.0
1962,3630,newly developed,-0.09968223919951323,388.0
1963,1925,mean months,-0.1003244646333562,773.0
1964,1858,years respectively,-0.10038610038610121,390.0
1965,2449,microcomputed tomography,-0.10115473441108534,146.0
1966,758,test performed,-0.1018206338503024,151.0
1967,1393,vertebral body,-0.10289576772409531,394.0
1968,1362,radiofrequency ablation,-0.10457038391224928,286.0
1969,2127,classification accuracy,-0.10482879719051755,199.0
1970,1093,needle biopsy,-0.10544400745187289,283.0
1971,443,renal failure,-0.10631857737419566,281.0
1972,19,plain radiographs,-0.10643093063920651,249.0
1973,3085,groups mean,-0.10671785028790752,278.0
1974,3291,resynchronization therapy,-0.10691823899371011,170.0
1975,189,noninvasive imaging,-0.10819672131147477,297.0
1976,70,using images,-0.10859106529209583,158.0
1977,2261,prenatal ultrasound,-0.10861423220973729,145.0
1978,2268,post hoc,-0.10895340326908985,319.0
1979,864,model showed,-0.10922509225092505,148.0
1980,3584,medical history,-0.10926517571885011,342.0
1981,1955,deviation sd,-0.10957960027567158,265.0
1982,3539,abnormal findings,-0.10985221674876862,223.0
1983,304,results highlight,-0.11029836381135745,191.0
1984,525,department ed,-0.11037160288408097,199.0
1985,1599,cells treated,-0.1106434155141315,184.0
1986,1534,material available,-0.1108975459069851,359.0
1987,1082,coronal plane,-0.11095152603231583,206.0
1988,909,difference observed,-0.11101485148514771,299.0
1989,3145,f fdg,-0.11142792826592642,297.0
1990,3127,molecular mechanisms,-0.1115241635687737,300.0
1991,1475,longitudinal circumferential,-0.11179245283018803,158.0
1992,3715,repeated measures,-0.11196911196911272,145.0
1993,508,venous drainage,-0.11199575371549908,211.0
1994,1165,parietal lobule,-0.11210571184995735,263.0
1995,3093,nine patients,-0.11235370611183333,648.0
1996,1098,patients bilateral,-0.1125653147549139,174.0
1997,202,imaging approach,-0.11260396673064654,176.0
1998,3599,assess whether,-0.11569826707441233,454.0
1999,2340,digital subtraction,-0.11590351594439938,405.0
2000,3437,obstructive pulmonary,-0.11663201663201637,187.0
2001,504,demonstrate feasibility,-0.11746384872080011,176.0
2002,2271,early stage,-0.11809270010469174,564.0
2003,1610,measured patients,-0.11849427168576117,181.0
2004,1272,fetal growth,-0.11867007672634244,232.0
2005,650,infarction mi,-0.11919040479760094,265.0
2006,2416,h h,-0.11980466630493784,184.0
2007,2783,patients lung,-0.120475113122172,213.0
2008,3477,detection characterization,-0.1212989493791785,127.0
2009,1660,doppler ultrasonography,-0.1227950575202388,262.0
2010,3130,patients ms,-0.12336448598130814,264.0
2011,3690,benign lesions,-0.12385793252430238,361.0
2012,2502,adverse event,-0.12500000000000025,230.0
2013,141,care patients,-0.12579058327477008,179.0
2014,2605,respiratory motion,-0.12603418379985123,336.0
2015,96,due low,-0.1260504201680671,150.0
2016,74,groups differences,-0.1265294615167749,204.0
2017,1189,multiple regression,-0.12727272727272532,433.0
2018,666,might provide,-0.12803738317756977,137.0
2019,1829,flow velocity,-0.1280612244897968,502.0
2020,492,bone tissue,-0.12902479912133605,360.0
2021,1434,using software,-0.12931562819203252,211.0
2022,675,room temperature,-0.13055117253387022,279.0
2023,2367,cortex left,-0.13109243697478956,156.0
2024,930,z score,-0.13138785205293568,176.0
2025,117,absorptiometry dxa,-0.131468531468531,423.0
2026,2694,distant metastasis,-0.1323932926829268,193.0
2027,465,hip arthroplasty,-0.13320436158987042,541.0
2028,84,bypass grafting,-0.13348529493523104,343.0
2029,3601,purpose present,-0.13357034027425035,263.0
2030,1440,years years,-0.13457750129601004,649.0
2031,1758,small number,-0.1348394768133171,243.0
2032,2507,cervical length,-0.13488811849984228,535.0
2033,1944,pulmonary vein,-0.1365872186876843,248.0
2034,2391,using analysis,-0.1366024518388803,260.0
2035,2801,patients treatment,-0.1366255144032929,166.0
2036,1119,volume reduction,-0.13667953667953656,177.0
2037,1145,propose novel,-0.1377358490566035,219.0
2038,1774,controls using,-0.13813358597820957,162.0
2039,2549,coronary sinus,-0.1383928571428569,155.0
2040,503,artery bypass,-0.14069610134054808,520.0
2041,2390,cell survival,-0.14128574920557285,170.0
2042,1310,mitral annular,-0.142834394904458,207.0
2043,778,cellular level,-0.14364089775561112,144.0
2044,807,wide variety,-0.14375987361769307,245.0
2045,2972,cardiac surgery,-0.1444166477143505,254.0
2046,760,longitudinal fasciculus,-0.14466230936819102,332.0
2047,1621,choroidal thickness,-0.14495152518325832,613.0
2048,1989,automated segmentation,-0.14622641509433948,155.0
2049,1746,screening mammography,-0.14641669186573983,269.0
2050,2614,transcranial magnetic,-0.14727812603101245,248.0
2051,2978,radiation oncology,-0.14754601226993888,333.0
2052,6,morphological features,-0.14891416752843864,240.0
2053,2998,right heart,-0.14955443626501336,386.0
2054,234,ultrasound ceus,-0.15000000000000008,144.0
2055,1363,interobserver reliability,-0.15037534571315642,173.0
2056,1480,arteriovenous fistula,-0.150632911392405,204.0
2057,2280,show high,-0.15122749590834653,154.0
2058,2715,survival months,-0.1515375153751543,176.0
2059,773,high diagnostic,-0.15174825174825243,217.0
2060,3112,successfully treated,-0.1520381931692988,414.0
2061,859,live cell,-0.1532258064516103,190.0
2062,2784,referral center,-0.15411195577055967,223.0
2063,2323,mean difference,-0.15508729680915098,644.0
2064,3220,widely used,-0.1555135900721739,1281.0
2065,1287,hip fracture,-0.1555407387651687,216.0
2066,3528,using model,-0.15555555555555545,203.0
2067,257,patients mean,-0.15640029596744337,1691.0
2068,3714,general anesthesia,-0.15660696181142167,331.0
2069,2748,years older,-0.15728491137051412,321.0
2070,1337,chest radiograph,-0.157767245918905,214.0
2071,683,preoperative imaging,-0.15803784677567473,253.0
2072,1448,retrospective included,-0.15826558265582635,292.0
2073,1110,average time,-0.1588235294117641,189.0
2074,1698,tomography spect,-0.15889494985043104,301.0
2075,3318,diabetic patients,-0.15990220048899748,327.0
2076,1320,imaging results,-0.16103768967205234,329.0
2077,3009,pediatric population,-0.16166970975256528,347.0
2078,1209,disorder characterized,-0.16171617161716262,245.0
2079,3263,stable patients,-0.161904761904761,136.0
2080,1180,using standardized,-0.16354515050167226,163.0
2081,1668,efficacy safety,-0.16632798976443133,442.0
2082,288,five cases,-0.16658199266158666,227.0
2083,2906,male subjects,-0.167195767195767,158.0
2084,679,real time,-0.16744697219474744,586.0
2085,1949,brain connectivity,-0.16795218443147897,281.0
2086,3053,structural heart,-0.1686746987951809,140.0
2087,3616,widespread use,-0.16934373565855965,205.0
2088,3118,oxygen saturation,-0.17003429174360282,293.0
2089,3240,medical therapy,-0.17021276595744791,320.0
2090,2806,high rates,-0.17059773828756078,176.0
2091,2742,analysed using,-0.17089552238806005,229.0
2092,946,scale scores,-0.17113665389527447,134.0
2093,1981,score range,-0.17131722525331256,157.0
2094,992,proposed approach,-0.1723330054547079,292.0
2095,3333,cell lung,-0.17300380228136825,455.0
2096,1759,myocardial blood,-0.17324840764331212,136.0
2097,623,stemi patients,-0.1737104825291181,261.0
2098,2469,aged years,-0.17509633479702516,2171.0
2099,2364,met criteria,-0.17547357926221369,176.0
2100,1517,provide useful,-0.17563117453347984,200.0
2101,1935,relatively high,-0.17742636884759844,264.0
2102,1525,experiments performed,-0.1783251231527096,181.0
2103,2556,endothelial cells,-0.178849144634524,575.0
2104,398,objective investigate,-0.18124999999999952,203.0
2105,1262,associated reduced,-0.18173425651170452,424.0
2106,2595,cell density,-0.1817490494296578,239.0
2107,2842,rv function,-0.1819905213270147,264.0
2108,66,radial strain,-0.18340026773761733,137.0
2109,1323,indocyanine green,-0.18341708542713428,365.0
2110,3170,cirrhotic patients,-0.18351024438410213,177.0
2111,600,artery occlusion,-0.18436592449177142,293.0
2112,2723,complications associated,-0.18481012658227805,146.0
2113,2846,signal change,-0.18503401360544164,136.0
2114,2117,scanned using,-0.18672510958046334,213.0
2115,1822,test results,-0.1868093470189988,329.0
2116,1346,identify predictors,-0.18705035971222747,130.0
2117,3102,multivariable analysis,-0.1880341880341887,330.0
2118,3057,period patients,-0.18863361547763038,360.0
2119,901,tomography imaging,-0.18865952443166734,722.0
2120,2808,thickness imt,-0.1891287586738622,223.0
2121,2135,environmental factors,-0.18969465648854922,142.0
2122,313,consisted patients,-0.19056785370548585,220.0
2123,137,testing performed,-0.1916241062308477,134.0
2124,1936,autosomal dominant,-0.19187675070027946,274.0
2125,3621,response rate,-0.19278230500582091,207.0
2126,2524,fluorescence spectroscopy,-0.19327217125382354,158.0
2127,231,young adult,-0.1933437337493502,143.0
2128,1880,tissue volume,-0.1933669790915652,149.0
2129,2936,tissue damage,-0.19371727748690978,185.0
2130,899,tissue doppler,-0.1938532241849774,397.0
2131,2640,patients receiving,-0.19483929379809858,538.0
2132,146,acute pancreatitis,-0.19489334195216554,201.0
2133,1941,left atrial,-0.19512618627069264,1207.0
2134,3504,well characterized,-0.19531875577456123,151.0
2135,3485,could identified,-0.1976878612716759,171.0
2136,387,antiplatelet therapy,-0.1980533220482441,156.0
2137,40,treatment option,-0.19812286689419709,387.0
2138,3681,important information,-0.1984251968503979,126.0
2139,2638,spectroscopy mrs,-0.19870129870129852,153.0
2140,2627,investigate role,-0.198731501057082,188.0
2141,7,intravenous injection,-0.19905381431105845,187.0
2142,958,tertiary referral,-0.19964093357271162,278.0
2143,3269,patients identified,-0.20024660912453707,406.0
2144,510,healthy participants,-0.2007526242820359,362.0
2145,235,structural integrity,-0.20130718954248591,154.0
2146,159,findings reveal,-0.20136986301369864,147.0
2147,3125,however data,-0.20150375939849563,134.0
2148,2421,mortality morbidity,-0.20167014613778722,161.0
2149,1556,corticospinal tract,-0.2022981554278802,223.0
2150,1427,total body,-0.20259217094316442,269.0
2151,1609,patients breast,-0.20340701683228626,295.0
2152,1027,angular gyrus,-0.20348058902275665,152.0
2153,1155,signs symptoms,-0.20354767184035505,255.0
2154,517,associated less,-0.20524344569288352,137.0
2155,2278,results support,-0.20589982181746158,400.0
2156,2259,valve replacement,-0.20695130557515898,782.0
2157,3260,surgical outcomes,-0.20806142034548933,271.0
2158,374,volume ml,-0.20863746958637447,245.0
2159,2110,taken together,-0.20886764463491286,704.0
2160,2864,relative controls,-0.20960144927536262,178.0
2161,2987,initial imaging,-0.21186440677965865,125.0
2162,1126,could lead,-0.21197208960705116,222.0
2163,2529,imaging methods,-0.21458863443596232,440.0
2164,1230,global longitudinal,-0.2161893177043017,391.0
2165,1419,ten healthy,-0.21702127659574472,136.0
2166,740,radiological features,-0.21929555895865235,179.0
2167,303,associated better,-0.21988304093567224,188.0
2168,2897,complications patients,-0.22051282051281154,258.0
2169,711,patients years,-0.22115996163747403,1153.0
2170,3647,immunohistochemical staining,-0.222368421052632,169.0
2171,2404,patients different,-0.22243285939968416,256.0
2172,3428,patients single,-0.2233276157804466,186.0
2173,3349,due lack,-0.22490974729241833,178.0
2174,734,flow rate,-0.22543192812715926,233.0
2175,1756,bone quality,-0.22592449922958388,255.0
2176,2979,middle frontal,-0.22764005465547446,343.0
2177,1184,value suvmax,-0.22838210933185943,188.0
2178,2892,time consuming,-0.2285012285012284,186.0
2179,3133,rarely reported,-0.22869318181818155,161.0
2180,438,hcc patients,-0.22885085574572103,156.0
2181,300,body weight,-0.23146067415730356,721.0
2182,415,hiv infection,-0.23161764705882326,210.0
2183,3643,intravascular ultrasound,-0.23190184049079868,378.0
2184,1173,patients newly,-0.2324225865209485,174.0
2185,527,expression levels,-0.23299033364515045,467.0
2186,3018,review conducted,-0.23333333333333267,147.0
2187,2866,bifurcation lesions,-0.23353293413173576,195.0
2188,212,cell membrane,-0.23381774662335347,526.0
2189,1808,observed using,-0.23383084577114652,141.0
2190,394,existing methods,-0.23438419503993194,164.0
2191,428,sentinel lymph,-0.23439295289161258,180.0
2192,3179,accuracy respectively,-0.23451798254947867,190.0
2193,3363,atrial la,-0.23534822601839728,199.0
2194,68,prospective patients,-0.23613445378151593,281.0
2195,3624,used investigate,-0.23744732089102924,348.0
2196,1001,emotion regulation,-0.23869452923221468,299.0
2197,1840,manual segmentation,-0.23884962222763864,196.0
2198,3007,inner ear,-0.23953900709219816,193.0
2199,1677,injury tbi,-0.23977164605138013,180.0
2200,2597,estimated glomerular,-0.24216084484159225,271.0
2201,2739,stroke volume,-0.24226868143241512,308.0
2202,3520,nihss score,-0.24227129337539413,192.0
2203,454,f f,-0.2424039320822163,217.0
2204,1308,patients followed,-0.2425163077472972,590.0
2205,1327,wave velocity,-0.24278438030560312,440.0
2206,1562,multimodal imaging,-0.24301792413505666,265.0
2207,3619,time first,-0.24354657687991027,155.0
2208,3463,herein present,-0.24603174603174607,155.0
2209,3075,used calculate,-0.24632015912825392,303.0
2210,2174,relatively common,-0.24652777777777796,142.0
2211,2868,studies reported,-0.24654377880184483,428.0
2212,3021,detection rates,-0.24661246612466017,273.0
2213,2282,inversion recovery,-0.24693035670953553,636.0
2214,2764,women aged,-0.2471483613185561,313.0
2215,1523,showed greater,-0.24871606749816635,339.0
2216,2796,images showed,-0.24904195973805549,302.0
2217,1830,contrast enhanced,-0.24940087145969458,241.0
2218,2687,natriuretic peptide,-0.25204398082886964,298.0
2219,2522,median time,-0.252277947932619,573.0
2220,2508,colorectal cancer,-0.25252642246995977,459.0
2221,1789,artery aneurysms,-0.2532258064516137,157.0
2222,211,liver fibrosis,-0.25467875079374275,513.0
2223,128,surgery patients,-0.25614896664619935,569.0
2224,2207,total resection,-0.25685785536159605,206.0
2225,2234,emission tomography,-0.2569011122611589,2696.0
2226,1318,past decade,-0.258172114743163,215.0
2227,607,patients small,-0.258429777916797,243.0
2228,2439,mitral valve,-0.2585230811820875,983.0
2229,2798,within first,-0.258717184344648,236.0
2230,2296,rates patients,-0.2596372838464784,162.0
2231,908,live imaging,-0.25964912280701746,148.0
2232,910,longitudinal changes,-0.260504201680672,155.0
2233,554,function patients,-0.2612612612612609,435.0
2234,974,coronary intervention,-0.2617728531855889,945.0
2235,2137,left superior,-0.2640509013785775,249.0
2236,647,coronary heart,-0.26489361702127623,166.0
2237,821,later life,-0.26561264822134345,144.0
2238,2698,scan performed,-0.26624203821656006,209.0
2239,1648,using combination,-0.2689363700399156,249.0
2240,2266,executive control,-0.2705035971223021,188.0
2241,326,bone remodeling,-0.27096774193548284,154.0
2242,3582,trial patients,-0.27199480181936286,161.0
2243,919,analysis method,-0.272373540856032,150.0
2244,986,nm nm,-0.2728048954034442,213.0
2245,2666,studies examined,-0.27510063254744177,184.0
2246,1166,survival rates,-0.27551020408163546,405.0
2247,2706,used reference,-0.2761363636363633,189.0
2248,1977,second trimester,-0.2774177020622517,221.0
2249,20,effects observed,-0.2793129200896198,170.0
2250,3693,patients aged,-0.2799171842650094,676.0
2251,1898,cardiac resynchronization,-0.28016194331983874,173.0
2252,3468,lower mean,-0.28041237113402273,204.0
2253,483,small intestine,-0.28142452448401434,183.0
2254,3508,patients normal,-0.28225976768743266,729.0
2255,3456,reviewed patients,-0.2841530054644787,390.0
2256,999,new species,-0.2852617079889805,218.0
2257,3,within min,-0.2864406779661015,169.0
2258,929,newly diagnosed,-0.2865947611710298,465.0
2259,972,plasma levels,-0.28735632183908155,250.0
2260,880,progressive disease,-0.2878464818763329,150.0
2261,916,imaging provides,-0.2885919835560122,156.0
2262,692,use ultrasound,-0.28888888888889,207.0
2263,2634,relaxation time,-0.2897935779816515,399.0
2264,1311,cardiac imaging,-0.29016050244242786,189.0
2265,499,therapy patients,-0.2909788867562365,379.0
2266,2959,metastases patients,-0.29144316730523595,163.0
2267,1529,vivo vitro,-0.29276500280426154,174.0
2268,577,radiation doses,-0.2929652715939457,329.0
2269,466,adverse effects,-0.2937697993664204,428.0
2270,1957,knee oa,-0.2938568714376184,290.0
2271,2769,propensity score,-0.295920889987639,189.0
2272,1960,cells found,-0.29607777405296665,192.0
2273,3540,new zealand,-0.2963580517770952,307.0
2274,3426,brain network,-0.2989921612542001,267.0
2275,3664,reson imaging,-0.299019170753455,706.0
2276,2492,patients undergo,-0.3012875536480701,297.0
2277,1056,colon cancer,-0.30188679245282773,160.0
2278,3129,coronary plaque,-0.30218242865137107,216.0
2279,2570,rate complications,-0.3035445757250267,157.0
2280,1217,volume measured,-0.30388768898488133,201.0
2281,1806,western blot,-0.3042537851478034,422.0
2282,3345,studies using,-0.3061488673139184,473.0
2283,2628,studies necessary,-0.30731707317073087,126.0
2284,3694,weeks postoperatively,-0.3076923076923023,120.0
2285,3663,used quantify,-0.30931496919173596,251.0
2286,3254,hepatic vein,-0.31042471042470676,134.0
2287,2250,structural magnetic,-0.3107438016528931,188.0
2288,3201,conducted retrospective,-0.31679123069257714,289.0
2289,1963,lower extremity,-0.3173396017699117,425.0
2290,2516,spatial temporal,-0.31860245514636293,241.0
2291,1178,uric acid,-0.3191780821917809,233.0
2292,13,escherichia coli,-0.31953813430568256,478.0
2293,1946,years underwent,-0.31964679911699795,543.0
2294,449,precentral gyrus,-0.32015418502202625,171.0
2295,1013,complication rate,-0.3202832709780867,470.0
2296,496,anterior cruciate,-0.3207879001055219,304.0
2297,2946,studies needed,-0.3215051411069827,668.0
2298,2506,mean values,-0.3220757825370686,391.0
2299,3747,complete remission,-0.32223644899701237,151.0
2300,190,correlated well,-0.3223880597014928,180.0
2301,915,method proposed,-0.32249269717624135,184.0
2302,836,neuronal activity,-0.32266016524448005,277.0
2303,2515,normal tissue,-0.3226615762203441,204.0
2304,1807,cardiac events,-0.32304739973133706,443.0
2305,2747,least months,-0.3239263803680978,216.0
2306,3607,time period,-0.3239436619718315,230.0
2307,1355,dna damage,-0.3242982704848318,301.0
2308,88,weeks treatment,-0.3268292682926833,134.0
2309,709,female mean,-0.32817337461300394,212.0
2310,3562,mean adc,-0.3292929292929274,163.0
2311,1612,kidney disease,-0.33222497347010854,587.0
2312,3415,benign tumors,-0.3350556153570148,161.0
2313,1515,surface morphology,-0.33548804137039506,173.0
2314,2879,help identify,-0.33595505617977517,253.0
2315,1505,lung injury,-0.33638025594149945,184.0
2316,1128,research needed,-0.3366515837104056,186.0
2317,291,results reveal,-0.33686690223792587,260.0
2318,3068,individual patients,-0.3374021909233183,154.0
2319,2913,identified using,-0.3375929611396254,293.0
2320,898,single cell,-0.33789954337899625,185.0
2321,689,selection patients,-0.33791348600508886,166.0
2322,2701,surgical procedure,-0.33853974121996294,407.0
2323,627,first trimester,-0.33908306854289394,249.0
2324,1845,internal capsule,-0.3402575820523471,273.0
2325,3753,determine prevalence,-0.34042968750000063,249.0
2326,3194,supramarginal gyrus,-0.3410187667560322,159.0
2327,3148,respectively mean,-0.3411025995227923,503.0
2328,2190,lymph nodes,-0.34122610000082854,1460.0
2329,3190,used analysis,-0.34155844155844517,263.0
2330,1255,cell surface,-0.3430488800217649,386.0
2331,2043,images evaluated,-0.34414607948442505,178.0
2332,1464,transvaginal ultrasound,-0.3442022667829116,188.0
2333,2265,thin film,-0.3452054794520543,126.0
2334,1916,retrospectively studied,-0.3484162895927597,165.0
2335,954,lung adenocarcinoma,-0.35071408569028284,202.0
2336,1697,filtration rate,-0.35097048657272006,400.0
2337,2671,using approach,-0.3515976087404659,208.0
2338,3168,core needle,-0.3538285058789793,199.0
2339,1501,spin echo,-0.3539325842696628,189.0
2340,1060,experimental conditions,-0.3550143266475641,177.0
2341,3735,improve understanding,-0.35501730103806234,171.0
2342,2731,expression level,-0.35504664970313776,161.0
2343,2835,antimicrobial activity,-0.35506003430531646,207.0
2344,2965,objective assess,-0.3567099567099566,206.0
2345,3719,correlations found,-0.35753920386007204,247.0
2346,1867,dynamic imaging,-0.35976447497546565,141.0
2347,1687,vascular endothelial,-0.35987590486039317,348.0
2348,1860,total consecutive,-0.36084452975047937,376.0
2349,858,cingulate cortex,-0.36154781002381975,907.0
2350,81,right atrial,-0.3625212947189091,266.0
2351,1854,myocardial infarction,-0.36305715726469484,2123.0
2352,3579,sleep apnea,-0.3632352941176478,247.0
2353,1078,molecular mechanism,-0.3656529516994624,146.0
2354,3445,intravenous administration,-0.3658536585365856,150.0
2355,3705,image quality,-0.36682295644335366,3595.0
2356,3567,york heart,-0.366831827455552,203.0
2357,120,across subjects,-0.3670071888006052,194.0
2358,1613,association found,-0.36802841918295043,148.0
2359,421,neuroimaging techniques,-0.36828358208955186,141.0
2360,200,using ultrasound,-0.36969001148105207,460.0
2361,1422,dendritic cells,-0.3705882352941148,126.0
2362,2334,atherosclerotic plaque,-0.37058823529411733,198.0
2363,2373,higher accuracy,-0.37065351418002396,167.0
2364,1710,elevated levels,-0.3710330138445151,134.0
2365,2338,optimal cutoff,-0.3711864406779659,146.0
2366,1083,motor function,-0.3712936046511625,262.0
2367,1483,grading system,-0.3718567860116567,203.0
2368,3396,mean preoperative,-0.37187948350071715,162.0
2369,1374,acute ischemic,-0.3758215335292548,521.0
2370,1526,results obtained,-0.37691885964912303,625.0
2371,873,cmr imaging,-0.37730061349693206,123.0
2372,2053,changes associated,-0.3776223776223778,270.0
2373,1915,methods using,-0.3779751332149195,152.0
2374,22,chronic hepatitis,-0.3785046728971962,162.0
2375,261,segmentation method,-0.3786885245901591,231.0
2376,1685,studies show,-0.38057354301572527,187.0
2377,2045,tumor growth,-0.38069908814589737,501.0
2378,2358,patients completed,-0.3817427385892119,230.0
2379,477,implant placement,-0.3820143884892096,236.0
2380,1805,coronary stenosis,-0.38233438485804394,202.0
2381,2184,months treatment,-0.3825910931174091,252.0
2382,354,systolic dysfunction,-0.38275862068965455,333.0
2383,2779,years males,-0.38301282051281943,239.0
2384,350,structural features,-0.3833852544132919,142.0
2385,642,temporal resolution,-0.38550247116968756,390.0
2386,377,patients using,-0.38661909009812834,394.0
2387,2881,molecular weight,-0.38684210526315765,294.0
2388,3195,superficial temporal,-0.38689818468824005,129.0
2389,3056,discriminant analysis,-0.38760918139345935,203.0
2390,2931,right frontal,-0.38783269961977235,170.0
2391,1387,hcm patients,-0.3883923389437031,239.0
2392,942,mutations gene,-0.38936605316973333,238.0
2393,3475,force spectroscopy,-0.38971255673222466,168.0
2394,2639,rankin scale,-0.3900252981568471,284.0
2395,2823,surgical planning,-0.39024163568773335,323.0
2396,2166,treatment treatment,-0.3905123339658444,147.0
2397,1704,lower levels,-0.39087591240875913,153.0
2398,3008,diabetic macular,-0.39110161258985854,183.0
2399,1894,delivery systems,-0.3917321207110379,206.0
2400,2513,analysis data,-0.39175126903553265,294.0
2401,1134,results confirmed,-0.39176954732510305,204.0
2402,3361,cardiac disease,-0.3922480620155035,184.0
2403,1729,moyamoya disease,-0.3937024403043823,242.0
2404,3183,side branch,-0.3943706020328369,194.0
2405,1798,ii iii,-0.398115512127029,368.0
2406,275,death myocardial,-0.39889196675900174,180.0
2407,1781,salivary glands,-0.3997517070142764,140.0
2408,1832,corpus callosum,-0.3999999999999925,924.0
2409,227,across groups,-0.4005982053838484,287.0
2410,2637,higher incidence,-0.4017714791851201,324.0
2411,1744,imaging biomarkers,-0.4019769357495895,244.0
2412,119,less known,-0.40254129606098976,144.0
2413,2809,patients postoperative,-0.40306748466257636,146.0
2414,2356,approved institutional,-0.40408542246982354,272.0
2415,3302,brain atrophy,-0.4050609615827009,284.0
2416,2279,diastolic function,-0.40509164969450034,612.0
2417,2378,bone marrow,-0.4063742022843809,1460.0
2418,584,gyrus right,-0.40644841269841314,241.0
2419,2147,carotid atherosclerosis,-0.40728314238952595,237.0
2420,588,joint space,-0.4085106382978728,224.0
2421,3072,using proposed,-0.4100902814657459,143.0
2422,455,little known,-0.41095890410958097,1050.0
2423,3514,imaging system,-0.4120554916096194,479.0
2424,1071,particularly useful,-0.4126984126984117,130.0
2425,2159,pain patients,-0.4130718954248363,158.0
2426,1132,pulmonary arteries,-0.4140944326990831,226.0
2427,2772,adc value,-0.4146371846776708,317.0
2428,2102,cancer nsclc,-0.4147637795275586,301.0
2429,2192,surface properties,-0.4150462962962958,163.0
2430,2575,aim determine,-0.41655841936145577,677.0
2431,730,resonance spectroscopy,-0.41656804733727565,352.0
2432,1765,scans patients,-0.4187134502924031,358.0
2433,1998,patients pulmonary,-0.41880341880341787,245.0
2434,3150,independent component,-0.41911764705882415,190.0
2435,1990,systematic review,-0.41928659840215937,601.0
2436,1593,longer duration,-0.41938997821350676,175.0
2437,3047,pooled sensitivity,-0.42201257861635316,183.0
2438,3536,enrolled prospective,-0.42372881355931835,125.0
2439,420,recruited patients,-0.42901178603807805,182.0
2440,192,temporal bone,-0.4321790090570059,312.0
2441,805,analysis methods,-0.43314121037464054,167.0
2442,3572,grade grade,-0.4332317692463945,248.0
2443,1543,new insights,-0.43325415676959417,336.0
2444,2320,metabolic activity,-0.43333333333334045,312.0
2445,1388,support vector,-0.4345864661654137,289.0
2446,615,therapeutic response,-0.4378109452736319,176.0
2447,837,showed high,-0.4380561259411363,640.0
2448,1670,therapy treatment,-0.43895348837209314,151.0
2449,3407,success rate,-0.4392462212916301,959.0
2450,3206,purpose article,-0.4418410041840999,176.0
2451,1342,data used,-0.4428362573099412,233.0
2452,3600,carotid endarterectomy,-0.4429844097995539,153.0
2453,1117,blood loss,-0.443590452492858,587.0
2454,1760,pedicle screw,-0.4469956033219342,305.0
2455,832,area volume,-0.44745762711864484,132.0
2456,1635,wide spectrum,-0.44771241830065406,137.0
2457,2619,neural networks,-0.44773204795451726,307.0
2458,213,imaging features,-0.4480421686746985,850.0
2459,3264,short axis,-0.4495603517186255,148.0
2460,490,operative time,-0.44973603167619836,435.0
2461,1580,respectively overall,-0.45098952270081355,149.0
2462,2093,glomerular filtration,-0.453761997449494,439.0
2463,161,surgical management,-0.4555674137317697,337.0
2464,98,matter volumes,-0.4563662374821166,145.0
2465,2602,pulse wave,-0.457574094401756,397.0
2466,3654,different imaging,-0.4576765907764143,240.0
2467,182,cellular uptake,-0.4582533498051896,423.0
2468,3117,analysis identified,-0.4591434398368459,307.0
2469,1204,negatively charged,-0.46060606060605985,152.0
2470,2925,inflammatory markers,-0.46107091172214454,177.0
2471,3451,paper propose,-0.46167883211678823,230.0
2472,2834,patients poor,-0.46184210526315767,169.0
2473,2189,could serve,-0.46211180124223705,186.0
2474,2562,strongly associated,-0.46289993192647955,425.0
2475,488,tube voltage,-0.4630099101175392,205.0
2476,3436,chart review,-0.4631512868801011,434.0
2477,2258,studies conducted,-0.4633533588203157,202.0
2478,248,greater patients,-0.46398537477148094,141.0
2479,1618,disease however,-0.46488549618320824,203.0
2480,1540,m m,-0.4649137222678714,414.0
2481,1192,mild cognitive,-0.4649414062500008,414.0
2482,3146,cell proliferation,-0.46564204263757897,587.0
2483,3748,using echocardiography,-0.4663507109004751,164.0
2484,1910,overall accuracy,-0.4680057388809173,233.0
2485,849,bone strength,-0.4693877551020406,230.0
2486,1404,independent predictor,-0.4718108276291263,892.0
2487,329,executive function,-0.4730667095839703,426.0
2488,3321,first years,-0.47522603978300265,146.0
2489,219,images used,-0.4754553129899888,270.0
2490,3221,alzheimer disease,-0.4772645829185737,1572.0
2491,890,imaging agent,-0.47787610619469045,135.0
2492,1741,cord injury,-0.4780600461893797,345.0
2493,1360,disability index,-0.4790286975717446,217.0
2494,3676,visceral fat,-0.4790731008122301,271.0
2495,2461,tumor tissue,-0.47908745247148343,210.0
2496,3464,mortality patients,-0.4796404845642812,361.0
2497,3471,maximum standardized,-0.4801284624648716,260.0
2498,1377,connectivity right,-0.4811410459587956,138.0
2499,3231,screening program,-0.4813278008298758,145.0
2500,2142,mr images,-0.4813464235624152,1144.0
2501,854,right side,-0.48159070598748904,317.0
2502,3343,pregnant women,-0.4816739790752606,446.0
2503,2622,growth factor,-0.48243197850184827,1169.0
2504,2941,cell lines,-0.484427201207027,775.0
2505,3027,patients healthy,-0.48475864690231946,911.0
2506,114,data including,-0.4852867830423934,139.0
2507,1251,common carotid,-0.4854409317803656,389.0
2508,1620,patients respectively,-0.48558175492849004,571.0
2509,2464,functional properties,-0.48640483383685706,115.0
2510,2571,using novel,-0.48818897637795267,310.0
2511,1101,associated severe,-0.4888888888888896,176.0
2512,1074,mtt assay,-0.4891304347826095,200.0
2513,2677,included analysis,-0.4892812105926875,388.0
2514,2010,determine effect,-0.4898876404494371,218.0
2515,2755,examinations performed,-0.4927319823251552,437.0
2516,553,published data,-0.4947368421052636,188.0
2517,833,brain activity,-0.4949205699870445,1037.0
2518,1614,surgical techniques,-0.49890109890111584,227.0
2519,1757,receiver operator,-0.502173913043477,154.0
2520,3070,tested using,-0.5032258064516117,234.0
2521,3751,range years,-0.5032348079936455,1651.0
2522,1911,plexiform layer,-0.5054913294797678,159.0
2523,475,imaging evaluation,-0.5056099732858419,167.0
2524,3570,low back,-0.5073739859629931,392.0
2525,3198,groups based,-0.5073825503355709,294.0
2526,2951,index bmi,-0.5077110389610396,695.0
2527,2581,determine relationship,-0.5081081081081067,188.0
2528,2608,respectively patients,-0.5084410072620948,599.0
2529,3546,used monitor,-0.5086956521739125,189.0
2530,2993,patients scheduled,-0.5091678420310296,190.0
2531,695,clinically important,-0.5109518935516891,192.0
2532,3357,cell imaging,-0.5122448979591839,251.0
2533,3483,without history,-0.5135802469135797,208.0
2534,1125,ventricular rv,-0.5168953351626837,347.0
2535,2785,neuroimaging data,-0.5173469387755097,169.0
2536,761,bile duct,-0.5173863451197651,588.0
2537,85,difficult diagnose,-0.5185185185185173,126.0
2538,2387,cancer imaging,-0.5192098092643054,206.0
2539,3602,materials methods,-0.5197957466562216,469.0
2540,3440,regression analyses,-0.520222045995238,656.0
2541,3384,bone grafting,-0.5213193885760241,216.0
2542,1725,analysis based,-0.5223880597014936,175.0
2543,2428,cell morphology,-0.5237111353928681,261.0
2544,749,showed excellent,-0.5245697546686199,247.0
2545,726,normal abnormal,-0.5259067357512958,203.0
2546,969,superior frontal,-0.5283783783783773,391.0
2547,1394,ages years,-0.5300758213984795,286.0
2548,1281,artery mca,-0.530555555555556,191.0
2549,2912,results demonstrated,-0.5326264023359447,559.0
2550,1034,factors influence,-0.5328947368421046,180.0
2551,2685,free wall,-0.5333989286104738,287.0
2552,719,data acquisition,-0.5340579710144925,268.0
2553,1428,subarachnoid hemorrhage,-0.5350961538461559,371.0
2554,2219,observed groups,-0.5354207436399209,171.0
2555,3472,disease progression,-0.5358977504109109,888.0
2556,2699,male mice,-0.536891679748823,171.0
2557,63,imaging data,-0.5379872777687161,868.0
2558,3495,analyses used,-0.5389521640091112,169.0
2559,2476,brain volume,-0.5418472063854042,297.0
2560,1316,patients months,-0.5420289855072459,187.0
2561,3086,investigated using,-0.5433054393305458,371.0
2562,1520,high quality,-0.5462365591397852,254.0
2563,1601,factors including,-0.5466591485762621,277.0
2564,2845,total cholesterol,-0.5488445378151255,209.0
2565,569,cerebrovascular reactivity,-0.5501858736059476,148.0
2566,1739,prospectively enrolled,-0.551030543829154,317.0
2567,3625,blood cells,-0.5510985116938351,324.0
2568,215,used test,-0.5521435692921223,213.0
2569,1494,evaluated patients,-0.5527034407427647,460.0
2570,842,quantitative imaging,-0.5528116397955168,213.0
2571,1075,longitudinal studies,-0.5540229885057477,241.0
2572,2177,measured using,-0.5546636140325767,1472.0
2573,2924,disease ad,-0.556316116988176,596.0
2574,253,volume fraction,-0.5569007263922523,350.0
2575,1146,patients exhibited,-0.557189089227924,262.0
2576,2510,included patients,-0.5603451818368613,1948.0
2577,1245,experimental results,-0.560469257358333,546.0
2578,1961,type iii,-0.5606586041089905,363.0
2579,1707,woman presented,-0.5628430049482681,368.0
2580,1350,high level,-0.5630888780961631,341.0
2581,3376,associated development,-0.5639344262295088,172.0
2582,1053,years sd,-0.564042850489054,173.0
2583,345,image registration,-0.5641711229946512,422.0
2584,2700,higher patients,-0.5644470084061325,761.0
2585,3590,optic nerve,-0.5648807680396412,760.0
2586,2693,therapeutic effect,-0.565985130111524,203.0
2587,2727,brachial plexus,-0.566292134831461,196.0
2588,1279,family history,-0.566666666666683,408.0
2589,3746,disease pd,-0.5671222755818257,404.0
2590,1048,images acquired,-0.5683688286544044,671.0
2591,3389,pseudomonas aeruginosa,-0.5698051948051955,195.0
2592,2044,patients present,-0.5700934579439264,305.0
2593,413,subcutaneous adipose,-0.5702811244979927,142.0
2594,2626,structure function,-0.5707044353335826,696.0
2595,3593,vertebral artery,-0.57089552238806,405.0
2596,2999,effective connectivity,-0.5756986634264885,206.0
2597,3153,positron emission,-0.5772060196422518,2665.0
2598,3268,parameters measured,-0.5778159931212371,224.0
2599,2430,thickness m,-0.5811320754716973,198.0
2600,1625,cutoff value,-0.58942420681551,396.0
2601,3189,patients diabetes,-0.589481885469419,194.0
2602,715,sonographic findings,-0.59016393442623,160.0
2603,2717,using conventional,-0.5908127208480574,352.0
2604,3534,bone graft,-0.5923076923076939,238.0
2605,2505,young patients,-0.5925971432959609,212.0
2606,765,patients liver,-0.5928783382789317,189.0
2607,1062,patients enrolled,-0.5934924078091083,684.0
2608,1793,scores patients,-0.5953125000000022,127.0
2609,3119,pathophysiological mechanisms,-0.5956521739130408,137.0
2610,3379,multiple logistic,-0.5959671396564614,210.0
2611,169,days later,-0.5964285714285705,167.0
2612,54,following surgery,-0.59648158328752,175.0
2613,1017,according presence,-0.596932515337423,139.0
2614,10,data acquired,-0.597452229299363,448.0
2615,197,oral cavity,-0.597740112994351,184.0
2616,2054,fraction ef,-0.5981707317073164,218.0
2617,2927,healthy adult,-0.5984447900466573,148.0
2618,742,inflammatory bowel,-0.5984752223634069,157.0
2619,2196,root mean,-0.5986143187066981,216.0
2620,824,multivariate logistic,-0.5997855457859758,608.0
2621,1971,images using,-0.6002458890425688,331.0
2622,3412,identified cases,-0.6003485332558813,159.0
2623,966,right hemisphere,-0.602247191011232,268.0
2624,2031,temporomandibular joint,-0.6037793667007156,257.0
2625,2314,spectroscopy nirs,-0.6038992688870846,177.0
2626,3322,brain injury,-0.6039209384541219,874.0
2627,917,new approach,-0.6056134382309175,303.0
2628,1455,ventricular tachycardia,-0.6071428571428577,170.0
2629,2462,approach used,-0.6096975516082571,254.0
2630,109,patients developed,-0.6098557264145342,667.0
2631,1105,chemical composition,-0.6114068441064627,201.0
2632,724,back pain,-0.614084128477355,737.0
2633,800,progenitor cells,-0.6147308781869678,155.0
2634,462,serum creatinine,-0.6160060481693497,294.0
2635,585,working memory,-0.6169996957095033,770.0
2636,3529,mouse brain,-0.6175953079178889,189.0
2637,3543,patients met,-0.6184659090909096,311.0
2638,3095,seven patients,-0.6191621411947243,694.0
2639,3364,patients reviewed,-0.6222222222222226,132.0
2640,3609,findings including,-0.6237623762376266,147.0
2641,731,abdominal ultrasound,-0.6238317757009351,178.0
2642,3434,min min,-0.6239167271847004,263.0
2643,931,region interest,-0.6248708010335888,569.0
2644,487,using method,-0.624999999999998,375.0
2645,2606,many years,-0.625000000000001,150.0
2646,3172,least squares,-0.6251908396946558,252.0
2647,3247,visual loss,-0.625429553264606,130.0
2648,2519,globus pallidus,-0.6267579046720158,233.0
2649,2933,pressure iop,-0.6268041237113425,152.0
2650,3320,cortical regions,-0.6276466621712747,358.0
2651,2819,elastic modulus,-0.6285745880791774,293.0
2652,997,fourteen patients,-0.631756756756758,187.0
2653,770,idiopathic pulmonary,-0.632530120481928,150.0
2654,2205,curve analysis,-0.6330193356470013,532.0
2655,1962,models using,-0.6337837837837843,134.0
2656,3137,values lower,-0.6341772151898745,167.0
2657,2456,patients surgical,-0.6349809885931558,167.0
2658,8,per second,-0.6363636363636381,140.0
2659,229,good excellent,-0.6368421052631591,143.0
2660,3476,syndrome patients,-0.6374781085814344,140.0
2661,434,serum albumin,-0.637691001697792,313.0
2662,3012,left middle,-0.637888333695415,277.0
2663,3395,used control,-0.6382385730211814,229.0
2664,2297,relaxation times,-0.6383419689119156,392.0
2665,1706,percentage patients,-0.639316239316238,154.0
2666,3324,patients cardiac,-0.6404494382022466,165.0
2667,2361,automatic segmentation,-0.6408544726301735,200.0
2668,1055,muscle strength,-0.6411504424778762,207.0
2669,3628,ml ml,-0.6441518202943456,198.0
2670,3665,varying degrees,-0.6444444444444433,145.0
2671,2890,parkinson disease,-0.6464352443701451,913.0
2672,2270,imaging examinations,-0.6468856172140413,168.0
2673,1882,cone beam,-0.6480887792848313,584.0
2674,1087,samples collected,-0.6497373029772375,265.0
2675,3157,results suggest,-0.6514974433893364,2973.0
2676,1871,showed reduced,-0.6553398058252424,225.0
2677,1142,multiple sclerosis,-0.6556729663462572,1042.0
2678,1810,nafld patients,-0.657754010695188,123.0
2679,1630,weeks gestation,-0.6589002745236611,872.0
2680,2923,groups showed,-0.659355429967924,304.0
2681,1570,findings provide,-0.6604982206405711,448.0
2682,2472,effective safe,-0.6623509369676283,216.0
2683,2788,higher rates,-0.6625000000000052,212.0
2684,934,plasma membrane,-0.6637486674609644,524.0
2685,2170,grade ii,-0.665505984766049,278.0
2686,1396,collected data,-0.6675129290079916,229.0
2687,2417,mean number,-0.6686567164179094,224.0
2688,1752,embryonic stem,-0.6707272821522994,285.0
2689,616,chest radiographs,-0.6708333333333325,161.0
2690,349,lesions identified,-0.6711864406779656,144.0
2691,173,acuity va,-0.6715867158671562,130.0
2692,538,features patients,-0.673110792545567,198.0
2693,3507,improve quality,-0.6742474916387962,144.0
2694,381,impairment mci,-0.6749816581071165,184.0
2695,2488,paper presents,-0.676470588235291,230.0
2696,2896,independently associated,-0.6799289520426235,1122.0
2697,1628,ppv npv,-0.6809462206616151,267.0
2698,306,control participants,-0.6820987654321005,221.0
2699,1252,time min,-0.6852687496430002,387.0
2700,2098,cox regression,-0.6897953173317625,478.0
2701,1879,knee arthroplasty,-0.6900982615268322,415.0
2702,2504,patients analyzed,-0.6908096280087529,287.0
2703,2002,disease chd,-0.6917385943279921,165.0
2704,357,groups respectively,-0.691771610221299,690.0
2705,2252,outcomes evaluated,-0.6923361034164341,163.0
2706,320,examine whether,-0.6932358318098724,237.0
2707,3341,wall motion,-0.6969798657718127,268.0
2708,750,sd years,-0.6971816161852405,368.0
2709,2591,underwent complete,-0.6985074626865687,162.0
2710,2962,present findings,-0.6990740740740741,151.0
2711,3369,liver spleen,-0.7013916500994044,196.0
2712,1306,studies revealed,-0.7014068331897798,349.0
2713,166,overall findings,-0.7030303030303078,116.0
2714,1061,patients recurrent,-0.7046979865771814,225.0
2715,1147,patients controls,-0.7050649830788059,1097.0
2716,1825,patients coronary,-0.707224334600759,310.0
2717,289,mr imaging,-0.7083037869082025,3128.0
2718,3215,similar patients,-0.7085377821393521,190.0
2719,2460,ventral striatum,-0.7086022740323876,339.0
2720,3555,median interquartile,-0.708624094799208,234.0
2721,3589,apparent diffusion,-0.7087960074859662,874.0
2722,1883,aortic dissection,-0.7096430474160869,444.0
2723,2405,matter hyperintensities,-0.709966592427616,311.0
2724,2222,provide new,-0.711822289156626,411.0
2725,3212,test whether,-0.7125000000000001,228.0
2726,902,currently used,-0.7140311804008913,229.0
2727,522,drug delivery,-0.7148686297201141,937.0
2728,65,fluoroscopy time,-0.7150684931506828,493.0
2729,2327,thickness measured,-0.7166882276843473,277.0
2730,2397,patients received,-0.7177033492822953,1500.0
2731,2770,brain stimulation,-0.7180383178696228,295.0
2732,1548,protein kinase,-0.7209459459459449,194.0
2733,1137,young adults,-0.7218253429308723,618.0
2734,2131,analysis software,-0.7237113402061847,156.0
2735,2756,higher control,-0.7239208633093531,175.0
2736,3410,activity score,-0.724832214765099,180.0
2737,1135,evaluation patients,-0.7252511257360555,361.0
2738,1818,confirmed presence,-0.7264346190028218,143.0
2739,2985,patients confirmed,-0.7315208156329642,205.0
2740,1684,macular degeneration,-0.7392248827449991,483.0
2741,2292,heart association,-0.7393800229621119,280.0
2742,174,matched healthy,-0.7419354838709675,230.0
2743,1837,review current,-0.7428571428571406,178.0
2744,1353,investigate impact,-0.7443609022556396,198.0
2745,2357,optimal treatment,-0.746621621621623,170.0
2746,267,strain strain,-0.7489726027397269,243.0
2747,2203,development new,-0.7508342602892093,375.0
2748,356,evoked potentials,-0.7509286412512196,167.0
2749,2435,early treatment,-0.7510638297872321,353.0
2750,2060,respectively differences,-0.7535601543318148,262.0
2751,1983,vas score,-0.7548387096774202,144.0
2752,1641,imaging dwi,-0.7552492593069682,451.0
2753,618,lower limb,-0.7590014402304355,465.0
2754,342,student test,-0.7590628853267571,162.0
2755,458,tomography mdct,-0.7597633136094645,214.0
2756,208,patients lower,-0.7611825192802044,329.0
2757,1369,data analyzed,-0.7612427712892601,501.0
2758,1080,retrospectively analysed,-0.7621359223301004,157.0
2759,2955,multivariate pattern,-0.7621621621621615,141.0
2760,151,regions interest,-0.7624338624338616,786.0
2761,624,memory performance,-0.7636995827538235,289.0
2762,2179,occipital cortex,-0.7659574468085107,160.0
2763,2657,liver biopsy,-0.7673387096774189,346.0
2764,3359,tyrosine kinase,-0.7682119205298009,145.0
2765,2091,treatment modalities,-0.7689604685212278,202.0
2766,2579,mechanism action,-0.7692307692307723,150.0
2767,819,lumbar puncture,-0.7706896551724145,149.0
2768,1224,distress syndrome,-0.7732541470407546,203.0
2769,2735,groups b,-0.7753807106598996,235.0
2770,2564,months mean,-0.7756410256410274,363.0
2771,3617,retrospective observational,-0.7763466042154576,221.0
2772,2645,findings show,-0.7776351970669134,202.0
2773,2122,tumor recurrence,-0.7780630756349428,263.0
2774,429,duration months,-0.7870402802101589,214.0
2775,944,pulsatility index,-0.7898305084745727,233.0
2776,1487,groups results,-0.7922141119221408,148.0
2777,1673,malignant tumors,-0.7927430093209054,243.0
2778,31,linear mixed,-0.7930635838150274,196.0
2779,2096,type type,-0.7949211908931707,267.0
2780,3256,brain magnetic,-0.7952948759265197,457.0
2781,2838,high mortality,-0.7963470319634709,218.0
2782,1469,noted patients,-0.7970297029702992,161.0
2783,2350,used imaging,-0.8013157894736823,261.0
2784,457,last decade,-0.8024316109422499,165.0
2785,3314,provide insight,-0.8025545502927104,260.0
2786,2032,mechanical ventilation,-0.803785488958989,182.0
2787,1996,factor vegf,-0.8040816326530619,197.0
2788,3392,modified rankin,-0.8047597665020195,309.0
2789,2344,reported cases,-0.8054567432222407,338.0
2790,271,showed highest,-0.8090523338048097,260.0
2791,3031,option patients,-0.8104477611940322,181.0
2792,892,endometrial cancer,-0.8126675913083669,187.0
2793,1439,high prevalence,-0.8144376555781856,305.0
2794,608,reviewed consecutive,-0.8187499999999954,131.0
2795,2221,younger years,-0.8198599618077624,280.0
2796,3712,tomography images,-0.8225574862137123,488.0
2797,1980,invasive procedures,-0.8235294117647045,170.0
2798,3424,snr cnr,-0.8249359521776267,210.0
2799,1454,principal component,-0.8272496584032792,326.0
2800,2204,treatment however,-0.8274774774774795,167.0
2801,1740,plaque rupture,-0.8287893231649176,189.0
2802,2995,fluorescein angiography,-0.8294255568581458,283.0
2803,3258,nuclear imaging,-0.830232558139536,153.0
2804,2568,samples obtained,-0.8372436423297778,189.0
2805,2632,endoscopic ultrasound,-0.8381795195954451,195.0
2806,1103,fat distribution,-0.838317757009347,156.0
2807,2070,interobserver agreement,-0.8388721047331309,490.0
2808,1812,obtained patients,-0.8403479701739861,483.0
2809,1500,mice bearing,-0.8403973509933768,141.0
2810,3736,right anterior,-0.841136671177266,222.0
2811,652,patients high,-0.8412674650698645,733.0
2812,3728,time surgery,-0.8454396504642274,180.0
2813,1814,criteria included,-0.8460431654676295,168.0
2814,3418,fluorescent probes,-0.8473118279569879,197.0
2815,2944,frequency bands,-0.8473684210526332,161.0
2816,1819,hemorrhage ich,-0.848275862068967,123.0
2817,297,performed mean,-0.8484848484848496,140.0
2818,3626,using modified,-0.8516129032258092,264.0
2819,1390,cognitive deficits,-0.8521400778210135,219.0
2820,3266,associated low,-0.8532731376975168,126.0
2821,3044,values measured,-0.8571428571428557,215.0
2822,1058,even patients,-0.857142857142861,130.0
2823,2904,antigen psa,-0.8582781456953663,144.0
2824,2419,artery dissection,-0.858657243816252,162.0
2825,1978,cardiac catheterization,-0.8603649416691603,197.0
2826,203,adverse cardiac,-0.8609865470852055,320.0
2827,2778,additional information,-0.8622019279553498,293.0
2828,1718,late gadolinium,-0.8638272345530893,288.0
2829,781,sudden cardiac,-0.8675386444708687,192.0
2830,1637,method used,-0.8683560753736153,514.0
2831,3354,calcium score,-0.8727272727272708,208.0
2832,532,past years,-0.8729458917835656,363.0
2833,3657,brain function,-0.8739142776043125,358.0
2834,1801,diseases including,-0.8777777777777762,158.0
2835,2468,patients available,-0.8785388127853876,148.0
2836,1933,proton therapy,-0.8798872662054837,223.0
2837,655,symptoms patients,-0.880772325020112,238.0
2838,207,heart disease,-0.8825690882645606,1281.0
2839,2467,objective determine,-0.8826086956521759,364.0
2840,1650,small animal,-0.8835820895522422,148.0
2841,2956,patients initial,-0.8912836767036443,148.0
2842,943,executive functions,-0.8920273348519375,178.0
2843,2555,mechanical properties,-0.8922860821725378,1121.0
2844,536,assessed whether,-0.8924623115577887,148.0
2845,2497,cells however,-0.8953488372093035,154.0
2846,1762,liver transplantation,-0.897199638663054,382.0
2847,2413,whole brain,-0.8978565304372663,476.0
2848,3067,coefficient adc,-0.8987781699701378,613.0
2849,2293,social cognition,-0.9029126213592206,155.0
2850,2160,tissue characterization,-0.9029850746268651,121.0
2851,1198,blood oxygenation,-0.9043712172158698,164.0
2852,2580,renal disease,-0.9049360146252269,275.0
2853,2672,consecutive series,-0.9054347826086978,238.0
2854,983,imaging systems,-0.9082437275985613,181.0
2855,3029,cognitive performance,-0.9090638930163455,322.0
2856,168,improve diagnostic,-0.9106999195494766,283.0
2857,894,pivotal role,-0.9107816711590323,218.0
2858,294,rheumatoid arthritis,-0.9112986211154559,540.0
2859,2883,less frequently,-0.9120805369127503,151.0
2860,1662,respectively conclusion,-0.9144157814871019,131.0
2861,2426,improve accuracy,-0.9144380275433128,332.0
2862,1338,tomography oct,-0.9190156599552585,1027.0
2863,2064,polyethylene glycol,-0.9197481396680031,206.0
2864,557,showed good,-0.9239379635873266,527.0
2865,2907,often used,-0.9248472505091635,239.0
2866,3038,pathological conditions,-0.9280155642023352,159.0
2867,2867,higher mortality,-0.9281437125748515,155.0
2868,978,males females,-0.9290441176470627,1064.0
2869,2557,women men,-0.9299600532623169,582.0
2870,2331,univariate analysis,-0.9305949008498547,657.0
2871,1111,abdomen pelvis,-0.9308957952468023,134.0
2872,785,patients locally,-0.9312169312169295,160.0
2873,3273,january july,-0.9333333333333332,154.0
2874,2333,brain areas,-0.9358190115545181,610.0
2875,687,respiratory failure,-0.9364969801553067,201.0
2876,2714,aim examine,-0.9372168284789643,181.0
2877,2302,potential use,-0.9397312859884837,272.0
2878,2422,subjects enrolled,-0.9411764705882346,160.0
2879,3473,time days,-0.9416666666666733,113.0
2880,2930,dynamic light,-0.9433502157193773,235.0
2881,1372,united states,-0.9434079240530853,502.0
2882,2434,biodistribution studies,-0.9450336071695308,171.0
2883,1491,scanning calorimetry,-0.945685279187816,207.0
2884,1349,layer rnfl,-0.9473098330241179,222.0
2885,2636,reward processing,-0.9517890772128065,133.0
2886,1315,time point,-0.9537811178957226,429.0
2887,868,mean square,-0.9539823008849493,231.0
2888,1589,prostate biopsy,-0.954720439963339,248.0
2889,861,limits agreement,-0.9564048396389475,332.0
2890,2125,controlled trials,-0.9582887700534762,336.0
2891,77,using multivariate,-0.9587628865979394,155.0
2892,882,linear model,-0.9596938775510188,209.0
2893,3759,consecutive patients,-0.960513121763962,3111.0
2894,1022,cognitive decline,-0.9642570281124497,343.0
2895,3020,spatial resolution,-0.9645208930588122,1291.0
2896,152,neuroimaging studies,-0.9652530779753747,504.0
2897,2237,percutaneous coronary,-0.9666191155492133,968.0
2898,3417,present new,-0.9671497584541066,182.0
2899,835,conservative treatment,-0.9697762897580293,358.0
2900,3405,subclinical atherosclerosis,-0.9703001579778857,249.0
2901,2245,assessment patients,-0.9719131614654014,247.0
2902,1934,strain rate,-0.974831496312742,508.0
2903,1749,tumor uptake,-0.9749103942652345,208.0
2904,3439,anatomical structures,-0.9753694581280795,330.0
2905,3167,scanning microscopy,-0.9771747031742186,284.0
2906,1446,using magnetic,-0.9789754219721664,570.0
2907,1413,respectively sensitivity,-0.9834938101788201,143.0
2908,3239,right middle,-0.9856887298747757,290.0
2909,2121,uptake values,-0.9869451697127957,270.0
2910,2374,patients benefit,-0.9891016200294542,146.0
2911,813,morphological characteristics,-0.9898477157360414,225.0
2912,1031,gradient echo,-0.9915088177661658,230.0
2913,1497,treatment plan,-0.9937500000000006,212.0
2914,702,purpose compare,-0.9945945945945941,276.0
2915,1664,sickle cell,-0.9962264150943402,176.0
2916,2081,mean dose,-0.9999999999999997,185.0
2917,1088,number patients,-1.0037629350893684,485.0
2918,1435,groups control,-1.0158730158730174,192.0
2919,1286,previous work,-1.0171842650103515,289.0
2920,171,patients grade,-1.018604651162792,219.0
2921,2377,med international,-1.023462814756978,464.0
2922,2078,operation time,-1.0292031321971447,228.0
2923,3171,safety efficacy,-1.0312997347480097,486.0
2924,748,value npv,-1.0322580645161314,240.0
2925,2538,small bowel,-1.0324770209757288,592.0
2926,1891,pulmonary arterial,-1.0327917282127024,368.0
2927,2572,silver nanoparticles,-1.0376832844574782,337.0
2928,1282,mesenchymal stem,-1.0390351522282697,406.0
2929,913,commonly performed,-1.0416666666666679,125.0
2930,172,treatment groups,-1.0469212782540906,292.0
2931,240,retrospectively evaluated,-1.0504807692307718,345.0
2932,156,cortex dlpfc,-1.0511627906976766,226.0
2933,179,immunosorbent assay,-1.0523809523809506,182.0
2934,1240,bone turnover,-1.0526162790697686,213.0
2935,804,cases reported,-1.0535117056856171,350.0
2936,1712,fibrous tissue,-1.0548672566371693,149.0
2937,344,aimed examine,-1.0549763033175361,159.0
2938,3180,osteoarthritis oa,-1.0570188133140408,332.0
2939,1738,metabolic tumor,-1.0588235294117658,180.0
2940,194,neural network,-1.06031941031941,274.0
2941,2444,aims determine,-1.0636871508379868,136.0
2942,1779,epithelial cells,-1.0657459967804779,599.0
2943,3010,active surveillance,-1.0675977653631297,147.0
2944,230,hepatitis b,-1.0716648291069448,216.0
2945,2299,ovarian cancer,-1.0845493562231734,266.0
2946,3160,previous reports,-1.0848708487084848,245.0
2947,1007,eligible patients,-1.0870530209617721,232.0
2948,2041,tomographic angiography,-1.0890475128262336,237.0
2949,366,quantitative evaluation,-1.0986027944111743,192.0
2950,643,caudate nucleus,-1.1034272141160495,229.0
2951,3638,tumor location,-1.1065088757396437,187.0
2952,1964,studies performed,-1.107174573498482,504.0
2953,3272,matter microstructure,-1.1072589382448546,146.0
2954,2768,patients brain,-1.108829568788502,216.0
2955,3711,ko mice,-1.1107279693486607,223.0
2956,534,performed months,-1.1111111111111114,214.0
2957,3169,treatment plans,-1.1129533678756462,179.0
2958,2752,within week,-1.1130952380952381,187.0
2959,670,web science,-1.1157167530224559,170.0
2960,1799,performed retrospective,-1.1170119638167504,348.0
2961,2704,several years,-1.118038528896671,152.0
2962,3752,images obtained,-1.1204590701487271,714.0
2963,3651,functional neuroimaging,-1.124539282250242,187.0
2964,3738,supplementary motor,-1.1325077399380814,236.0
2965,3480,using mr,-1.1326732673267337,132.0
2966,1011,bone loss,-1.1335404861999645,816.0
2967,2486,based results,-1.1346241457858726,293.0
2968,2966,evidence suggests,-1.1353711790393037,364.0
2969,2180,chest computed,-1.1376518218623497,281.0
2970,2585,studies demonstrated,-1.1380927566440884,520.0
2971,1509,could useful,-1.1382875605815772,271.0
2972,1264,facial nerve,-1.1397849462365606,212.0
2973,2598,endothelial function,-1.1404958677685963,276.0
2974,2625,b c,-1.1437374245472849,425.0
2975,1928,contrast enhancement,-1.1461593172119462,586.0
2976,3199,fatty liver,-1.148000723719922,423.0
2977,3297,internal external,-1.1489864864864878,179.0
2978,2523,experimental data,-1.1547619047619075,291.0
2979,2243,institutional review,-1.1562460686878844,910.0
2980,967,superior longitudinal,-1.1606591143151337,245.0
2981,3373,diagnosed patients,-1.1663401602849517,177.0
2982,3671,fluorescent proteins,-1.1684964200477328,144.0
2983,2729,weeks surgery,-1.1698113207547192,155.0
2984,1544,mean sd,-1.17532156093307,1172.0
2985,471,disease process,-1.175971731448767,128.0
2986,1402,matter integrity,-1.1768379960962925,323.0
2987,1893,however remains,-1.1779334500875664,177.0
2988,2707,bone mass,-1.1791284403669715,388.0
2989,1595,characterized using,-1.1805132666376676,230.0
2990,2015,chest wall,-1.1842608482471197,291.0
2991,442,stroke patients,-1.1873623743417918,742.0
2992,1268,type collagen,-1.187866108786612,167.0
2993,728,well known,-1.1912087912087823,271.0
2994,1939,hypertension patients,-1.1940594059405947,134.0
2995,2306,deep venous,-1.195505617977528,152.0
2996,792,fracture healing,-1.1958271236959772,236.0
2997,645,pain relief,-1.1965811965811952,280.0
2998,372,better understanding,-1.199223516361622,569.0
2999,3249,worse outcomes,-1.2017621145374389,124.0
3000,1802,basal cell,-1.2049713193116642,137.0
3001,2609,provide additional,-1.2105263157894721,230.0
3002,3002,hypertension ph,-1.2120300751879725,182.0
3003,1112,system using,-1.2131868131868138,184.0
3004,665,mouse model,-1.2134769937295768,667.0
3005,820,might contribute,-1.213924050632908,137.0
3006,594,neurological symptoms,-1.21531576330184,260.0
3007,2155,developed new,-1.2160798738833418,203.0
3008,3658,test showed,-1.2175226586102714,155.0
3009,2389,new york,-1.2261203585147242,266.0
3010,1225,superior parietal,-1.2303872889771612,177.0
3011,1043,aims investigate,-1.2309859154929552,171.0
3012,973,patients assessed,-1.2336448598130805,264.0
3013,2548,scans obtained,-1.2347338935574235,228.0
3014,380,alveolar bone,-1.234829191182929,327.0
3015,1465,article reviews,-1.2348761103319303,281.0
3016,1581,dose escalation,-1.240875912408757,150.0
3017,3532,patients prior,-1.2436837815810937,218.0
3018,2990,patients evaluated,-1.2451775371442981,603.0
3019,497,nasal cavity,-1.2481762917933152,191.0
3020,1785,together data,-1.251152073732721,181.0
3021,3131,diagnostic criteria,-1.251515151515155,413.0
3022,2018,remains challenging,-1.2523584905660397,295.0
3023,1299,marrow edema,-1.2537710736468495,157.0
3024,2423,screw fixation,-1.2562277580071124,353.0
3025,3259,matter volume,-1.2569384835479245,573.0
3026,2144,maxillary sinus,-1.2596964586846557,415.0
3027,2743,tumor imaging,-1.2598425196850398,160.0
3028,3674,respiratory distress,-1.2606624055781521,288.0
3029,3078,patients cerebral,-1.2609625668449223,131.0
3030,593,january june,-1.2622950819672092,231.0
3031,3399,blot analysis,-1.2690647482014432,162.0
3032,1482,paediatric patients,-1.2696228338430187,235.0
3033,2945,functional fmri,-1.2697368421052666,193.0
3034,889,patients eligible,-1.2720379146919434,122.0
3035,1260,processing speed,-1.2722948870392392,214.0
3036,1269,patients males,-1.2735177865612661,358.0
3037,1384,type iv,-1.2760736196319031,208.0
3038,1131,pulmonary artery,-1.2811363883748683,1201.0
3039,3702,fmri data,-1.2842000398485753,481.0
3040,1905,analysis confirmed,-1.2878787878787883,187.0
3041,351,taking account,-1.2883341823739198,281.0
3042,390,tumor response,-1.2895161290322572,246.0
3043,1431,gadolinium enhancement,-1.2924487123526864,315.0
3044,2620,approach using,-1.2953020134228204,193.0
3045,1965,procedure performed,-1.3014084507042225,182.0
3046,1817,superparamagnetic iron,-1.304024767801855,162.0
3047,2832,response treatment,-1.3040380047505917,305.0
3048,165,ventromedial prefrontal,-1.307127429805608,178.0
3049,153,years male,-1.3131054131054154,419.0
3050,108,determine whether,-1.3149785618893741,1909.0
3051,2559,brain functional,-1.3209891435464431,233.0
3052,806,society magnetic,-1.3216463808008254,528.0
3053,446,cancer detection,-1.3232726630146703,386.0
3054,2209,present work,-1.323404255319149,311.0
3055,25,patients undergoing,-1.3257774090462113,2647.0
3056,373,cortical thickness,-1.333203494518948,1235.0
3057,2958,bovine serum,-1.333333333333328,180.0
3058,3060,without evidence,-1.3340425531914892,209.0
3059,2676,ascending aortic,-1.334806629834253,151.0
3060,1551,contact angle,-1.3352941176470563,227.0
3061,3684,patients total,-1.336708860759497,363.0
3062,3185,direct comparison,-1.337068965517242,141.0
3063,17,four patients,-1.347042906841896,968.0
3064,2022,microscopy afm,-1.3487819370172294,454.0
3065,3391,electronic medical,-1.3532338308457728,160.0
3066,822,value ppv,-1.3534246575342481,247.0
3067,1705,spatial distribution,-1.3542372881355935,329.0
3068,1530,patients examined,-1.354802259887006,218.0
3069,2337,asymptomatic patients,-1.356097560975612,417.0
3070,95,patients good,-1.3568281938326014,154.0
3071,701,mild moderate,-1.3569587628865938,405.0
3072,1583,lymph node,-1.364036120926584,1797.0
3073,1012,imaging patients,-1.3648711943793879,564.0
3074,1602,healthy subjects,-1.380361276804273,1394.0
3075,3049,using functional,-1.382346832814126,512.0
3076,498,years ago,-1.3835616438356073,202.0
3077,1382,analyses demonstrated,-1.3893129770992367,140.0
3078,1270,flow cytometry,-1.3904498816101043,669.0
3079,1972,months years,-1.3954504094631524,284.0
3080,1283,studies found,-1.3986798679867938,163.0
3081,1187,vessel wall,-1.3999069334574221,414.0
3082,2200,total knee,-1.4080857414190773,485.0
3083,3577,abdominal aorta,-1.4142821095129954,248.0
3084,1468,mortality rate,-1.4149892933618868,413.0
3085,1197,total volume,-1.420118343195268,150.0
3086,2157,diagnostic test,-1.4206278026905848,176.0
3087,1658,patients performed,-1.4230822391154134,264.0
3088,1861,address issue,-1.4262516914749646,170.0
3089,2577,controls mean,-1.4288065843621276,248.0
3090,1344,data suggest,-1.431712604521527,1005.0
3091,3688,assess diagnostic,-1.4319042871385845,167.0
3092,260,tumor necrosis,-1.4529411764705784,247.0
3093,409,patients higher,-1.4579842931937186,474.0
3094,104,information obtained,-1.4601973684210514,193.0
3095,386,used examine,-1.4602941176470563,331.0
3096,2721,potentially used,-1.4627087198515796,146.0
3097,1945,young children,-1.4656099241902143,217.0
3098,1210,vector machine,-1.4656272147413187,220.0
3099,3140,analyses showed,-1.4683974038941618,342.0
3100,191,aimed identify,-1.4687499999999987,188.0
3101,3295,radiation therapy,-1.4714421252371939,1193.0
3102,756,determine factors,-1.4734982332155526,139.0
3103,1588,congenital heart,-1.475206611570246,595.0
3104,1067,beam computed,-1.4769230769230817,448.0
3105,3371,dose gy,-1.4775510204081599,181.0
3106,2380,macular edema,-1.4832455216016844,414.0
3107,1407,mean duration,-1.4839285714285742,277.0
3108,570,light scattering,-1.4877656724415043,350.0
3109,1028,underwent imaging,-1.4917968749999997,201.0
3110,1241,aqueous solution,-1.492346938775516,225.0
3111,2490,used obtain,-1.4951456310679558,154.0
3112,2074,higher rate,-1.4986568986568989,323.0
3113,2141,soft tissues,-1.5001164144353862,379.0
3114,2658,used treatment,-1.5047080979284309,235.0
3115,884,performed cases,-1.5101123595505666,224.0
3116,3457,elderly patients,-1.5102564102564107,342.0
3117,3645,levels measured,-1.5135446685878962,202.0
3118,1462,prognostic value,-1.5151477058453724,709.0
3119,1348,surgical repair,-1.518028534370941,308.0
3120,1924,various types,-1.5214559386973205,209.0
3121,1528,posterior cingulate,-1.522327790973867,442.0
3122,2777,mrna expression,-1.5226713532513174,304.0
3123,3560,important roles,-1.5233480176211478,182.0
3124,3280,postoperative course,-1.52465753424657,159.0
3125,2922,peripapillary retinal,-1.5250000000000008,122.0
3126,1099,right coronary,-1.525731186329282,318.0
3127,2905,patients associated,-1.5290808638874929,258.0
3128,2455,diffusivity md,-1.5364758698092031,185.0
3129,3307,controls respectively,-1.536507936507938,176.0
3130,39,nuclear magnetic,-1.5367588932806318,168.0
3131,1904,across multiple,-1.539419087136928,159.0
3132,1143,resonance medicine,-1.5451374519657113,594.0
3133,3669,patients rheumatoid,-1.5465116279069788,133.0
3134,2621,inversely correlated,-1.548334243582745,225.0
3135,3721,valuable information,-1.5509151414309494,239.0
3136,1726,frequently associated,-1.5524475524475485,148.0
3137,3050,tensor imaging,-1.5547909079492641,1168.0
3138,3416,underwent percutaneous,-1.5635738831615176,175.0
3139,1444,high incidence,-1.5686847599164895,221.0
3140,1406,levels associated,-1.5688311688311614,302.0
3141,869,drug resistance,-1.570212765957448,123.0
3142,94,specificity accuracy,-1.5715302491103333,576.0
3143,2158,differential scanning,-1.5769230769230755,205.0
3144,561,using scanning,-1.5817549284885923,372.0
3145,1354,ventricular dysfunction,-1.5847715736040668,223.0
3146,3450,fluorescently labeled,-1.584905660377359,140.0
3147,1003,tumor cell,-1.589690721649479,257.0
3148,2512,participants completed,-1.5962686567164193,186.0
3149,401,effective dose,-1.5970149253731392,535.0
3150,2670,assigned groups,-1.5988286969253296,156.0
3151,2371,however studies,-1.5999999999999976,328.0
3152,3691,medical record,-1.6100161550888505,151.0
3153,811,arthritis ra,-1.613946117274165,268.0
3154,1719,analysis used,-1.6166845493562196,735.0
3155,3633,different patients,-1.6181268882175222,206.0
3156,3420,photoelectron spectroscopy,-1.6241116751269054,237.0
3157,1389,evaluation performed,-1.62536023054755,188.0
3158,2235,substantia nigra,-1.6265912305516284,230.0
3159,2220,become increasingly,-1.627254509018037,140.0
3160,2354,days days,-1.629408572978839,231.0
3161,2876,positively correlated,-1.6324524261449331,1082.0
3162,1967,vast majority,-1.6359408033826615,219.0
3163,840,cardiac output,-1.643918105178644,325.0
3164,1409,multivariate cox,-1.6447552447552451,196.0
3165,598,difference mean,-1.6460829493087514,188.0
3166,2624,imaging allows,-1.6585365853658551,136.0
3167,1229,years range,-1.662559092341632,1486.0
3168,1042,international society,-1.670062898321324,666.0
3169,2782,ms patients,-1.6709224655449406,482.0
3170,1863,mean time,-1.6758248730964462,539.0
3171,2749,four cases,-1.675829383886255,272.0
3172,33,prognostic factor,-1.6765168735793,340.0
3173,1596,gyrus left,-1.6797101449275351,183.0
3174,1778,might useful,-1.6806174957118392,213.0
3175,2803,moderate severe,-1.682266009852219,683.0
3176,1259,iterative reconstruction,-1.6842240117130343,517.0
3177,1787,using technique,-1.68510638297872,264.0
3178,2758,superior temporal,-1.6892857142857158,473.0
3179,3595,artery calcification,-1.6931372549019625,157.0
3180,1339,however differences,-1.7044417767106856,229.0
3181,1405,findings included,-1.705882352941179,135.0
3182,32,current literature,-1.7111111111111115,231.0
3183,1678,disease patients,-1.7140883977900587,730.0
3184,3141,subjects using,-1.714102564102563,191.0
3185,1376,aortic wall,-1.7170731707317057,176.0
3186,1889,use imaging,-1.7214137214137268,276.0
3187,414,intraobserver interobserver,-1.7222222222222283,124.0
3188,1179,showed difference,-1.72262773722628,472.0
3189,2442,hazard ratios,-1.7259842519685022,137.0
3190,1476,could achieved,-1.7267508610792215,160.0
3191,1690,signal intensity,-1.7276682198617603,1326.0
3192,2130,retrospective conducted,-1.733333333333333,122.0
3193,2590,rating scale,-1.7428571428571464,427.0
3194,511,cell division,-1.7520847121111882,217.0
3195,1059,imaging computed,-1.754530477759475,213.0
3196,1985,ethylene glycol,-1.7547619047619014,201.0
3197,1542,showed lower,-1.757510729613736,455.0
3198,3000,seventeen patients,-1.7602040816326538,150.0
3199,2304,remain unclear,-1.7614248479583072,327.0
3200,1761,methods used,-1.7621495327102774,419.0
3201,2349,patients low,-1.7670667306768992,428.0
3202,2321,respectively results,-1.7691931540342305,268.0
3203,845,left anterior,-1.7702372393961163,648.0
3204,1073,found patients,-1.7764891631979425,764.0
3205,283,fully understood,-1.7804878048780306,219.0
3206,3435,time patients,-1.7838610827374852,236.0
3207,1887,future studies,-1.7953367875647415,693.0
3208,3257,abdominal computed,-1.7957746478873284,153.0
3209,3530,grey matter,-1.7968625365594246,654.0
3210,3429,measurements taken,-1.8044831880448369,161.0
3211,1051,confounding factors,-1.8067183462532272,184.0
3212,3403,spectroscopy ftir,-1.8074866310160411,169.0
3213,3041,fractional anisotropy,-1.8087840400515736,1282.0
3214,888,carotid thickness,-1.8110486891385813,509.0
3215,2799,patients eyes,-1.8178877259752648,233.0
3216,513,node metastasis,-1.8222222222222244,396.0
3217,1995,man presented,-1.8224380767362802,354.0
3218,1495,present aimed,-1.8279200280603345,367.0
3219,1442,advanced imaging,-1.8347718865598026,310.0
3220,661,data obtained,-1.8429469901168003,641.0
3221,3154,fat mass,-1.8429708222811714,579.0
3222,2238,higher sensitivity,-1.8554794520547946,258.0
3223,282,levels serum,-1.8574850299401284,141.0
3224,1471,green icg,-1.8611111111111163,134.0
3225,560,cell line,-1.8672012449478061,921.0
3226,338,patients copd,-1.8680822826808223,204.0
3227,1852,provides new,-1.8721518987341803,204.0
3228,3454,interest roi,-1.8725620835857022,262.0
3229,2035,cancer patients,-1.874933254227243,1374.0
3230,988,fa values,-1.8760806916426538,315.0
3231,782,chinese patients,-1.879674796747974,136.0
3232,3459,healthy control,-1.8820864067439396,674.0
3233,3202,data sets,-1.8828179397911147,597.0
3234,2708,analysis demonstrated,-1.8854517611026012,456.0
3235,737,root canal,-1.8867924528301896,375.0
3236,3685,mean differences,-1.892119565217389,211.0
3237,1667,using imaging,-1.8939641109298582,387.0
3238,2919,multiple comparisons,-1.8969298245614066,173.0
3239,1222,enhancement lge,-1.8975265017667882,179.0
3240,3155,technique used,-1.898310987288874,474.0
3241,1136,microscopy images,-1.900736377025034,239.0
3242,2124,cancer cells,-1.905257886830229,1392.0
3243,2860,second third,-1.907859078590786,192.0
3244,677,regions including,-1.908878504672903,215.0
3245,16,healthy controls,-1.9126997161157246,3261.0
3246,3523,analyses performed,-1.9218232044198966,773.0
3247,1489,different sizes,-1.9263157894736915,122.0
3248,43,performed different,-1.9283018867924553,146.0
3249,941,emergency department,-1.9361771609347993,921.0
3250,1663,serious adverse,-1.9374999999999916,155.0
3251,1919,cell cycle,-1.9396004700352454,393.0
3252,1597,interest rois,-1.942625169147488,194.0
3253,599,brain imaging,-1.9461279461279346,510.0
3254,2546,motor neuron,-1.9523809523809623,205.0
3255,962,laser irradiation,-1.954022988505746,170.0
3256,2129,studies investigated,-1.956164383561646,238.0
3257,1717,plaque burden,-1.9567474048442854,195.0
3258,3227,without differences,-1.9568181818181853,123.0
3259,2736,patients retrospectively,-1.9590277777777738,217.0
3260,201,showed association,-1.959375000000001,209.0
3261,2970,eleven patients,-1.9605095541401272,243.0
3262,1116,doxorubicin dox,-1.9749216300940355,150.0
3263,3200,analysis using,-1.9767605633802885,401.0
3264,2027,perfusion imaging,-1.9778078484438364,522.0
3265,3316,pancreatic cancer,-1.990150913423347,464.0
3266,1892,prostate cancer,-1.994757161444445,1973.0
3267,2688,natural history,-2.002366863905327,376.0
3268,3452,high signal,-2.0116687066503456,277.0
3269,2623,provide better,-2.0147757255936654,166.0
3270,3327,management patients,-2.0162271805273826,497.0
3271,516,role development,-2.0229607250755284,186.0
3272,3741,lv diastolic,-2.0270613107822344,306.0
3273,2061,months median,-2.027916251246261,226.0
3274,2762,head neck,-2.028099173553725,1227.0
3275,2485,remained stable,-2.0312499999999996,325.0
3276,1792,necrosis factor,-2.034782608695643,156.0
3277,552,support hypothesis,-2.039575971731446,222.0
3278,580,general linear,-2.047876447876442,156.0
3279,844,performed without,-2.049999999999996,205.0
3280,3043,disease severity,-2.054203587637772,436.0
3281,3739,serum levels,-2.060732984293198,576.0
3282,69,patients among,-2.064646464646456,146.0
3283,2870,performed identify,-2.0648464163822564,275.0
3284,1208,cancer pca,-2.066666666666679,248.0
3285,441,nude mice,-2.069078947368424,185.0
3286,206,participants underwent,-2.07446808510638,325.0
3287,2813,therefore aim,-2.079365079365078,131.0
3288,1732,head trauma,-2.0794520547945163,253.0
3289,476,patients stable,-2.080075901328272,261.0
3290,542,percentage change,-2.0814310051107343,149.0
3291,1436,imaging parameters,-2.088848594741611,256.0
3292,2643,false lumen,-2.0999999999999988,168.0
3293,1373,low sensitivity,-2.11595744680851,153.0
3294,617,method evaluated,-2.1168141592920424,184.0
3295,550,brain structures,-2.117711171662129,268.0
3296,3299,radial diffusivity,-2.1345291479820547,340.0
3297,1906,successfully applied,-2.136842105263153,203.0
3298,3679,determine impact,-2.1496183206106836,128.0
3299,1958,without complications,-2.1535070140280586,199.0
3300,2484,analysis variance,-2.159465478841865,606.0
3301,2471,grip strength,-2.1656250000000004,154.0
3302,1278,independent prognostic,-2.165975103734437,174.0
3303,2916,right superior,-2.1826086956521653,251.0
3304,2443,systolic blood,-2.1873602555327425,448.0
3305,879,axial diffusivity,-2.1903930131004286,228.0
3306,2154,recent years,-2.190747330960851,648.0
3307,1617,component analysis,-2.1926514399205557,480.0
3308,2986,atomic force,-2.1932972241029107,1045.0
3309,2771,facial expressions,-2.194037940379406,176.0
3310,3458,potential improve,-2.1982456140350917,179.0
3311,2935,inflammatory response,-2.2007812500000083,313.0
3312,1037,able detect,-2.2042031523642645,203.0
3313,2294,oct imaging,-2.2050420168067246,164.0
3314,1700,measurements using,-2.2077922077922056,150.0
3315,3173,patients aortic,-2.2124999999999706,177.0
3316,1171,showed strong,-2.220809248554913,226.0
3317,1257,fully automated,-2.221374045801526,194.0
3318,106,day day,-2.2242990654205625,170.0
3319,1238,could potentially,-2.2364127498649333,262.0
3320,425,patients groups,-2.2427385892116103,690.0
3321,2228,force microscopy,-2.243819723337798,967.0
3322,3174,mammalian cells,-2.246853146853138,189.0
3323,1244,data set,-2.259986902423056,406.0
3324,2534,could help,-2.2621621621621615,279.0
3325,1478,adipose tissue,-2.2658851344695132,935.0
3326,1835,premotor cortex,-2.267841409691633,198.0
3327,470,used create,-2.292944038929446,152.0
3328,3344,investigate effect,-2.3024060556907275,439.0
3329,2066,squamous cell,-2.3040544539804704,581.0
3330,791,fluid csf,-2.3048106448311154,417.0
3331,797,portal vein,-2.3065352318364396,596.0
3332,3033,carlo simulations,-2.3084507042253564,149.0
3333,359,magn reson,-2.3130027151841457,1308.0
3334,657,subjective image,-2.3168391345249293,262.0
3335,3094,determined using,-2.320634920634914,714.0
3336,768,several studies,-2.3422098936661984,347.0
3337,3152,period years,-2.369177608845891,281.0
3338,632,well established,-2.3692307692307613,336.0
3339,2689,scan time,-2.369387755102048,301.0
3340,3587,patients underwent,-2.3698602326852236,6598.0
3341,1943,mean range,-2.3755102040816367,291.0
3342,3188,showed large,-2.376758409785928,134.0
3343,3632,patients however,-2.379043280182228,373.0
3344,3612,much lower,-2.3835182250396194,160.0
3345,3207,lung parenchyma,-2.399999999999999,136.0
3346,699,neck pain,-2.404261363636355,217.0
3347,2481,leg pain,-2.4072689511941903,173.0
3348,752,old male,-2.408823529411763,117.0
3349,3443,measurements made,-2.433426183844018,208.0
3350,3720,successful patients,-2.436538461538468,181.0
3351,2726,lesion glycolysis,-2.4444444444444495,165.0
3352,2049,fluorescence lifetime,-2.452459016393443,187.0
3353,2256,microscopy used,-2.453097345132745,198.0
3354,2218,diagnostic accuracy,-2.457612216566408,1967.0
3355,3526,associated changes,-2.4588235294117697,209.0
3356,2099,drug administration,-2.4615384615384572,160.0
3357,2552,wound healing,-2.4684167350287107,295.0
3358,1008,prepared using,-2.4707236842105273,203.0
3359,14,met inclusion,-2.470770937326684,518.0
3360,2343,qualitative quantitative,-2.4749999999999974,318.0
3361,1472,radiation exposure,-2.4758389261745033,1302.0
3362,3559,computed tomography,-2.4765085214187548,10753.0
3363,1085,early detection,-2.4905956112852627,681.0
3364,1109,neural activity,-2.5008689081979534,649.0
3365,984,imaging protocol,-2.5061295971978925,265.0
3366,1054,operating characteristics,-2.506382978723406,186.0
3367,733,reson med,-2.5067803735511416,598.0
3368,3406,early visual,-2.510204081632649,123.0
3369,3045,functional networks,-2.5210237659963424,197.0
3370,1969,near infrared,-2.526177024482105,353.0
3371,2501,surgical correction,-2.5266055045871614,153.0
3372,3760,brain lesions,-2.5392156862744995,259.0
3373,3696,findings indicate,-2.5476190476190457,535.0
3374,148,rv systolic,-2.5538461538461603,166.0
3375,633,stress disorder,-2.559645232815966,148.0
3376,2161,stent thrombosis,-2.573033707865166,229.0
3377,408,enrolled patients,-2.5796093582313837,724.0
3378,546,fluorescence intensity,-2.5959339263024215,227.0
3379,1675,test hypothesis,-2.6054380664652528,392.0
3380,3397,new imaging,-2.605952380952381,199.0
3381,251,sclerosis ms,-2.6114638045215757,506.0
3382,846,controls patients,-2.614396456256927,454.0
3383,3374,system cns,-2.623639191290825,241.0
3384,130,identified patients,-2.639846743295019,795.0
3385,1572,sensitive detection,-2.65625,150.0
3386,369,signaling pathway,-2.659952038369303,282.0
3387,2977,aimed determine,-2.662528618672082,588.0
3388,515,retrospective analysis,-2.682592121982219,812.0
3389,3353,cholangiopancreatography ercp,-2.7076923076923123,253.0
3390,1015,motor cortex,-2.7173959445037386,439.0
3391,2126,mean arterial,-2.7245791245791224,238.0
3392,3537,difference groups,-2.724649298597208,412.0
3393,2335,patients treated,-2.7494099134539587,2410.0
3394,2167,classification system,-2.7529411764706326,351.0
3395,3023,low contrast,-2.7543624161073867,152.0
3396,2150,left side,-2.755450236966808,323.0
3397,505,raman spectroscopy,-2.7557364914877858,255.0
3398,494,current knowledge,-2.759649122807019,143.0
3399,847,novel technique,-2.764974245768952,244.0
3400,1319,external rotation,-2.768584758942452,207.0
3401,1253,multiple myeloma,-2.7780821917808276,169.0
3402,67,middle ear,-2.780520870495901,293.0
3403,3551,distal radius,-2.792307692307684,231.0
3404,3161,using diffusion,-2.81201413427562,173.0
3405,242,cervical cancer,-2.812242945958881,482.0
3406,361,hydrogen peroxide,-2.820359281437137,157.0
3407,1070,gray matter,-2.82182048842372,1534.0
3408,3080,mean diffusivity,-2.827220178665255,427.0
3409,3006,potential application,-2.8279909706546422,232.0
3410,2968,used estimate,-2.8345794392523436,337.0
3411,1566,blood vessels,-2.8369870713884313,515.0
3412,3062,matched control,-2.8623188405797135,158.0
3413,1395,range motion,-2.866423524048315,503.0
3414,1734,subgroup analysis,-2.8705248990578656,248.0
3415,2059,imaging using,-2.876200640341503,525.0
3416,3278,great potential,-2.8817629179331297,499.0
3417,3742,patients major,-2.8848484848484848,204.0
3418,571,aimed investigate,-2.888032454361072,791.0
3419,3214,cardiac cycle,-2.88900979325353,225.0
3420,1233,parietal lobe,-2.8999999999999977,203.0
3421,131,multivariate analysis,-2.903178133295088,1891.0
3422,3039,schizophrenia patients,-2.9041095890411,212.0
3423,1288,patients presented,-2.908097165991914,653.0
3424,2437,patients disease,-2.916369047619054,239.0
3425,3550,functional changes,-2.9180327868852474,178.0
3426,2891,years patients,-2.9370370370370322,793.0
3427,3521,diagnostic value,-2.954888139748692,497.0
3428,639,studies suggested,-2.9552238805969964,198.0
3429,2199,observational studies,-2.963128491620094,156.0
3430,3234,analyses revealed,-2.970370370370345,401.0
3431,1162,low bone,-2.987551867219915,225.0
3432,563,treatment outcomes,-2.9892617449664263,262.0
3433,2921,ventricle lv,-2.99240506329112,197.0
3434,583,time intervals,-3.006860158311346,154.0
3435,1456,functional groups,-3.015658362989334,223.0
3436,1693,bone volume,-3.031578947368421,306.0
3437,178,effective method,-3.060044150110386,239.0
3438,982,breast cancer,-3.0689053993268187,3973.0
3439,1634,heart rate,-3.088570106432212,972.0
3440,2249,cardiovascular diseases,-3.097178683385588,260.0
3441,1234,patients isolated,-3.102304147465434,198.0
3442,2830,lung nodules,-3.108108108108113,150.0
3443,875,resonance imaging,-3.1158752061388344,11670.0
3444,1000,tertiary care,-3.1186170212765973,286.0
3445,2375,stem cells,-3.129953917050677,1132.0
3446,341,range iqr,-3.133470225872701,218.0
3447,2500,fdg positron,-3.135135135135148,140.0
3448,93,nsclc patients,-3.1453250222618045,203.0
3449,3527,results indicated,-3.1465333107306326,649.0
3450,302,used evaluation,-3.16129032258067,140.0
3451,3348,diabetic retinopathy,-3.161627267729526,355.0
3452,1086,performed within,-3.166469893742621,298.0
3453,2760,commonly used,-3.1826792963464086,1120.0
3454,3186,survival os,-3.1874310915104718,413.0
3455,1733,patients mild,-3.223188405797103,278.0
3456,180,partial least,-3.243784786641938,186.0
3457,1714,quantitative analysis,-3.24722222222223,668.0
3458,2264,included total,-3.2484848484848454,134.0
3459,1441,differences patients,-3.2501240694789137,177.0
3460,1826,protein gfp,-3.257142857142849,114.0
3461,2372,neural correlates,-3.2658835046500325,457.0
3462,1644,contrast agent,-3.2683531495067086,1059.0
3463,2586,subcortical structures,-3.2805970149253785,157.0
3464,753,blood pressure,-3.2903050531708424,2231.0
3465,1127,motor area,-3.2918918918918996,261.0
3466,1470,cardiac magnetic,-3.2923076923077064,856.0
3467,1293,lv function,-3.2943127962085335,331.0
3468,1504,tomography cbct,-3.2971542025149,470.0
3469,1049,disease nafld,-3.31875,177.0
3470,1432,based upon,-3.3197278911564565,244.0
3471,3644,thirty patients,-3.323627684964208,211.0
3472,823,cell carcinoma,-3.3285044737963534,868.0
3473,3492,arterial pressure,-3.334731934731923,311.0
3474,789,mean value,-3.3543524416135915,259.0
3475,258,without need,-3.3638009049773685,354.0
3476,1959,density bmd,-3.370941883767542,623.0
3477,3022,brain tumors,-3.3727272727272632,371.0
3478,3378,memory task,-3.377955911823654,196.0
3479,3089,death patients,-3.3782608695652208,148.0
3480,1499,intracranial pressure,-3.4051813471502563,186.0
3481,674,appropriate treatment,-3.431088082901558,231.0
3482,2277,imaging modalities,-3.440201005025144,1141.0
3483,2039,inflammatory cells,-3.4540540540540667,142.0
3484,0,cerebrospinal fluid,-3.4629091613403062,941.0
3485,1771,often associated,-3.464516129032252,179.0
3486,1671,patients schizophrenia,-3.467244701348747,295.0
3487,1571,hundred patients,-3.4745614035087855,466.0
3488,79,pedicle screws,-3.491872791519427,183.0
3489,2514,previously described,-3.4980747451868734,468.0
3490,2678,computed tomographic,-3.498425898425906,818.0
3491,3549,cardiogenic shock,-3.510275689223057,149.0
3492,2732,grade iii,-3.515463917525765,155.0
3493,71,first step,-3.52617079889807,256.0
3494,2187,cognitive impairment,-3.5562535434856417,939.0
3495,881,weeks weeks,-3.5719626168224194,273.0
3496,379,investigated impact,-3.582938388625585,140.0
3497,998,novel method,-3.583525789068547,475.0
3498,1247,system based,-3.604651162790696,155.0
3499,1046,treatment strategies,-3.6081175106300742,331.0
3500,3557,metabolic syndrome,-3.608657630083062,393.0
3501,2952,many studies,-3.6168224299065486,215.0
3502,480,used determine,-3.6238109133352823,786.0
3503,2991,prognostic factors,-3.6276650682404994,443.0
3504,1,vs patients,-3.628762541806027,175.0
3505,363,fluorescence microscopy,-3.6311406155703354,872.0
3506,55,index ri,-3.634615384615405,135.0
3507,24,total subjects,-3.636363636363641,200.0
3508,1533,low high,-3.66164383561643,297.0
3509,2885,retrospectively reviewed,-3.675461741424818,1393.0
3510,2821,type ii,-3.689154568744644,800.0
3511,2065,negatively associated,-3.6970873786407785,224.0
3512,1417,imaging analysis,-3.6996978851963704,157.0
3513,3319,quality life,-3.7101482326111497,957.0
3514,3393,vitro studies,-3.7153846153846177,138.0
3515,2013,imaging technique,-3.739794754846073,713.0
3516,3334,matter lesions,-3.7421052631579013,158.0
3517,3016,men women,-3.74387510008007,1417.0
3518,932,middle cerebral,-3.7640977443608827,801.0
3519,3675,subjects mean,-3.76912751677851,216.0
3520,368,drug release,-3.777746980795897,533.0
3521,744,data available,-3.780368098159528,474.0
3522,3491,minor complications,-3.79336492890995,138.0
3523,1639,total lesion,-3.802416918429002,203.0
3524,3337,therapeutic target,-3.809150326797402,186.0
3525,776,cancer screening,-3.8102564102564,743.0
3526,3304,limb ischemia,-3.815217391304335,135.0
3527,2208,analysis included,-3.882352941176469,240.0
3528,252,diffraction xrd,-3.8851485148515024,327.0
3529,945,thoracic aortic,-3.888888888888896,200.0
3530,2971,median iqr,-3.90061349693252,187.0
3531,44,whereas patients,-3.909090909090897,215.0
3532,3028,frequently used,-3.9183856502241974,257.0
3533,1140,patients congenital,-3.9441176470588224,149.0
3534,1160,together findings,-3.969738339021622,239.0
3535,1751,studies showed,-3.9918575063613058,444.0
3536,238,potential therapeutic,-4.000226500566263,203.0
3537,1795,underlying mechanism,-4.021276595744701,189.0
3538,1403,provides evidence,-4.042487046632119,249.0
3539,266,image contrast,-4.04344941956883,167.0
3540,2288,analysis showed,-4.061016949152557,1797.0
3541,2733,obstructive sleep,-4.06153846153846,231.0
3542,479,planning target,-4.077272727272721,138.0
3543,935,laser scanning,-4.087444100447192,491.0
3544,42,lesions showed,-4.093548387096764,141.0
3545,337,attenuation correction,-4.1329341317365,203.0
3546,2918,quantum dots,-4.141856392294199,275.0
3547,518,univariate multivariate,-4.16439649359407,423.0
3548,2853,retrograde cholangiopancreatography,-4.169767441860478,326.0
3549,1696,novel approach,-4.185365853658552,312.0
3550,3003,catheter ablation,-4.190834697217671,217.0
3551,555,present first,-4.249076517150394,244.0
3552,841,presence absence,-4.2689574839837015,547.0
3553,3159,model used,-4.277507919746551,494.0
3554,419,frontal lobe,-4.326604181687093,353.0
3555,3274,patients diagnosed,-4.328934010152272,1066.0
3556,1745,review board,-4.379757785467115,610.0
3557,1307,ejection fraction,-4.384120171673743,2043.0
3558,328,tests performed,-4.392899408284021,232.0
3559,1021,adult patients,-4.394607843137261,815.0
3560,1186,renal function,-4.417849898580123,726.0
3561,3315,radical prostatectomy,-4.450267379679152,219.0
3562,244,adverse outcomes,-4.450267379679157,219.0
3563,794,imaging dti,-4.467346938775546,597.0
3564,1309,radiation dose,-4.500526131182055,1645.0
3565,2071,artery aneurysm,-4.529577464788738,201.0
3566,2009,patients type,-4.544723618090452,532.0
3567,1553,light microscopy,-4.548070907195009,464.0
3568,3275,using computed,-4.591093117408907,378.0
3569,3230,radiographic findings,-4.662695924764883,201.0
3570,2393,electron microscope,-4.698491379310353,507.0
3571,769,microscopy sem,-4.734872463228429,865.0
3572,187,experimental groups,-4.779069767441871,137.0
3573,1100,protein levels,-4.821040850587589,356.0
3574,2433,among participants,-4.823684210526308,141.0
3575,878,patients without,-4.852108803248896,2595.0
3576,827,fluorescence imaging,-4.885714285714284,648.0
3577,2429,structural brain,-4.888636363636361,239.0
3578,3219,uptake value,-4.902684563758403,487.0
3579,1721,surrogate marker,-4.905970149253738,173.0
3580,872,growth rate,-4.9163716814159235,271.0
3581,2273,medical management,-4.946604215456679,179.0
3582,3069,randomized receive,-4.9543378995433915,175.0
3583,953,physiological conditions,-4.988235294117657,216.0
3584,2737,endothelial growth,-5.010958904109568,413.0
3585,1841,infrared spectroscopy,-5.026442307692322,697.0
3586,2328,used model,-5.038610038610021,225.0
3587,1545,endoscopic retrograde,-5.068965517241399,336.0
3588,1770,among patients,-5.1013326365299125,1914.0
3589,1645,myocardial perfusion,-5.1122185942601766,740.0
3590,3351,patients used,-5.120689655172423,165.0
3591,2246,important factor,-5.145454545454551,283.0
3592,1477,findings demonstrate,-5.15527426160339,298.0
3593,3525,available patients,-5.228915662650609,217.0
3594,582,tissue engineering,-5.252348016017473,519.0
3595,2850,performed using,-5.257668711656466,1714.0
3596,2943,hematoxylin eosin,-5.259813084112163,134.0
3597,3064,however still,-5.261870503597141,159.0
3598,1029,ventricular volume,-5.292452830188679,187.0
3599,1703,poor outcomes,-5.320152091254739,212.0
3600,3114,lower patients,-5.356521739130455,448.0
3601,3281,effective treatment,-5.436199722607496,585.0
3602,1438,high levels,-5.469565217391286,357.0
3603,682,inferior parietal,-5.510290237467021,454.0
3604,2185,function tests,-5.610563380281688,257.0
3605,658,diagnostic therapeutic,-5.669916434540379,345.0
3606,1175,blood glucose,-5.695808383233544,164.0
3607,544,mean deviation,-5.769287020109701,509.0
3608,3581,used generate,-5.793893129770971,165.0
3609,3083,recently proposed,-5.821752265861012,205.0
3610,3620,decision making,-5.8900255754475666,490.0
3611,825,activation patterns,-5.892700729927016,207.0
3612,3700,unclear whether,-5.895219885277299,328.0
3613,1213,complete resection,-5.901319261213731,211.0
3614,1679,studies evaluated,-5.928571428571435,166.0
3615,309,confocal laser,-5.9455245428296255,461.0
3616,673,vivo imaging,-5.976744186046524,514.0
3617,2115,ventricular ejection,-6.091417910447789,653.0
3618,2242,tumor volume,-6.12500000000001,700.0
3619,290,specificity sensitivity,-6.130057803468219,303.0
3620,435,assessed using,-6.189550634272186,1822.0
3621,1345,potential applications,-6.225900681596905,278.0
3622,1324,independent observers,-6.249999999999992,125.0
3623,2254,patients prostate,-6.319626168224354,161.0
3624,23,fourier transform,-6.366526757607553,731.0
3625,2797,disease course,-6.402985074626913,143.0
3626,2401,cervical spine,-6.4085430968725845,712.0
3627,3614,diffusion tensor,-6.5920844327177575,1388.0
3628,237,intraclass coefficients,-6.627848101265832,238.0
3629,3100,heart failure,-6.637723872137728,2185.0
3630,101,visual field,-6.642651296829995,461.0
3631,1567,different methods,-6.695035460992939,295.0
3632,2313,quality control,-6.784074941452002,204.0
3633,2153,bipolar disorder,-6.857142857142894,400.0
3634,1947,lv mass,-6.934782608695624,580.0
3635,340,liver disease,-6.977256216820347,766.0
3636,3104,median years,-7.0639556377079264,1124.0
3637,3109,followed months,-7.079300291545211,213.0
3638,1331,tuberculosis tb,-7.137254901960829,140.0
3639,2298,detection rate,-7.180721466587812,557.0
3640,3175,gene expression,-7.181205505457954,934.0
3641,903,right ventricular,-7.201021856372397,1458.0
3642,2201,overall survival,-7.236656173487352,1544.0
3643,378,gleason score,-7.237327188940117,349.0
3644,3229,served controls,-7.266666666666788,109.0
3645,3158,new technique,-7.285714285714269,195.0
3646,907,identifying patients,-7.286227544910163,156.0
3647,2030,popliteal artery,-7.432524271844672,251.0
3648,1449,results showed,-7.461295001978127,1951.0
3649,3598,time points,-7.513621262458416,1028.0
3650,2058,highlight importance,-7.592771084337362,137.0
3651,3325,patients excluded,-7.650205761316834,169.0
3652,506,within weeks,-7.723529411764637,202.0
3653,3134,due high,-7.738582677165377,252.0
3654,2139,disease cvd,-7.7559322033897935,176.0
3655,3210,multivariate analyses,-7.863414634146319,403.0
3656,1182,major role,-8.019631901840498,152.0
3657,2630,imaging findings,-8.022188905547242,1274.0
3658,2730,high frequency,-8.034482758620664,233.0
3659,2020,basal ganglia,-8.106824385805288,958.0
3660,3449,preoperative planning,-8.109821428571449,293.0
3661,1850,male patients,-8.174273858921188,394.0
3662,2095,target volume,-8.28223844282232,460.0
3663,2376,iron oxide,-8.342007434944218,440.0
3664,651,failure patients,-8.348031496062967,171.0
3665,1050,adverse events,-8.350757575757582,1359.0
3666,2342,resonance mr,-8.359459459459393,1031.0
3667,3101,surgical procedures,-8.36040609137054,366.0
3668,1592,diffusion coefficient,-8.443594646271436,960.0
3669,2116,prognosis patients,-8.456603773584863,297.0
3670,2960,provide valuable,-8.565517241379307,184.0
3671,863,cardiovascular mortality,-8.577272727272709,222.0
3672,1626,examined using,-8.654970760233907,400.0
3673,994,results indicate,-8.690462143559568,1498.0
3674,2527,cases cases,-8.704347826086988,273.0
3675,460,showed reduction,-8.801954397394155,229.0
3676,2398,used analyze,-8.847457627118676,290.0
3677,2974,basilar artery,-8.87108433734936,199.0
3678,1322,six patients,-8.908045977011488,775.0
3679,2352,stem cell,-8.926123414319473,827.0
3680,2441,assessed patients,-8.962962962963028,242.0
3681,3326,present results,-9.05868263473057,244.0
3682,1076,imaging performed,-9.123122238586191,659.0
3683,1199,provide first,-9.23673469387756,219.0
3684,649,aim identify,-9.277777777777713,167.0
3685,3479,adc values,-9.315789473684205,885.0
3686,1039,recently introduced,-9.537254901960736,128.0
3687,735,node metastases,-9.612919896640834,209.0
3688,3283,acute phase,-9.712500000000002,259.0
3689,1842,assess impact,-9.745748987854272,236.0
3690,1202,associated mortality,-9.78691588785047,308.0
3691,2981,alkaline phosphatase,-9.98375634517771,298.0
3692,877,percent patients,-10.096969696969657,196.0
3693,1862,therapeutic potential,-10.181818181818148,140.0
3694,2948,microscopy analysis,-10.333333333333352,155.0
3695,938,differences observed,-10.537284894837423,501.0
3696,3618,cardiac function,-10.626691042047565,692.0
3697,1856,microscopy tem,-10.680076997112597,491.0
3698,1347,using test,-10.69014084507044,230.0
3699,936,transmission electron,-11.17218132506774,1683.0
3700,1586,imaging protocols,-11.226168224299071,154.0
3701,195,mouse models,-11.446153846153845,248.0
3702,2888,waist circumference,-11.500000000000034,230.0
3703,36,fmri studies,-11.62923976608192,163.0
3704,1834,using single,-11.982524271844627,187.0
3705,2109,described literature,-12.327272727272689,226.0
3706,1877,brain structure,-12.749999999999865,459.0
3707,572,biomedical applications,-12.761904761904722,335.0
3708,263,underlying mechanisms,-12.937499999999941,345.0
3709,1167,histological analysis,-12.97872340425532,244.0
3710,1922,magnetic resonance,-13.264287545213723,16284.0
3711,2226,measurements performed,-13.390291262135992,431.0
3712,686,patients renal,-13.674418604651196,196.0
3713,2618,underwent coronary,-13.687150837988893,250.0
3714,1414,could provide,-14.062500000000014,375.0
3715,3356,inferior vena,-14.073684210526432,382.0
3716,236,curve auc,-14.136512667660151,668.0
3717,3467,extracellular matrix,-14.14100719424463,468.0
3718,334,diagnostic performance,-14.168206229860473,1306.0
3719,2744,studies patients,-14.295652173913055,274.0
3720,893,femoral neck,-14.546551724138027,767.0
3721,3120,subjects patients,-15.061728395061749,244.0
3722,3061,associated poor,-15.072392638036716,332.0
3723,2050,specificity respectively,-15.191011235955052,312.0
3724,3381,years median,-15.355670103092919,331.0
3725,1024,showed similar,-15.46626506024095,389.0
3726,56,within month,-15.690322580645015,128.0
3727,4,intervention patients,-15.727272727272773,173.0
3728,233,exclusion criteria,-16.170731707317113,221.0
3729,2473,transform infrared,-16.34355518112896,651.0
3730,713,white matter,-16.360933305802025,4402.0
3731,315,five different,-17.099999999999866,171.0
3732,436,feasibility using,-17.678571428571612,225.0
3733,852,failure hf,-17.686956521739074,226.0
3734,2409,within months,-17.947169811320848,464.0
3735,163,published periodicals,-18.719371727748793,303.0
3736,3099,rat model,-18.883367556468063,351.0
3737,1371,cerebral artery,-20.1161494616848,951.0
3738,2902,antibiotic therapy,-20.215789473684275,167.0
3739,1888,anterior insula,-20.512280701754463,222.0
3740,295,wide range,-20.92330383480835,865.0
3741,2957,included mean,-23.148936170212682,320.0
3742,3136,data analysis,-24.047058823529447,392.0
3743,184,retrospective series,-28.894117647058582,307.0
3744,646,standardized uptake,-29.6191780821921,569.0
3745,91,direct current,-30.0521739130437,128.0
3746,1336,better understand,-30.3157894736837,360.0
3747,3498,pulmonary hypertension,-30.86640726329463,730.0
3748,2225,techniques including,-32.00000000000015,160.0
3749,246,signal intensities,-37.58421052631584,193.0
3750,2878,differences groups,-43.25371024734963,572.0
3751,2765,aim present,-45.49434571890172,745.0
3752,2926,board approval,-49.16250000000047,171.0
3753,2682,patients asymptomatic,-49.775000000000105,181.0
3754,1954,analyzed using,-51.148672566372085,1014.0
3755,133,different types,-52.75337423312991,518.0
3756,3531,scanning electron,-60.40656668017773,2443.0
3757,1702,different techniques,-93.00000000000014,155.0
3758,1652,patients ischemic,-101.77500000000151,177.0
3759,620,matched controls,-103.02500000000038,317.0
3760,1912,nanoparticles nps,-151.11428571428928,258.0
